DE102004028751A1 - New 4-heterocyclyl-1-acyl-piperidine derivatives, useful e.g. for treating headache, diabetes and cardiovascular disease, are antagonists of calcitonin-gene related peptide - Google Patents
New 4-heterocyclyl-1-acyl-piperidine derivatives, useful e.g. for treating headache, diabetes and cardiovascular disease, are antagonists of calcitonin-gene related peptide Download PDFInfo
- Publication number
- DE102004028751A1 DE102004028751A1 DE200410028751 DE102004028751A DE102004028751A1 DE 102004028751 A1 DE102004028751 A1 DE 102004028751A1 DE 200410028751 DE200410028751 DE 200410028751 DE 102004028751 A DE102004028751 A DE 102004028751A DE 102004028751 A1 DE102004028751 A1 DE 102004028751A1
- Authority
- DE
- Germany
- Prior art keywords
- oxo
- piperidin
- ylmethyl
- dihydro
- tetrahydro
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 208000024172 Cardiovascular disease Diseases 0.000 title claims description 3
- 206010019233 Headaches Diseases 0.000 title claims description 3
- 231100000869 headache Toxicity 0.000 title claims description 3
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 title description 7
- 239000005557 antagonist Substances 0.000 title description 3
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract description 59
- 239000000203 mixture Substances 0.000 claims abstract description 46
- 150000003839 salts Chemical class 0.000 claims abstract description 32
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 238000000034 method Methods 0.000 claims abstract description 18
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000003814 drug Substances 0.000 claims abstract description 8
- 150000007522 mineralic acids Chemical class 0.000 claims abstract description 4
- 150000007524 organic acids Chemical class 0.000 claims abstract description 4
- 235000005985 organic acids Nutrition 0.000 claims abstract description 4
- -1 1H-indazol-5-ylmethyl Chemical group 0.000 claims description 1168
- GOHSCIHNZMVWTO-UHFFFAOYSA-N 4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1N1C(=O)NC2=CC=CC=C2CC1 GOHSCIHNZMVWTO-UHFFFAOYSA-N 0.000 claims description 84
- GRHLCKUKYPZZNW-UHFFFAOYSA-N 4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidine-1-carboxylic acid Chemical compound C1CN(C(=O)O)CCC1N1C(=O)NC(C=2C=CC=CC=2)=N1 GRHLCKUKYPZZNW-UHFFFAOYSA-N 0.000 claims description 45
- 125000004484 1-methylpiperidin-4-yl group Chemical group CN1CCC(CC1)* 0.000 claims description 38
- RWTNPBWLLIMQHL-UHFFFAOYSA-N fexofenadine Chemical compound C1=CC(C(C)(C(O)=O)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 RWTNPBWLLIMQHL-UHFFFAOYSA-N 0.000 claims description 38
- 125000004194 piperazin-1-yl group Chemical group [H]N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 28
- 125000004195 4-methylpiperazin-1-yl group Chemical group [H]C([H])([H])N1C([H])([H])C([H])([H])N(*)C([H])([H])C1([H])[H] 0.000 claims description 27
- 238000004519 manufacturing process Methods 0.000 claims description 18
- 238000006243 chemical reaction Methods 0.000 claims description 16
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 12
- 150000004677 hydrates Chemical class 0.000 claims description 12
- 150000003254 radicals Chemical class 0.000 claims description 12
- 125000001255 4-fluorophenyl group Chemical group [H]C1=C([H])C(*)=C([H])C([H])=C1F 0.000 claims description 11
- 229910052757 nitrogen Inorganic materials 0.000 claims description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 10
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 10
- 150000001412 amines Chemical class 0.000 claims description 8
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 8
- RFSSPVKNWPBMGC-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(C)C=2)CC1 RFSSPVKNWPBMGC-UHFFFAOYSA-N 0.000 claims description 7
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 7
- 239000000460 chlorine Substances 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- WWDIMHNQCZZVBR-UHFFFAOYSA-N 2-[(1-methylindazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=C2N(C)N=CC2=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 WWDIMHNQCZZVBR-UHFFFAOYSA-N 0.000 claims description 5
- 201000010099 disease Diseases 0.000 claims description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 5
- 150000003141 primary amines Chemical class 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- WSDBFOFLZFVDHZ-UHFFFAOYSA-N 1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-2-[[7-(trifluoromethyl)-1h-indazol-5-yl]methyl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(C=2)C(F)(F)F)CC1 WSDBFOFLZFVDHZ-UHFFFAOYSA-N 0.000 claims description 4
- UOEBWJXYOFGXGI-UHFFFAOYSA-N 1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-2-[[7-(trifluoromethyl)-1h-indazol-5-yl]methyl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(C=2)C(F)(F)F)CC1 UOEBWJXYOFGXGI-UHFFFAOYSA-N 0.000 claims description 4
- QRLSZUJLPAFPMA-UHFFFAOYSA-N 1-[4-(4-fluorophenyl)piperazin-1-yl]-2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1=CC(F)=CC=C1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=CC=2)CC1 QRLSZUJLPAFPMA-UHFFFAOYSA-N 0.000 claims description 4
- NQBUSMVLSKZSIH-UHFFFAOYSA-N 1-[4-(4-fluorophenyl)piperidin-1-yl]-2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1=CC(F)=CC=C1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=CC=2)CC1 NQBUSMVLSKZSIH-UHFFFAOYSA-N 0.000 claims description 4
- XXIOTYQIXIXURU-UHFFFAOYSA-N 1-[4-(dimethylamino)piperidin-1-yl]-2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CC(N(C)C)CCN1C(=O)C(CC=1C=C2C=NNC2=CC=1)CC(=O)N1CCC(N2C(NC3=CC=CC=C3CC2)=O)CC1 XXIOTYQIXIXURU-UHFFFAOYSA-N 0.000 claims description 4
- JEAPKQNDMABVJM-UHFFFAOYSA-N 1-[4-(dimethylamino)piperidin-1-yl]-2-(1h-indazol-5-ylmethyl)-4-[4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CC(N(C)C)CCN1C(=O)C(CC=1C=C2C=NNC2=CC=1)CC(=O)N1CCC(N2C(NC(=N2)C=2C=CC=CC=2)=O)CC1 JEAPKQNDMABVJM-UHFFFAOYSA-N 0.000 claims description 4
- NWHIBYVNWIJHMQ-UHFFFAOYSA-N 1-[4-(dimethylamino)piperidin-1-yl]-2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CC(N(C)C)CCN1C(=O)C(CC=1C=C2C=NNC2=C(C)C=1)CC(=O)N1CCC(N2C(NC3=CC=CC=C3CC2)=O)CC1 NWHIBYVNWIJHMQ-UHFFFAOYSA-N 0.000 claims description 4
- LDXXELUVIUNIRO-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)-1,4-diazepan-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=CC=2)CCC1 LDXXELUVIUNIRO-UHFFFAOYSA-N 0.000 claims description 4
- QVWBPCBGNLDSBR-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC(=N2)C=2C=CC=CC=2)=O)CC=2C=C3C=NNC3=CC=2)CC1 QVWBPCBGNLDSBR-UHFFFAOYSA-N 0.000 claims description 4
- JIGKSOBXBLBSSV-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=CC=2)CC1 JIGKSOBXBLBSSV-UHFFFAOYSA-N 0.000 claims description 4
- BBAQRHFPIUJPLH-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC(=N2)C=2C=CC=CC=2)=O)CC=2C=C3C=NNC3=CC=2)CC1 BBAQRHFPIUJPLH-UHFFFAOYSA-N 0.000 claims description 4
- PNXMCDSJUBORSM-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-1-[4-(1-methylsulfonylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(S(=O)(=O)C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=CC=2)CC1 PNXMCDSJUBORSM-UHFFFAOYSA-N 0.000 claims description 4
- XGLSJNFWCDRXLY-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-1-[4-(4-methyl-1,4-diazepan-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=CC=2)CC1 XGLSJNFWCDRXLY-UHFFFAOYSA-N 0.000 claims description 4
- VBQWUURFPKHWLX-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC(=N2)C=2C=CC=CC=2)=O)CC=2C=C3C=NNC3=CC=2)CC1 VBQWUURFPKHWLX-UHFFFAOYSA-N 0.000 claims description 4
- CCEIZWFCMPPTLL-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCCCC1 CCEIZWFCMPPTLL-UHFFFAOYSA-N 0.000 claims description 4
- ZPFLALZYSGICAB-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1C1CCNCC1 ZPFLALZYSGICAB-UHFFFAOYSA-N 0.000 claims description 4
- MAKURRXRRNLCAI-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC(=N2)C=2C=CC=CC=2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCNCC1 MAKURRXRRNLCAI-UHFFFAOYSA-N 0.000 claims description 4
- JQKMYOKCVXDSFQ-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC(=N2)C=2C=CC=CC=2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCCCC1 JQKMYOKCVXDSFQ-UHFFFAOYSA-N 0.000 claims description 4
- RBTAUXBDAUKZIM-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC(=N2)C=2C=CC=CC=2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCN1C1CCNCC1 RBTAUXBDAUKZIM-UHFFFAOYSA-N 0.000 claims description 4
- RXVRIEYJKOLFIM-UHFFFAOYSA-N 2-(1h-indol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=CNC3=CC=2)CC1 RXVRIEYJKOLFIM-UHFFFAOYSA-N 0.000 claims description 4
- HFLDDQPKRKQOGL-UHFFFAOYSA-N 2-(1h-indol-5-ylmethyl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=CNC3=CC=2)CC1 HFLDDQPKRKQOGL-UHFFFAOYSA-N 0.000 claims description 4
- WFVOWEMPXYYRBC-UHFFFAOYSA-N 2-(1h-indol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=CNC2=CC=1)C(=O)N(CC1)CCC1C1CCNCC1 WFVOWEMPXYYRBC-UHFFFAOYSA-N 0.000 claims description 4
- QFOHJFSCEOHQPM-UHFFFAOYSA-N 2-(2h-benzotriazol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3N=NNC3=CC=2)CC1 QFOHJFSCEOHQPM-UHFFFAOYSA-N 0.000 claims description 4
- JAILYKIPLHBCHU-UHFFFAOYSA-N 2-(2h-benzotriazol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3N=NNC3=CC=2)CC1 JAILYKIPLHBCHU-UHFFFAOYSA-N 0.000 claims description 4
- UBVHUWDDAGZNJZ-UHFFFAOYSA-N 2-[(1,7-dimethylindazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NN(C)C3=C(C)C=2)CC1 UBVHUWDDAGZNJZ-UHFFFAOYSA-N 0.000 claims description 4
- MFCIHRVGFISLLL-UHFFFAOYSA-N 2-[(1,7-dimethylindazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NN(C)C3=C(C)C=2)CC1 MFCIHRVGFISLLL-UHFFFAOYSA-N 0.000 claims description 4
- PVXSFRYHAWGEAA-UHFFFAOYSA-N 2-[(1,7-dimethylindazol-5-yl)methyl]-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NN(C)C3=C(C)C=2)CC1 PVXSFRYHAWGEAA-UHFFFAOYSA-N 0.000 claims description 4
- ALFGMMMQWSWUAD-UHFFFAOYSA-N 2-[(1,7-dimethylindazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NN(C)C=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 ALFGMMMQWSWUAD-UHFFFAOYSA-N 0.000 claims description 4
- LUBYFZHVWICPOD-UHFFFAOYSA-N 2-[(1,7-dimethylindazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NN(C)C=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 LUBYFZHVWICPOD-UHFFFAOYSA-N 0.000 claims description 4
- ZGYCDUQTFFLZQV-UHFFFAOYSA-N 2-[(1-methylindazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NN(C)C3=CC=2)CC1 ZGYCDUQTFFLZQV-UHFFFAOYSA-N 0.000 claims description 4
- ARUHBIPOIIYYBY-UHFFFAOYSA-N 2-[(1-methylindazol-5-yl)methyl]-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NN(C)C3=CC=2)CC1 ARUHBIPOIIYYBY-UHFFFAOYSA-N 0.000 claims description 4
- CFZNTRPKVRIPOV-UHFFFAOYSA-N 2-[(1-methylindazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C=1C=C2N(C)N=CC2=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 CFZNTRPKVRIPOV-UHFFFAOYSA-N 0.000 claims description 4
- FKCVLTZZDWOVFK-UHFFFAOYSA-N 2-[(7-bromo-1h-indazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(Br)C=2)CC1 FKCVLTZZDWOVFK-UHFFFAOYSA-N 0.000 claims description 4
- OPUBEUINTGAXAV-UHFFFAOYSA-N 2-[(7-bromo-1h-indazol-5-yl)methyl]-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(Br)C=2)CC1 OPUBEUINTGAXAV-UHFFFAOYSA-N 0.000 claims description 4
- ABTADQJPOZKKRP-UHFFFAOYSA-N 2-[(7-bromo-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(Br)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 ABTADQJPOZKKRP-UHFFFAOYSA-N 0.000 claims description 4
- NRSYDJINSQVESQ-UHFFFAOYSA-N 2-[(7-bromo-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(Br)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 NRSYDJINSQVESQ-UHFFFAOYSA-N 0.000 claims description 4
- BQQWMXCTIXPKCJ-UHFFFAOYSA-N 2-[(7-chloro-1h-indazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(Cl)C=2)CC1 BQQWMXCTIXPKCJ-UHFFFAOYSA-N 0.000 claims description 4
- MPYCDTJAJDAZDT-UHFFFAOYSA-N 2-[(7-chloro-1h-indazol-5-yl)methyl]-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(Cl)C=2)CC1 MPYCDTJAJDAZDT-UHFFFAOYSA-N 0.000 claims description 4
- LMIDZLBXECWYPA-UHFFFAOYSA-N 2-[(7-chloro-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(Cl)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 LMIDZLBXECWYPA-UHFFFAOYSA-N 0.000 claims description 4
- VWKVWOUITMFQDZ-UHFFFAOYSA-N 2-[(7-chloro-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(Cl)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 VWKVWOUITMFQDZ-UHFFFAOYSA-N 0.000 claims description 4
- BYUDNPGSSRBZPH-UHFFFAOYSA-N 2-[(7-chloro-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(Cl)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 BYUDNPGSSRBZPH-UHFFFAOYSA-N 0.000 claims description 4
- NGKLZJCGCOZNCZ-UHFFFAOYSA-N 2-[(7-ethyl-1h-indazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCN(C)CC1 NGKLZJCGCOZNCZ-UHFFFAOYSA-N 0.000 claims description 4
- XZJRQMCZUMIIMF-UHFFFAOYSA-N 2-[(7-ethyl-1h-indazol-5-yl)methyl]-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCN(C)CC1 XZJRQMCZUMIIMF-UHFFFAOYSA-N 0.000 claims description 4
- UQIMMKCOGWQZKV-UHFFFAOYSA-N 2-[(7-ethyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 UQIMMKCOGWQZKV-UHFFFAOYSA-N 0.000 claims description 4
- ATWMCCCIVBMWPI-UHFFFAOYSA-N 2-[(7-ethyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 ATWMCCCIVBMWPI-UHFFFAOYSA-N 0.000 claims description 4
- GTHPXKILNSXABW-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 GTHPXKILNSXABW-UHFFFAOYSA-N 0.000 claims description 4
- AVQYBBNRZPTECQ-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 AVQYBBNRZPTECQ-UHFFFAOYSA-N 0.000 claims description 4
- DPECPILRSYPHMK-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 DPECPILRSYPHMK-UHFFFAOYSA-N 0.000 claims description 4
- HZLNKUXJWQBCFZ-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-pyridin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1=CC=NC=C1 HZLNKUXJWQBCFZ-UHFFFAOYSA-N 0.000 claims description 4
- GUTYZGFFKLQMOW-UHFFFAOYSA-N 2-[(7-methyl-1h-indol-5-yl)methyl]-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=CNC3=C(C)C=2)CC1 GUTYZGFFKLQMOW-UHFFFAOYSA-N 0.000 claims description 4
- YDZKRJZVQLIZLS-UHFFFAOYSA-N 2-[(7-methyl-1h-indol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=CNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 YDZKRJZVQLIZLS-UHFFFAOYSA-N 0.000 claims description 4
- JHNPWKMDUBIBFI-UHFFFAOYSA-N 2-[(7-methyl-2h-benzotriazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3N=NNC3=C(C)C=2)CC1 JHNPWKMDUBIBFI-UHFFFAOYSA-N 0.000 claims description 4
- DWRSHKHNLIAJHD-UHFFFAOYSA-N 2-[(7-methyl-2h-benzotriazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2N=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 DWRSHKHNLIAJHD-UHFFFAOYSA-N 0.000 claims description 4
- CVASQQZUCJQTFC-UHFFFAOYSA-N 2-[(7-methyl-2h-benzotriazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C=1C=2N=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 CVASQQZUCJQTFC-UHFFFAOYSA-N 0.000 claims description 4
- PTQZASHZCCXSDX-UHFFFAOYSA-N 4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)-2-[[7-(trifluoromethyl)-1h-indazol-5-yl]methyl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C(F)(F)F)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 PTQZASHZCCXSDX-UHFFFAOYSA-N 0.000 claims description 4
- 229940127597 CGRP antagonist Drugs 0.000 claims description 4
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 4
- 150000004649 carbonic acid derivatives Chemical class 0.000 claims description 4
- 229940088597 hormone Drugs 0.000 claims description 4
- 239000005556 hormone Substances 0.000 claims description 4
- 230000002757 inflammatory effect Effects 0.000 claims description 4
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims description 4
- KSWYDNAENGHWKD-UHFFFAOYSA-N n-[1-[4-(dimethylamino)piperidin-1-yl]-3-(1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N(C)C)CCN1C(=O)C(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)CC1=CC=C(NN=C2)C2=C1 KSWYDNAENGHWKD-UHFFFAOYSA-N 0.000 claims description 4
- IZPRHTFVGYTZPK-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCCCC1 IZPRHTFVGYTZPK-UHFFFAOYSA-N 0.000 claims description 4
- DIGXJMONEQSRHX-UHFFFAOYSA-N n-[3-(1h-indol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=CNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 DIGXJMONEQSRHX-UHFFFAOYSA-N 0.000 claims description 4
- TWSXEZBAFOYZDB-UHFFFAOYSA-N n-[3-(1h-indol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=CNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 TWSXEZBAFOYZDB-UHFFFAOYSA-N 0.000 claims description 4
- CHYSPZZTCUWIOS-UHFFFAOYSA-N n-[3-(1h-indol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=CNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 CHYSPZZTCUWIOS-UHFFFAOYSA-N 0.000 claims description 4
- JZIIHPVBJXXSAS-UHFFFAOYSA-N n-[3-(7-bromo-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(Br)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 JZIIHPVBJXXSAS-UHFFFAOYSA-N 0.000 claims description 4
- IOZKQJFCJXMVLB-UHFFFAOYSA-N n-[3-(7-bromo-1h-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(Br)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 IOZKQJFCJXMVLB-UHFFFAOYSA-N 0.000 claims description 4
- YZZJCHIBBGLKKW-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-[4-(1-methylsulfonylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCN(S(C)(=O)=O)CC1 YZZJCHIBBGLKKW-UHFFFAOYSA-N 0.000 claims description 4
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 4
- 150000003335 secondary amines Chemical class 0.000 claims description 4
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 4
- IYOUDBOSUPHKQI-UHFFFAOYSA-N 1-[4-(1,4-diazepan-1-yl)piperidin-1-yl]-2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCCNCC1 IYOUDBOSUPHKQI-UHFFFAOYSA-N 0.000 claims description 3
- KYRHKXZXMXCLAG-UHFFFAOYSA-N 1-[4-(4-fluorophenyl)piperazin-1-yl]-2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1=CC=C(F)C=C1 KYRHKXZXMXCLAG-UHFFFAOYSA-N 0.000 claims description 3
- HBMOEKOGIULTSS-UHFFFAOYSA-N 1-[4-(4-fluorophenyl)piperidin-1-yl]-2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1=CC=C(F)C=C1 HBMOEKOGIULTSS-UHFFFAOYSA-N 0.000 claims description 3
- XHTKIZOGTCKYTC-UHFFFAOYSA-N 1-[4-(4-methyl-1,4-diazepan-1-yl)piperidin-1-yl]-2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(C)C=2)CC1 XHTKIZOGTCKYTC-UHFFFAOYSA-N 0.000 claims description 3
- FIKNHBQEIFWZBE-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCNCC1 FIKNHBQEIFWZBE-UHFFFAOYSA-N 0.000 claims description 3
- YKMAWWQFZCYJOG-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-yl-1,4-diazepan-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCCN1C1CCNCC1 YKMAWWQFZCYJOG-UHFFFAOYSA-N 0.000 claims description 3
- MYXRARGXENVRGP-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCN1C1CCNCC1 MYXRARGXENVRGP-UHFFFAOYSA-N 0.000 claims description 3
- HHLNFGCMKQTFPE-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-pyridin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCN1C1=CC=NC=C1 HHLNFGCMKQTFPE-UHFFFAOYSA-N 0.000 claims description 3
- ITYWUFNHYXRDLZ-UHFFFAOYSA-N 2-(1h-indol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=CNC2=CC=1)C(=O)N(CC1)CCN1C1CCNCC1 ITYWUFNHYXRDLZ-UHFFFAOYSA-N 0.000 claims description 3
- HARVKCSHDHJESZ-UHFFFAOYSA-N 2-(2h-benzotriazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2N=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCNCC1 HARVKCSHDHJESZ-UHFFFAOYSA-N 0.000 claims description 3
- KKAWSKUSUJIFQR-UHFFFAOYSA-N 2-(2h-benzotriazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2N=NNC2=CC=1)C(=O)N(CC1)CCN1C1CCNCC1 KKAWSKUSUJIFQR-UHFFFAOYSA-N 0.000 claims description 3
- GOEQCLTXWYXCGV-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)-1,4-diazepan-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(C)C=2)CCC1 GOEQCLTXWYXCGV-UHFFFAOYSA-N 0.000 claims description 3
- IIAGZQLYIQBUTQ-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(C)C=2)CC1 IIAGZQLYIQBUTQ-UHFFFAOYSA-N 0.000 claims description 3
- PZMUJDBBGZUSRY-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCCCC1 PZMUJDBBGZUSRY-UHFFFAOYSA-N 0.000 claims description 3
- IMOLZKDDDDTYFR-UHFFFAOYSA-N 2-[(7-methyl-1h-indol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=CNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 IMOLZKDDDDTYFR-UHFFFAOYSA-N 0.000 claims description 3
- VKKPYVVWYLTYGT-UHFFFAOYSA-N 2-[(7-methyl-1h-indol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=CNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 VKKPYVVWYLTYGT-UHFFFAOYSA-N 0.000 claims description 3
- POZRQHMPEFIMQJ-UHFFFAOYSA-N 4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)-2-[[7-(trifluoromethyl)-1h-indazol-5-yl]methyl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C(F)(F)F)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 POZRQHMPEFIMQJ-UHFFFAOYSA-N 0.000 claims description 3
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 3
- 208000019695 Migraine disease Diseases 0.000 claims description 3
- 230000001154 acute effect Effects 0.000 claims description 3
- 230000017531 blood circulation Effects 0.000 claims description 3
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims description 3
- 239000003085 diluting agent Substances 0.000 claims description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 3
- 229910052739 hydrogen Inorganic materials 0.000 claims description 3
- 239000001257 hydrogen Substances 0.000 claims description 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 3
- FDCKZGZTUPFHIG-UHFFFAOYSA-N methyl 2-[4-[1-[3-(7-methyl-1h-indazol-5-yl)-2-[[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carbonyl]amino]propanoyl]piperidin-4-yl]piperidin-1-yl]acetate Chemical compound C1CN(CC(=O)OC)CCC1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 FDCKZGZTUPFHIG-UHFFFAOYSA-N 0.000 claims description 3
- 206010027599 migraine Diseases 0.000 claims description 3
- YAPITGBABBVFNA-UHFFFAOYSA-N n-[1-[4-(1,4-diazepan-1-yl)piperidin-1-yl]-3-(1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCCNCC1 YAPITGBABBVFNA-UHFFFAOYSA-N 0.000 claims description 3
- LZOMUYLVFIQXPC-UHFFFAOYSA-N n-[1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxo-3-[7-(trifluoromethyl)-1h-indazol-5-yl]propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(C=2)C(F)(F)F)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 LZOMUYLVFIQXPC-UHFFFAOYSA-N 0.000 claims description 3
- KVIBIYSZSOTIDM-UHFFFAOYSA-N n-[1-[4-(dimethylamino)piperidin-1-yl]-3-(7-methyl-1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N(C)C)CCN1C(=O)C(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)CC1=CC(C)=C(NN=C2)C2=C1 KVIBIYSZSOTIDM-UHFFFAOYSA-N 0.000 claims description 3
- ACBUOLKZSUMZRW-UHFFFAOYSA-N n-[3-(1,7-dimethylindazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=NN(C)C3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 ACBUOLKZSUMZRW-UHFFFAOYSA-N 0.000 claims description 3
- JUXUUWNZVAJNRI-UHFFFAOYSA-N n-[3-(1,7-dimethylindazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=NN(C)C3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 JUXUUWNZVAJNRI-UHFFFAOYSA-N 0.000 claims description 3
- COWDMCMLTYKOTH-UHFFFAOYSA-N n-[3-(1,7-dimethylindazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NN(C)C=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 COWDMCMLTYKOTH-UHFFFAOYSA-N 0.000 claims description 3
- MUEDLTZWDHCUEZ-UHFFFAOYSA-N n-[3-(1-methylindazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=NN(C)C3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 MUEDLTZWDHCUEZ-UHFFFAOYSA-N 0.000 claims description 3
- ILKWMVQYAGBHIC-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)-1,4-diazepan-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CCC1 ILKWMVQYAGBHIC-UHFFFAOYSA-N 0.000 claims description 3
- DBMVUFBNYQDJKJ-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 DBMVUFBNYQDJKJ-UHFFFAOYSA-N 0.000 claims description 3
- FFWADUFIOWFLQH-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC(=N2)C=2C=CC=CC=2)=O)CC1 FFWADUFIOWFLQH-UHFFFAOYSA-N 0.000 claims description 3
- VOOOBUKYUWZWML-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 VOOOBUKYUWZWML-UHFFFAOYSA-N 0.000 claims description 3
- NFDKEYJQGCQZHA-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC(=N2)C=2C=CC=CC=2)=O)CC1 NFDKEYJQGCQZHA-UHFFFAOYSA-N 0.000 claims description 3
- GDBPMSFWSBCXJW-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC(=N2)C=2C=CC=CC=2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCNCC1 GDBPMSFWSBCXJW-UHFFFAOYSA-N 0.000 claims description 3
- RFHSNDHHMMIAQG-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-yl-1,4-diazepan-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCCN1C1CCNCC1 RFHSNDHHMMIAQG-UHFFFAOYSA-N 0.000 claims description 3
- HMUQUWRVMLAGKX-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCN1C1CCNCC1 HMUQUWRVMLAGKX-UHFFFAOYSA-N 0.000 claims description 3
- WLKINYUEVIRDDL-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCN1C1=CC=NC=C1 WLKINYUEVIRDDL-UHFFFAOYSA-N 0.000 claims description 3
- HCLHGMFJOGZJEX-UHFFFAOYSA-N n-[3-(1h-indol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=CNC2=CC=1)C(=O)N(CC1)CCC1N1CCNCC1 HCLHGMFJOGZJEX-UHFFFAOYSA-N 0.000 claims description 3
- OLAFEWROLQJOKI-UHFFFAOYSA-N n-[3-(2h-benzotriazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3N=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 OLAFEWROLQJOKI-UHFFFAOYSA-N 0.000 claims description 3
- KHKMLYBMJUHVHM-UHFFFAOYSA-N n-[3-(2h-benzotriazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3N=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 KHKMLYBMJUHVHM-UHFFFAOYSA-N 0.000 claims description 3
- ZWVFWJZWFAVRLQ-UHFFFAOYSA-N n-[3-(2h-benzotriazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3N=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 ZWVFWJZWFAVRLQ-UHFFFAOYSA-N 0.000 claims description 3
- LUPPWCOFRPKDLE-UHFFFAOYSA-N n-[3-(2h-benzotriazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2N=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCNCC1 LUPPWCOFRPKDLE-UHFFFAOYSA-N 0.000 claims description 3
- ZVSHDUHOKVGPKG-UHFFFAOYSA-N n-[3-(2h-benzotriazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2N=NNC2=CC=1)C(=O)N(CC1)CCN1C1CCNCC1 ZVSHDUHOKVGPKG-UHFFFAOYSA-N 0.000 claims description 3
- AWFBOVFGVYFQPL-UHFFFAOYSA-N n-[3-(7-bromo-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(Br)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 AWFBOVFGVYFQPL-UHFFFAOYSA-N 0.000 claims description 3
- RDLXQTXJHTZHBQ-UHFFFAOYSA-N n-[3-(7-chloro-1h-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(Cl)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 RDLXQTXJHTZHBQ-UHFFFAOYSA-N 0.000 claims description 3
- QVAQAOBLQYQMIZ-UHFFFAOYSA-N n-[3-(7-chloro-1h-indazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(Cl)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 QVAQAOBLQYQMIZ-UHFFFAOYSA-N 0.000 claims description 3
- XEJCCUUMPQVNLT-UHFFFAOYSA-N n-[3-(7-chloro-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(Cl)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 XEJCCUUMPQVNLT-UHFFFAOYSA-N 0.000 claims description 3
- RSGBRGQLTQOQKL-UHFFFAOYSA-N n-[3-(7-ethyl-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCN(C)CC1 RSGBRGQLTQOQKL-UHFFFAOYSA-N 0.000 claims description 3
- UOBGBVJWIWTDII-UHFFFAOYSA-N n-[3-(7-ethyl-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCN(C)CC1 UOBGBVJWIWTDII-UHFFFAOYSA-N 0.000 claims description 3
- DYRGKUCUMUJARX-UHFFFAOYSA-N n-[3-(7-ethyl-1h-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCN(C)CC1 DYRGKUCUMUJARX-UHFFFAOYSA-N 0.000 claims description 3
- ZWTOCQVAMRUUKB-UHFFFAOYSA-N n-[3-(7-ethyl-1h-indazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 ZWTOCQVAMRUUKB-UHFFFAOYSA-N 0.000 claims description 3
- UNXBHRYDHYDYPR-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 UNXBHRYDHYDYPR-UHFFFAOYSA-N 0.000 claims description 3
- BUDKABKOCUHPNH-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-yl-1,4-diazepan-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCCN1C1CCNCC1 BUDKABKOCUHPNH-UHFFFAOYSA-N 0.000 claims description 3
- VPKFMNLJBYUCEQ-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 VPKFMNLJBYUCEQ-UHFFFAOYSA-N 0.000 claims description 3
- FPZINKKKSUVKAS-UHFFFAOYSA-N n-[3-(7-methyl-1h-indol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=CNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 FPZINKKKSUVKAS-UHFFFAOYSA-N 0.000 claims description 3
- UCZBMMAYFVEHEV-UHFFFAOYSA-N n-[3-(7-methyl-2h-benzotriazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3N=NNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 UCZBMMAYFVEHEV-UHFFFAOYSA-N 0.000 claims description 3
- PNZFFLPGWFUXQS-UHFFFAOYSA-N n-[3-(7-methyl-2h-benzotriazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3N=NNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 PNZFFLPGWFUXQS-UHFFFAOYSA-N 0.000 claims description 3
- NLYVMQHIVRVCLQ-UHFFFAOYSA-N n-[3-(7-methyl-2h-benzotriazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2N=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 NLYVMQHIVRVCLQ-UHFFFAOYSA-N 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 238000011282 treatment Methods 0.000 claims description 3
- BAXOFTOLAUCFNW-UHFFFAOYSA-N 1H-indazole Chemical compound C1=CC=C2C=NNC2=C1 BAXOFTOLAUCFNW-UHFFFAOYSA-N 0.000 claims description 2
- LBZSSSUCYXLEBQ-UHFFFAOYSA-N 2-(2h-benzotriazol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2N=NNC2=CC=1)C(=O)N(CC1)CCC1C1CCNCC1 LBZSSSUCYXLEBQ-UHFFFAOYSA-N 0.000 claims description 2
- XIWIFFXVSOSILQ-UHFFFAOYSA-N 2-amino-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-3-[7-(trifluoromethyl)-1H-indazol-5-yl]propan-1-one Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(N)CC=2C=C3C=NNC3=C(C=2)C(F)(F)F)CC1 XIWIFFXVSOSILQ-UHFFFAOYSA-N 0.000 claims description 2
- AWQXELMZOYQYIA-UHFFFAOYSA-N 2-amino-3-(7-methyl-1H-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)-1,4-diazepan-1-yl]propan-1-one Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(N)CC=2C=C3C=NNC3=C(C)C=2)CCC1 AWQXELMZOYQYIA-UHFFFAOYSA-N 0.000 claims description 2
- ITFWEGFMSZEHPU-UHFFFAOYSA-N 4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)-n-[1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)-3-[7-(trifluoromethyl)-1h-indazol-5-yl]propan-2-yl]piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C(F)(F)F)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 ITFWEGFMSZEHPU-UHFFFAOYSA-N 0.000 claims description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 2
- 208000006561 Cluster Headache Diseases 0.000 claims description 2
- 206010012735 Diarrhoea Diseases 0.000 claims description 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 claims description 2
- 208000012659 Joint disease Diseases 0.000 claims description 2
- 208000019693 Lung disease Diseases 0.000 claims description 2
- 208000007920 Neurogenic Inflammation Diseases 0.000 claims description 2
- 206010060862 Prostate cancer Diseases 0.000 claims description 2
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 2
- 206010039085 Rhinitis allergic Diseases 0.000 claims description 2
- 206010040047 Sepsis Diseases 0.000 claims description 2
- 206010042496 Sunburn Diseases 0.000 claims description 2
- 201000010105 allergic rhinitis Diseases 0.000 claims description 2
- 206010003246 arthritis Diseases 0.000 claims description 2
- 208000006673 asthma Diseases 0.000 claims description 2
- 239000000969 carrier Substances 0.000 claims description 2
- 208000018912 cluster headache syndrome Diseases 0.000 claims description 2
- 229910052731 fluorine Inorganic materials 0.000 claims description 2
- 239000011737 fluorine Substances 0.000 claims description 2
- 208000027866 inflammatory disease Diseases 0.000 claims description 2
- RBRVRAXCOUBAOZ-UHFFFAOYSA-N methyl 2-[4-[1-[2-(1h-indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butanoyl]piperidin-4-yl]piperidin-1-yl]acetate Chemical compound C1CN(CC(=O)OC)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=CC=2)CC1 RBRVRAXCOUBAOZ-UHFFFAOYSA-N 0.000 claims description 2
- BEXZNCXQEONLIL-UHFFFAOYSA-N methyl 2-[4-[1-[2-[(7-methyl-1h-indazol-5-yl)methyl]-4-oxo-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butanoyl]piperidin-4-yl]piperidin-1-yl]acetate Chemical compound C1CN(CC(=O)OC)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(C)C=2)CC1 BEXZNCXQEONLIL-UHFFFAOYSA-N 0.000 claims description 2
- 229960005181 morphine Drugs 0.000 claims description 2
- 210000002200 mouth mucosa Anatomy 0.000 claims description 2
- LRILPJKWHGMNAH-UHFFFAOYSA-N n-[1-[4-(1,4-diazepan-1-yl)piperidin-1-yl]-3-(7-methyl-1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCCNCC1 LRILPJKWHGMNAH-UHFFFAOYSA-N 0.000 claims description 2
- CGERLZHNNGSFNL-UHFFFAOYSA-N n-[1-[4-(4-fluorophenyl)piperazin-1-yl]-3-(1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1=CC(F)=CC=C1N1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 CGERLZHNNGSFNL-UHFFFAOYSA-N 0.000 claims description 2
- RNEGHEJJRXSLML-UHFFFAOYSA-N n-[1-[4-(4-fluorophenyl)piperazin-1-yl]-3-(7-methyl-1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1=CC=C(F)C=C1 RNEGHEJJRXSLML-UHFFFAOYSA-N 0.000 claims description 2
- PBZNRLWQUMVMFM-UHFFFAOYSA-N n-[1-[4-(4-fluorophenyl)piperidin-1-yl]-3-(7-methyl-1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1=CC=C(F)C=C1 PBZNRLWQUMVMFM-UHFFFAOYSA-N 0.000 claims description 2
- YHFXEBXEYNENPP-UHFFFAOYSA-N n-[3-(1,7-dimethylindazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NN(C)C=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 YHFXEBXEYNENPP-UHFFFAOYSA-N 0.000 claims description 2
- YRJZDFZGQCSDCA-UHFFFAOYSA-N n-[3-(1-methylindazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=C2N(C)N=CC2=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 YRJZDFZGQCSDCA-UHFFFAOYSA-N 0.000 claims description 2
- CPZAVOIKEIGEIK-UHFFFAOYSA-N n-[3-(1-methylindazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=C2N(C)N=CC2=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 CPZAVOIKEIGEIK-UHFFFAOYSA-N 0.000 claims description 2
- WIBDENBYVBBOQI-UHFFFAOYSA-N n-[3-(1-methylindazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=C2N(C)N=CC2=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 WIBDENBYVBBOQI-UHFFFAOYSA-N 0.000 claims description 2
- VKWCGVVIJCOJOO-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]-4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC(=N2)C=2C=CC=CC=2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCCCC1 VKWCGVVIJCOJOO-UHFFFAOYSA-N 0.000 claims description 2
- KIPAHHDKAPQEAE-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC(=N2)C=2C=CC=CC=2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCN1C1CCNCC1 KIPAHHDKAPQEAE-UHFFFAOYSA-N 0.000 claims description 2
- DJWXKBBQUPRIIB-UHFFFAOYSA-N n-[3-(7-chloro-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(Cl)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 DJWXKBBQUPRIIB-UHFFFAOYSA-N 0.000 claims description 2
- WYBBQNKRPATSLS-UHFFFAOYSA-N n-[3-(7-ethyl-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 WYBBQNKRPATSLS-UHFFFAOYSA-N 0.000 claims description 2
- LTDPTZPYGVKUOG-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 LTDPTZPYGVKUOG-UHFFFAOYSA-N 0.000 claims description 2
- XBXIWOWLUAGDHE-UHFFFAOYSA-N n-[3-(7-methyl-1h-indol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=CNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 XBXIWOWLUAGDHE-UHFFFAOYSA-N 0.000 claims description 2
- ANQNDBFEASKZFZ-UHFFFAOYSA-N n-[3-(7-methyl-1h-indol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=CNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 ANQNDBFEASKZFZ-UHFFFAOYSA-N 0.000 claims description 2
- VWEMUIJUWRCORH-UHFFFAOYSA-N n-[3-(7-methyl-1h-indol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=CNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 VWEMUIJUWRCORH-UHFFFAOYSA-N 0.000 claims description 2
- UCTPHTZTHUSVOG-UHFFFAOYSA-N n-[3-(7-methyl-1h-indol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=CNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 UCTPHTZTHUSVOG-UHFFFAOYSA-N 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000002243 precursor Substances 0.000 claims description 2
- 230000003449 preventive effect Effects 0.000 claims description 2
- 238000011321 prophylaxis Methods 0.000 claims description 2
- 230000005855 radiation Effects 0.000 claims description 2
- 230000035939 shock Effects 0.000 claims description 2
- 208000024891 symptom Diseases 0.000 claims description 2
- 239000003053 toxin Substances 0.000 claims description 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 2
- ASSKVPFEZFQQNQ-UHFFFAOYSA-N Benzoxazolone Natural products C1=CC=C2OC(O)=NC2=C1 ASSKVPFEZFQQNQ-UHFFFAOYSA-N 0.000 claims 4
- 230000002792 vascular Effects 0.000 claims 3
- PAMIQIKDUOTOBW-UHFFFAOYSA-N 1-methylpiperidine Chemical compound CN1CCCCC1 PAMIQIKDUOTOBW-UHFFFAOYSA-N 0.000 claims 2
- 230000010339 dilation Effects 0.000 claims 2
- ACZUGNXHENKDCY-UHFFFAOYSA-N 2-amino-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-3-[7-(trifluoromethyl)-1H-indazol-5-yl]propan-1-one Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(N)CC=2C=C3C=NNC3=C(C=2)C(F)(F)F)CC1 ACZUGNXHENKDCY-UHFFFAOYSA-N 0.000 claims 1
- IWKOBIPTTBNYKH-UHFFFAOYSA-N 2-amino-1-[4-(4-methyl-1,4-diazepan-1-yl)piperidin-1-yl]-3-(7-methyl-1H-indazol-5-yl)propan-1-one Chemical compound C1CN(C)CCCN1C1CCN(C(=O)C(N)CC=2C=C3C=NNC3=C(C)C=2)CC1 IWKOBIPTTBNYKH-UHFFFAOYSA-N 0.000 claims 1
- PJJRJZRNRSEBNO-UHFFFAOYSA-N 2-amino-3-(1H-indol-5-yl)-1-(4-piperidin-4-ylpiperidin-1-yl)propan-1-one Chemical compound C=1C=C2NC=CC2=CC=1CC(N)C(=O)N(CC1)CCC1C1CCNCC1 PJJRJZRNRSEBNO-UHFFFAOYSA-N 0.000 claims 1
- CIKGNTMCJKDTAN-UHFFFAOYSA-N 4-chloro-3h-1,3-benzoxazol-2-one Chemical compound ClC1=CC=CC2=C1NC(=O)O2 CIKGNTMCJKDTAN-UHFFFAOYSA-N 0.000 claims 1
- CMGDVUCDZOBDNL-UHFFFAOYSA-N 4-methyl-2h-benzotriazole Chemical compound CC1=CC=CC2=NNN=C12 CMGDVUCDZOBDNL-UHFFFAOYSA-N 0.000 claims 1
- WKVRPEDIIULDMN-UHFFFAOYSA-N 5-[2-amino-3-oxo-3-(4-piperidin-1-ylpiperidin-1-yl)propyl]-1,3-dihydrobenzimidazol-2-one Chemical compound C=1C=C2NC(=O)NC2=CC=1CC(N)C(=O)N(CC1)CCC1N1CCCCC1 WKVRPEDIIULDMN-UHFFFAOYSA-N 0.000 claims 1
- LYVBPAIIMSSODL-UHFFFAOYSA-N 6-[2-amino-3-oxo-3-(4-piperidin-1-ylpiperidin-1-yl)propyl]-3H-1,3-benzoxazol-2-one Chemical compound C=1C=C2NC(=O)OC2=CC=1CC(N)C(=O)N(CC1)CCC1N1CCCCC1 LYVBPAIIMSSODL-UHFFFAOYSA-N 0.000 claims 1
- CNEGMLWHCMAUJC-UHFFFAOYSA-N 6-[2-amino-3-oxo-3-(4-piperidin-1-ylpiperidin-1-yl)propyl]-4-chloro-1,3-dihydrobenzimidazol-2-one Chemical compound C=1C(Cl)=C2NC(=O)NC2=CC=1CC(N)C(=O)N(CC1)CCC1N1CCCCC1 CNEGMLWHCMAUJC-UHFFFAOYSA-N 0.000 claims 1
- KMHHWCPTROQUFM-UHFFFAOYSA-N 7-bromo-1h-indazole Chemical compound BrC1=CC=CC2=C1NN=C2 KMHHWCPTROQUFM-UHFFFAOYSA-N 0.000 claims 1
- UCFNXMRHHCYKHU-UHFFFAOYSA-N 7-ethyl-1h-indazole Chemical compound CCC1=CC=CC2=C1NN=C2 UCFNXMRHHCYKHU-UHFFFAOYSA-N 0.000 claims 1
- 206010027304 Menopausal symptoms Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 230000002950 deficient Effects 0.000 claims 1
- 229940011871 estrogen Drugs 0.000 claims 1
- 239000000262 estrogen Substances 0.000 claims 1
- FATAVLOOLIRUNA-UHFFFAOYSA-N formylmethyl Chemical group [CH2]C=O FATAVLOOLIRUNA-UHFFFAOYSA-N 0.000 claims 1
- PFKJFBUWIJXCKG-UHFFFAOYSA-N methyl 2-[4-[1-[3-(1h-indazol-5-yl)-2-[[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carbonyl]amino]propanoyl]piperidin-4-yl]piperidin-1-yl]acetate Chemical compound C1CN(CC(=O)OC)CCC1C1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 PFKJFBUWIJXCKG-UHFFFAOYSA-N 0.000 claims 1
- SZXVIDSAJXTTRJ-UHFFFAOYSA-N n-[1-[4-(dimethylamino)piperidin-1-yl]-3-(1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidine-1-carboxamide Chemical compound C1CC(N(C)C)CCN1C(=O)C(NC(=O)N1CCC(CC1)N1C(NC(=N1)C=1C=CC=CC=1)=O)CC1=CC=C(NN=C2)C2=C1 SZXVIDSAJXTTRJ-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 1
- 230000001681 protective effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000000144 pharmacologic effect Effects 0.000 abstract description 4
- 150000003053 piperidines Chemical class 0.000 abstract description 2
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 34
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 32
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 27
- 239000013543 active substance Substances 0.000 description 27
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 26
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 25
- 0 COC(C(Cc1cc(N)c(*(*)*I)c(N)c1)*C(*1CCC(*)CC1)=O)=O Chemical compound COC(C(Cc1cc(N)c(*(*)*I)c(N)c1)*C(*1CCC(*)CC1)=O)=O 0.000 description 22
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 21
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 19
- 239000000543 intermediate Substances 0.000 description 19
- 239000002585 base Substances 0.000 description 17
- 235000019439 ethyl acetate Nutrition 0.000 description 17
- 238000010168 coupling process Methods 0.000 description 16
- 239000000741 silica gel Substances 0.000 description 16
- 229910002027 silica gel Inorganic materials 0.000 description 16
- 239000002904 solvent Substances 0.000 description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- 230000008878 coupling Effects 0.000 description 14
- 238000005859 coupling reaction Methods 0.000 description 14
- 239000000243 solution Substances 0.000 description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 13
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 239000004480 active ingredient Substances 0.000 description 12
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 12
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 10
- 239000011780 sodium chloride Substances 0.000 description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 9
- 239000011541 reaction mixture Substances 0.000 description 9
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical class [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 8
- 108091006905 Human Serum Albumin Proteins 0.000 description 8
- 102000008100 Human Serum Albumin Human genes 0.000 description 8
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 8
- 150000008064 anhydrides Chemical class 0.000 description 8
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 8
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 7
- 239000008346 aqueous phase Substances 0.000 description 7
- 239000012043 crude product Substances 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- 239000008215 water for injection Substances 0.000 description 7
- 102100025588 Calcitonin gene-related peptide 1 Human genes 0.000 description 6
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- 239000012317 TBTU Substances 0.000 description 6
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000004440 column chromatography Methods 0.000 description 6
- 238000002347 injection Methods 0.000 description 6
- 239000007924 injection Substances 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- PFKFTWBEEFSNDU-UHFFFAOYSA-N 1,1'-Carbonyldiimidazole Substances C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 5
- JCBUCXVYWVRNMK-UHFFFAOYSA-N 1,7-dimethylindazole Chemical compound CC1=CC=CC2=C1N(C)N=C2 JCBUCXVYWVRNMK-UHFFFAOYSA-N 0.000 description 5
- 229920002261 Corn starch Polymers 0.000 description 5
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 5
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 5
- 229910004373 HOAc Inorganic materials 0.000 description 5
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000003042 antagnostic effect Effects 0.000 description 5
- 229960000686 benzalkonium chloride Drugs 0.000 description 5
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 5
- 239000002775 capsule Substances 0.000 description 5
- 239000008120 corn starch Substances 0.000 description 5
- 125000005843 halogen group Chemical group 0.000 description 5
- 235000019359 magnesium stearate Nutrition 0.000 description 5
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 5
- 229920000053 polysorbate 80 Polymers 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 5
- BDNKZNFMNDZQMI-UHFFFAOYSA-N 1,3-diisopropylcarbodiimide Chemical compound CC(C)N=C=NC(C)C BDNKZNFMNDZQMI-UHFFFAOYSA-N 0.000 description 4
- BWZVCCNYKMEVEX-UHFFFAOYSA-N 2,4,6-Trimethylpyridine Chemical compound CC1=CC(C)=NC(C)=C1 BWZVCCNYKMEVEX-UHFFFAOYSA-N 0.000 description 4
- HJBLUNHMOKFZQX-UHFFFAOYSA-N 3-hydroxy-1,2,3-benzotriazin-4-one Chemical compound C1=CC=C2C(=O)N(O)N=NC2=C1 HJBLUNHMOKFZQX-UHFFFAOYSA-N 0.000 description 4
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 4
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 4
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 4
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 4
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 4
- 239000000556 agonist Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Chemical compound BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 4
- BGRWYRAHAFMIBJ-UHFFFAOYSA-N diisopropylcarbodiimide Natural products CC(C)NC(=O)NC(C)C BGRWYRAHAFMIBJ-UHFFFAOYSA-N 0.000 description 4
- 235000019253 formic acid Nutrition 0.000 description 4
- 229940116364 hard fat Drugs 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 239000000594 mannitol Substances 0.000 description 4
- 235000010355 mannitol Nutrition 0.000 description 4
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 4
- 229940068968 polysorbate 80 Drugs 0.000 description 4
- SCVFZCLFOSHCOH-UHFFFAOYSA-M potassium acetate Chemical compound [K+].CC([O-])=O SCVFZCLFOSHCOH-UHFFFAOYSA-M 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000007858 starting material Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- SWCPUEIUOMKNMR-NDEPHWFRSA-N (2s)-2-(1h-indazol-5-ylmethyl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)[C@H](CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=CC=2)CC1 SWCPUEIUOMKNMR-NDEPHWFRSA-N 0.000 description 3
- 125000003626 1,2,4-triazol-1-yl group Chemical group [*]N1N=C([H])N=C1[H] 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- ASOKPJOREAFHNY-UHFFFAOYSA-N 1-Hydroxybenzotriazole Chemical compound C1=CC=C2N(O)N=NC2=C1 ASOKPJOREAFHNY-UHFFFAOYSA-N 0.000 description 3
- OKPVYDIKPDACKI-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=CC=2)CC1 OKPVYDIKPDACKI-UHFFFAOYSA-N 0.000 description 3
- RNLLWWNYDXFCTJ-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-[4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC(=N2)C=2C=CC=CC=2)=O)CCN1C(=O)CC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1C1CCNCC1 RNLLWWNYDXFCTJ-UHFFFAOYSA-N 0.000 description 3
- ZJYIYOAMAOGNMK-UHFFFAOYSA-N 2-(1h-indol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=CNC3=CC=2)CC1 ZJYIYOAMAOGNMK-UHFFFAOYSA-N 0.000 description 3
- MPYBEVFHIVWJGS-UHFFFAOYSA-N 2-(2h-benzotriazol-5-ylmethyl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3N=NNC3=CC=2)CC1 MPYBEVFHIVWJGS-UHFFFAOYSA-N 0.000 description 3
- WUTXKMURVXRJDP-UHFFFAOYSA-N 2-[(1,7-dimethylindazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NN(C)C=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 WUTXKMURVXRJDP-UHFFFAOYSA-N 0.000 description 3
- JRVGZPRQODDEDI-UHFFFAOYSA-N 2-[(1-methylindazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NN(C)C3=CC=2)CC1 JRVGZPRQODDEDI-UHFFFAOYSA-N 0.000 description 3
- UXKVHLFBDFLXIU-UHFFFAOYSA-N 2-[(1-methylindazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=C2N(C)N=CC2=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 UXKVHLFBDFLXIU-UHFFFAOYSA-N 0.000 description 3
- JKCWANGVFUYGOM-UHFFFAOYSA-N 2-[(7-bromo-1h-indazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(Br)C=2)CC1 JKCWANGVFUYGOM-UHFFFAOYSA-N 0.000 description 3
- FTHOWWCPASOYAM-UHFFFAOYSA-N 2-[(7-chloro-1h-indazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(Cl)C=2)CC1 FTHOWWCPASOYAM-UHFFFAOYSA-N 0.000 description 3
- VDDXGEQKSUXPDI-UHFFFAOYSA-N 2-[(7-ethyl-1h-indazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCN(C)CC1 VDDXGEQKSUXPDI-UHFFFAOYSA-N 0.000 description 3
- SOYSFKUGUAKDQZ-UHFFFAOYSA-N 2-[(7-ethyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 SOYSFKUGUAKDQZ-UHFFFAOYSA-N 0.000 description 3
- WQLHPFAHLLILCE-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=NNC3=C(C)C=2)CC1 WQLHPFAHLLILCE-UHFFFAOYSA-N 0.000 description 3
- FNGFCPIKSRLITH-UHFFFAOYSA-N 2-[(7-methyl-1h-indol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=CNC3=C(C)C=2)CC1 FNGFCPIKSRLITH-UHFFFAOYSA-N 0.000 description 3
- FCNXWSLBDLYJPP-UHFFFAOYSA-N 2-[(7-methyl-2h-benzotriazol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3N=NNC3=C(C)C=2)CC1 FCNXWSLBDLYJPP-UHFFFAOYSA-N 0.000 description 3
- NEJFXSKIWQAKFT-UHFFFAOYSA-N 2-[(7-methyl-2h-benzotriazol-5-yl)methyl]-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3N=NNC3=C(C)C=2)CC1 NEJFXSKIWQAKFT-UHFFFAOYSA-N 0.000 description 3
- ZBBBZOPXMYEBES-UHFFFAOYSA-N 2-[(7-methyl-2h-benzotriazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C=1C=2N=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 ZBBBZOPXMYEBES-UHFFFAOYSA-N 0.000 description 3
- GQRSVTOKENGEPQ-UHFFFAOYSA-N 3-(1h-indazol-5-ylmethyl)-4-methoxy-4-oxobutanoic acid Chemical compound COC(=O)C(CC(O)=O)CC1=CC=C2NN=CC2=C1 GQRSVTOKENGEPQ-UHFFFAOYSA-N 0.000 description 3
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 3
- 108010078311 Calcitonin Gene-Related Peptide Receptors Proteins 0.000 description 3
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 3
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000007983 Tris buffer Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 3
- 150000008041 alkali metal carbonates Chemical class 0.000 description 3
- 229910001860 alkaline earth metal hydroxide Inorganic materials 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- DNKYDHSONDSTNJ-XJVRLEFXSA-N chembl1910953 Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)NCC(=O)NCC(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)N)[C@@H](C)O)[C@@H](C)O)C(C)C)[C@@H](C)O)C1=CN=CN1 DNKYDHSONDSTNJ-XJVRLEFXSA-N 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 239000007903 gelatin capsule Substances 0.000 description 3
- NPZTUJOABDZTLV-UHFFFAOYSA-N hydroxybenzotriazole Substances O=C1C=CC=C2NNN=C12 NPZTUJOABDZTLV-UHFFFAOYSA-N 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- YUQZFRQZPBDPBU-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 YUQZFRQZPBDPBU-UHFFFAOYSA-N 0.000 description 3
- SDCFABJBQPNRBY-UHFFFAOYSA-N n-[3-(1h-indol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=CNC2=CC=1)C(=O)N(CC1)CCN1C1CCNCC1 SDCFABJBQPNRBY-UHFFFAOYSA-N 0.000 description 3
- HJALVTXWXNDEOU-UHFFFAOYSA-N n-[3-(7-bromo-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NNC3=C(Br)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 HJALVTXWXNDEOU-UHFFFAOYSA-N 0.000 description 3
- QKPXPDHRNNCNKQ-UHFFFAOYSA-N n-[3-(7-bromo-1h-indazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(Br)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 QKPXPDHRNNCNKQ-UHFFFAOYSA-N 0.000 description 3
- 238000005580 one pot reaction Methods 0.000 description 3
- 239000003208 petroleum Substances 0.000 description 3
- 229910000027 potassium carbonate Inorganic materials 0.000 description 3
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 3
- UCPYLLCMEDAXFR-UHFFFAOYSA-N triphosgene Chemical compound ClC(Cl)(Cl)OC(=O)OC(Cl)(Cl)Cl UCPYLLCMEDAXFR-UHFFFAOYSA-N 0.000 description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 3
- CMDWTTLTEQKNOX-ONNFQVAWSA-N (e)-3-methoxycarbonyl-4-(7-methyl-1h-indazol-5-yl)but-3-enoic acid Chemical compound COC(=O)C(\CC(O)=O)=C\C1=CC(C)=C2NN=CC2=C1 CMDWTTLTEQKNOX-ONNFQVAWSA-N 0.000 description 2
- 125000001607 1,2,3-triazol-1-yl group Chemical group [*]N1N=NC([H])=C1[H] 0.000 description 2
- WJQKKIWBZATYHN-UHFFFAOYSA-N 1-[4-(1,4-diazepan-1-yl)piperidin-1-yl]-2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCCNCC1 WJQKKIWBZATYHN-UHFFFAOYSA-N 0.000 description 2
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 2
- MRYYJGQKVGZGSB-UHFFFAOYSA-N 1-methyl-4-piperidin-4-ylpiperazine Chemical compound C1CN(C)CCN1C1CCNCC1 MRYYJGQKVGZGSB-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- YJKMYHNMBGQQQZ-UHFFFAOYSA-N 1h-indazole-5-carbaldehyde Chemical compound O=CC1=CC=C2NN=CC2=C1 YJKMYHNMBGQQQZ-UHFFFAOYSA-N 0.000 description 2
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 2
- 125000001917 2,4-dinitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C(=C1*)[N+]([O-])=O)[N+]([O-])=O 0.000 description 2
- LIJMRSFQIPLTLG-UHFFFAOYSA-N 2-(1h-indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butanoic acid Chemical compound C1CC2=CC=CC=C2NC(=O)N1C(CC1)CCN1C(=O)CC(C(=O)O)CC1=CC=C(NN=C2)C2=C1 LIJMRSFQIPLTLG-UHFFFAOYSA-N 0.000 description 2
- HGYSRWFGBAQPOV-UHFFFAOYSA-N 2-(1h-indol-5-ylmethyl)-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)butane-1,4-dione Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)CC(CC=1C=C2C=CNC2=CC=1)C(=O)N(CC1)CCC1N1CCNCC1 HGYSRWFGBAQPOV-UHFFFAOYSA-N 0.000 description 2
- CTPDSKVQLSDPLC-UHFFFAOYSA-N 2-(oxolan-2-ylmethoxy)ethanol Chemical compound OCCOCC1CCCO1 CTPDSKVQLSDPLC-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- IUEJVZYKJPZVOZ-UHFFFAOYSA-N 2-[(7-bromo-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(Br)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 IUEJVZYKJPZVOZ-UHFFFAOYSA-N 0.000 description 2
- STPZZXREBBJADO-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-1-[4-(1-methylsulfonylpiperidin-4-yl)piperidin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCN(S(C)(=O)=O)CC1 STPZZXREBBJADO-UHFFFAOYSA-N 0.000 description 2
- ZNRGYKKAKIBSQD-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperidin-4-yl-1,4-diazepan-1-yl)butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCCN1C1CCNCC1 ZNRGYKKAKIBSQD-UHFFFAOYSA-N 0.000 description 2
- WJIASVPOEPPXHG-UHFFFAOYSA-N 2-[(7-methyl-1h-indazol-5-yl)methyl]-4-oxo-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butanoic acid Chemical compound C1CC2=CC=CC=C2NC(=O)N1C(CC1)CCN1C(=O)CC(C(O)=O)CC(C=C1C)=CC2=C1NN=C2 WJIASVPOEPPXHG-UHFFFAOYSA-N 0.000 description 2
- XFKSTLGKAYGUGZ-UHFFFAOYSA-N 2-[(7-methyl-1h-indol-5-yl)methyl]-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butane-1,4-dione Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC=2C=C3C=CNC3=C(C)C=2)CC1 XFKSTLGKAYGUGZ-UHFFFAOYSA-N 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 2
- QRAFJHXNLQTXQW-UHFFFAOYSA-N 2-methylpropyl hydrogen carbonate Chemical compound CC(C)COC(O)=O QRAFJHXNLQTXQW-UHFFFAOYSA-N 0.000 description 2
- USOSUQZREODCRK-UHFFFAOYSA-N 3-piperidin-4-yl-4,5-dihydro-1h-1,3-benzodiazepin-2-one Chemical compound O=C1NC2=CC=CC=C2CCN1C1CCNCC1 USOSUQZREODCRK-UHFFFAOYSA-N 0.000 description 2
- ULLUCMRRDCGLDL-UHFFFAOYSA-N 4-(1h-indazol-5-yl)-3-methoxycarbonylbut-3-enoic acid Chemical compound COC(=O)C(CC(O)=O)=CC1=CC=C2NN=CC2=C1 ULLUCMRRDCGLDL-UHFFFAOYSA-N 0.000 description 2
- XMEIPWKOKFTBLJ-UHFFFAOYSA-N 4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)-n-[1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)-3-[7-(trifluoromethyl)-1h-indazol-5-yl]propan-2-yl]piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C(F)(F)F)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 XMEIPWKOKFTBLJ-UHFFFAOYSA-N 0.000 description 2
- RFWJAPZSRMTDMI-UHFFFAOYSA-N 4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)-2-[[7-(trifluoromethyl)-1h-indazol-5-yl]methyl]butane-1,4-dione Chemical compound C=1C=2C=NNC=2C(C(F)(F)F)=CC=1CC(CC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 RFWJAPZSRMTDMI-UHFFFAOYSA-N 0.000 description 2
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 description 2
- XNBGCSBABKFOIK-UHFFFAOYSA-N 4-methoxy-3-[(7-methyl-1h-indazol-5-yl)methyl]-4-oxobutanoic acid Chemical compound COC(=O)C(CC(O)=O)CC1=CC(C)=C2NN=CC2=C1 XNBGCSBABKFOIK-UHFFFAOYSA-N 0.000 description 2
- GJZLKBBRMQSNKG-UHFFFAOYSA-N 7-methyl-1h-indazole-5-carbaldehyde Chemical compound CC1=CC(C=O)=CC2=C1NN=C2 GJZLKBBRMQSNKG-UHFFFAOYSA-N 0.000 description 2
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 2
- 241001136792 Alle Species 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- UGJMXCAKCUNAIE-UHFFFAOYSA-N Gabapentin Chemical compound OC(=O)CC1(CN)CCCCC1 UGJMXCAKCUNAIE-UHFFFAOYSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
- 150000001242 acetic acid derivatives Chemical class 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 125000005079 alkoxycarbonylmethyl group Chemical group 0.000 description 2
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 description 2
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide group Chemical group [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 description 2
- RQPZNWPYLFFXCP-UHFFFAOYSA-L barium dihydroxide Chemical compound [OH-].[OH-].[Ba+2] RQPZNWPYLFFXCP-UHFFFAOYSA-L 0.000 description 2
- 229910001863 barium hydroxide Inorganic materials 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- YHNUDLCUIKMNSN-UHFFFAOYSA-N bis(1,2,4-triazol-1-yl)methanone Chemical compound C1=NC=NN1C(=O)N1C=NC=N1 YHNUDLCUIKMNSN-UHFFFAOYSA-N 0.000 description 2
- 229910052794 bromium Inorganic materials 0.000 description 2
- 125000001246 bromo group Chemical group Br* 0.000 description 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 2
- 229910000024 caesium carbonate Inorganic materials 0.000 description 2
- 102000008323 calcitonin gene-related peptide receptor activity proteins Human genes 0.000 description 2
- MIOPJNTWMNEORI-UHFFFAOYSA-N camphorsulfonic acid Chemical compound C1CC2(CS(O)(=O)=O)C(=O)CC1C2(C)C MIOPJNTWMNEORI-UHFFFAOYSA-N 0.000 description 2
- 150000001718 carbodiimides Chemical class 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 125000001309 chloro group Chemical group Cl* 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000006184 cosolvent Substances 0.000 description 2
- PAFZNILMFXTMIY-UHFFFAOYSA-N cyclohexylamine Chemical compound NC1CCCCC1 PAFZNILMFXTMIY-UHFFFAOYSA-N 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- OCLXJTCGWSSVOE-UHFFFAOYSA-N ethanol etoh Chemical compound CCO.CCO OCLXJTCGWSSVOE-UHFFFAOYSA-N 0.000 description 2
- 238000003958 fumigation Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 description 2
- 229940041682 inhalant solution Drugs 0.000 description 2
- 229910052740 iodine Inorganic materials 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- COTNUBDHGSIOTA-UHFFFAOYSA-N meoh methanol Chemical compound OC.OC COTNUBDHGSIOTA-UHFFFAOYSA-N 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- SSSGPQUHAXSGBS-UHFFFAOYSA-N n-[1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxo-3-[7-(trifluoromethyl)-1h-indazol-5-yl]propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NNC3=C(C=2)C(F)(F)F)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 SSSGPQUHAXSGBS-UHFFFAOYSA-N 0.000 description 2
- WIWNRNPZMRDRDK-UHFFFAOYSA-N n-[3-(1,7-dimethylindazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NN(C)C3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 WIWNRNPZMRDRDK-UHFFFAOYSA-N 0.000 description 2
- YZHBDAJSCBTALA-UHFFFAOYSA-N n-[3-(1,7-dimethylindazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NN(C)C=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 YZHBDAJSCBTALA-UHFFFAOYSA-N 0.000 description 2
- RCCMHBUEEBIPAF-UHFFFAOYSA-N n-[3-(1-methylindazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NN(C)C3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 RCCMHBUEEBIPAF-UHFFFAOYSA-N 0.000 description 2
- FARAGZFKRXYDCW-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC(=N2)C=2C=CC=CC=2)=O)CC1 FARAGZFKRXYDCW-UHFFFAOYSA-N 0.000 description 2
- UPEOWADRHCRAEU-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-[4-(1-methylsulfonylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(S(=O)(=O)C)CCC1C1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 UPEOWADRHCRAEU-UHFFFAOYSA-N 0.000 description 2
- JVQORQHMXYHJGK-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-[4-(4-methyl-1,4-diazepan-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCCN1C1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 JVQORQHMXYHJGK-UHFFFAOYSA-N 0.000 description 2
- UWSSUNOVPYBNDW-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1N1CCNCC1 UWSSUNOVPYBNDW-UHFFFAOYSA-N 0.000 description 2
- DSUOOHUMZOPRCL-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1C1CCNCC1 DSUOOHUMZOPRCL-UHFFFAOYSA-N 0.000 description 2
- KLZCVIISHRHCAJ-UHFFFAOYSA-N n-[3-(1h-indol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC3=CC=CC=C3CC2)=O)CCN1C(=O)NC(CC=1C=C2C=CNC2=CC=1)C(=O)N(CC1)CCC1C1CCNCC1 KLZCVIISHRHCAJ-UHFFFAOYSA-N 0.000 description 2
- AOSINGGGCGDLGC-UHFFFAOYSA-N n-[3-(7-bromo-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(Br)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 AOSINGGGCGDLGC-UHFFFAOYSA-N 0.000 description 2
- VXJLLRURMRBWMK-UHFFFAOYSA-N n-[3-(7-chloro-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NNC3=C(Cl)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 VXJLLRURMRBWMK-UHFFFAOYSA-N 0.000 description 2
- YHUCZHAIBAJIFO-UHFFFAOYSA-N n-[3-(7-chloro-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(Cl)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 YHUCZHAIBAJIFO-UHFFFAOYSA-N 0.000 description 2
- NGDKOJPZKIVIMZ-UHFFFAOYSA-N n-[3-(7-ethyl-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(CC)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 NGDKOJPZKIVIMZ-UHFFFAOYSA-N 0.000 description 2
- LXSPJCIHXUVARZ-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 LXSPJCIHXUVARZ-UHFFFAOYSA-N 0.000 description 2
- WSMZBCQNXDMOGS-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCCCC1 WSMZBCQNXDMOGS-UHFFFAOYSA-N 0.000 description 2
- YVFRSYMKYVUDJQ-UHFFFAOYSA-N n-[3-(7-methyl-2h-benzotriazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1C1CCN(C(=O)C(CC=2C=C3N=NNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 YVFRSYMKYVUDJQ-UHFFFAOYSA-N 0.000 description 2
- BTMLHLPSYXIOPG-UHFFFAOYSA-N n-[3-(7-methyl-2h-benzotriazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2N=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1CCNCC1 BTMLHLPSYXIOPG-UHFFFAOYSA-N 0.000 description 2
- XRKQMIFKHDXFNQ-UHFFFAOYSA-N n-cyclohexyl-n-ethylcyclohexanamine Chemical compound C1CCCCC1N(CC)C1CCCCC1 XRKQMIFKHDXFNQ-UHFFFAOYSA-N 0.000 description 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- 125000000538 pentafluorophenyl group Chemical group FC1=C(F)C(F)=C(*)C(F)=C1F 0.000 description 2
- 238000010647 peptide synthesis reaction Methods 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 235000011056 potassium acetate Nutrition 0.000 description 2
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- AQHHHDLHHXJYJD-UHFFFAOYSA-N propranolol Chemical compound C1=CC=C2C(OCC(O)CNC(C)C)=CC=CC2=C1 AQHHHDLHHXJYJD-UHFFFAOYSA-N 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 125000004309 pyranyl group Chemical group O1C(C=CC=C1)* 0.000 description 2
- 125000004076 pyridyl group Chemical group 0.000 description 2
- 238000003127 radioimmunoassay Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 125000001424 substituent group Chemical group 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 229960003708 sumatriptan Drugs 0.000 description 2
- KQKPFRSPSRPDEB-UHFFFAOYSA-N sumatriptan Chemical compound CNS(=O)(=O)CC1=CC=C2NC=C(CCN(C)C)C2=C1 KQKPFRSPSRPDEB-UHFFFAOYSA-N 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- WHRNULOCNSKMGB-UHFFFAOYSA-N tetrahydrofuran thf Chemical compound C1CCOC1.C1CCOC1 WHRNULOCNSKMGB-UHFFFAOYSA-N 0.000 description 2
- 229960000257 tiotropium bromide Drugs 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 230000024883 vasodilation Effects 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- RQEUFEKYXDPUSK-SSDOTTSWSA-N (1R)-1-phenylethanamine Chemical compound C[C@@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-SSDOTTSWSA-N 0.000 description 1
- RQEUFEKYXDPUSK-ZETCQYMHSA-N (1S)-1-phenylethanamine Chemical compound C[C@H](N)C1=CC=CC=C1 RQEUFEKYXDPUSK-ZETCQYMHSA-N 0.000 description 1
- QBYIENPQHBMVBV-HFEGYEGKSA-N (2R)-2-hydroxy-2-phenylacetic acid Chemical compound O[C@@H](C(O)=O)c1ccccc1.O[C@@H](C(O)=O)c1ccccc1 QBYIENPQHBMVBV-HFEGYEGKSA-N 0.000 description 1
- RDJGLLICXDHJDY-NSHDSACASA-N (2s)-2-(3-phenoxyphenyl)propanoic acid Chemical compound OC(=O)[C@@H](C)C1=CC=CC(OC=2C=CC=CC=2)=C1 RDJGLLICXDHJDY-NSHDSACASA-N 0.000 description 1
- METKIMKYRPQLGS-GFCCVEGCSA-N (R)-atenolol Chemical compound CC(C)NC[C@@H](O)COC1=CC=C(CC(N)=O)C=C1 METKIMKYRPQLGS-GFCCVEGCSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TWBNMYSKRDRHAT-RCWTXCDDSA-N (S)-timolol hemihydrate Chemical compound O.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1.CC(C)(C)NC[C@H](O)COC1=NSN=C1N1CCOCC1 TWBNMYSKRDRHAT-RCWTXCDDSA-N 0.000 description 1
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 1
- CFGDUGSIBUXRMR-UHFFFAOYSA-N 1,2-dihydropyrrol-2-ide Chemical class C=1C=[C-]NC=1 CFGDUGSIBUXRMR-UHFFFAOYSA-N 0.000 description 1
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 1
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 1
- PJUPKRYGDFTMTM-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1 PJUPKRYGDFTMTM-UHFFFAOYSA-N 0.000 description 1
- JZUMPNUYDJBTNO-UHFFFAOYSA-N 1-hydroxybenzotriazole;hydrate Chemical compound O.C1=CC=C2N(O)N=NC2=C1.C1=CC=C2N(O)N=NC2=C1 JZUMPNUYDJBTNO-UHFFFAOYSA-N 0.000 description 1
- UIKHKLFBHLPAPO-UHFFFAOYSA-N 2,3-diacetyl-2,3-dihydroxybutanedioic acid Chemical compound CC(=O)C(O)(C(O)=O)C(O)(C(C)=O)C(O)=O UIKHKLFBHLPAPO-UHFFFAOYSA-N 0.000 description 1
- GBJFSZCDZHSAOP-UHFFFAOYSA-N 2,3-dihydroxy-4-methoxy-4-oxobutanoic acid Chemical compound COC(=O)C(O)C(O)C(O)=O GBJFSZCDZHSAOP-UHFFFAOYSA-N 0.000 description 1
- XBPPXPXTFKMWSC-UHFFFAOYSA-N 2-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxylic acid Chemical compound OC(=O)N1CCCCC1N1C(=O)NC2=CC=CC=C2CC1 XBPPXPXTFKMWSC-UHFFFAOYSA-N 0.000 description 1
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
- JXZZEXZZKAWDSP-UHFFFAOYSA-N 3-(2-(4-Benzamidopiperid-1-yl)ethyl)indole Chemical compound C1CN(CCC=2C3=CC=CC=C3NC=2)CCC1NC(=O)C1=CC=CC=C1 JXZZEXZZKAWDSP-UHFFFAOYSA-N 0.000 description 1
- YRIKNOYMTYUQGT-UHFFFAOYSA-N 4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)-n-[1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)-3-[7-(trifluoromethyl)-1h-indazol-5-yl]propan-2-yl]piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C(F)(F)F)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 YRIKNOYMTYUQGT-UHFFFAOYSA-N 0.000 description 1
- XAQJNRJYGMJSSF-UHFFFAOYSA-N 4-oxo-4-(4-piperazin-1-ylpiperidin-1-yl)butanal Chemical compound N1(CCNCC1)C1CCN(CC1)C(CCC=O)=O XAQJNRJYGMJSSF-UHFFFAOYSA-N 0.000 description 1
- STVHMYNPQCLUNJ-UHFFFAOYSA-N 5-bromo-1h-indazole Chemical compound BrC1=CC=C2NN=CC2=C1 STVHMYNPQCLUNJ-UHFFFAOYSA-N 0.000 description 1
- OUNQFZFHLJLFAR-UHFFFAOYSA-N 5-bromo-7-methyl-1h-indazole Chemical compound CC1=CC(Br)=CC2=C1NN=C2 OUNQFZFHLJLFAR-UHFFFAOYSA-N 0.000 description 1
- BSYNRYMUTXBXSQ-FOQJRBATSA-N 59096-14-9 Chemical compound CC(=O)OC1=CC=CC=C1[14C](O)=O BSYNRYMUTXBXSQ-FOQJRBATSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- WKEMJKQOLOHJLZ-UHFFFAOYSA-N Almogran Chemical compound C1=C2C(CCN(C)C)=CNC2=CC=C1CS(=O)(=O)N1CCCC1 WKEMJKQOLOHJLZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 1
- ZJZAADHMASZFKL-TULCARLLSA-N CC(CCC1)CCN1C(CC1)CCC1=CC(C(Cc(cc1C)cc(/C=C\C=C)c1N)NC(N(CC1)CCC1C(C)(CCC1=CC=CCC1N1)C1=O)=O)=O Chemical compound CC(CCC1)CCN1C(CC1)CCC1=CC(C(Cc(cc1C)cc(/C=C\C=C)c1N)NC(N(CC1)CCC1C(C)(CCC1=CC=CCC1N1)C1=O)=O)=O ZJZAADHMASZFKL-TULCARLLSA-N 0.000 description 1
- MFFXSBWZZUKVEO-UHFFFAOYSA-N CN(C)C(CC1)CCN1C(C(Cc(cc1Cl)cc(N2)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)=O Chemical compound CN(C)C(CC1)CCN1C(C(Cc(cc1Cl)cc(N2)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)=O MFFXSBWZZUKVEO-UHFFFAOYSA-N 0.000 description 1
- NFRJYZURDHWOML-UHFFFAOYSA-N CN(CC1)CCC1C(CC1)CCN1C(C(CC(N(CC1)CCC1N(CCC1=CC=CCC1N1)C1=O)=O)Cc(cc1Br)cc2c1nccc2)=O Chemical compound CN(CC1)CCC1C(CC1)CCN1C(C(CC(N(CC1)CCC1N(CCC1=CC=CCC1N1)C1=O)=O)Cc(cc1Br)cc2c1nccc2)=O NFRJYZURDHWOML-UHFFFAOYSA-N 0.000 description 1
- MVJQSTUBOMIURG-UHFFFAOYSA-N CN(CC1)CCC1C(CC1)CCN1C(C(CC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)Cc(cc1O2)ccc1NC2=O)=O Chemical compound CN(CC1)CCC1C(CC1)CCN1C(C(CC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)Cc(cc1O2)ccc1NC2=O)=O MVJQSTUBOMIURG-UHFFFAOYSA-N 0.000 description 1
- RCIBMJMIOCUNOF-UHFFFAOYSA-N CN(CC1)CCC1C(CC1)CCN1C(C(Cc(cc1N2)cc(Cl)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)=O Chemical compound CN(CC1)CCC1C(CC1)CCN1C(C(Cc(cc1N2)cc(Cl)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)=O RCIBMJMIOCUNOF-UHFFFAOYSA-N 0.000 description 1
- YEYQENQBMCAJID-UHFFFAOYSA-N CN(CC1)CCC1N(CC1)CCN1C(C(CC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)Cc(cc1)cc(N2)c1NC2=O)=O Chemical compound CN(CC1)CCC1N(CC1)CCN1C(C(CC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)Cc(cc1)cc(N2)c1NC2=O)=O YEYQENQBMCAJID-UHFFFAOYSA-N 0.000 description 1
- AHEVBXIHCLUEKI-UHFFFAOYSA-N CN(CC1)CCC1N(CC1)CCN1C(C(Cc(cc1Cl)cc(N2)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)=O Chemical compound CN(CC1)CCC1N(CC1)CCN1C(C(Cc(cc1Cl)cc(N2)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)=O AHEVBXIHCLUEKI-UHFFFAOYSA-N 0.000 description 1
- ISECDZNNFXGUCD-UHFFFAOYSA-N CN(CC1)CCN1C(CC1)CCN1C(C(Cc(cc1Cl)cc(N2)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)=O Chemical compound CN(CC1)CCN1C(CC1)CCN1C(C(Cc(cc1Cl)cc(N2)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)=O ISECDZNNFXGUCD-UHFFFAOYSA-N 0.000 description 1
- CHZRTXKKKOYGJO-UHFFFAOYSA-N CN(CCc1ccccc1N1)C1=O Chemical compound CN(CCc1ccccc1N1)C1=O CHZRTXKKKOYGJO-UHFFFAOYSA-N 0.000 description 1
- VVUPNBPFNVLLEH-UHFFFAOYSA-N CN1N=C(c2ccccc2)NC1=O Chemical compound CN1N=C(c2ccccc2)NC1=O VVUPNBPFNVLLEH-UHFFFAOYSA-N 0.000 description 1
- UUHYITULYDTBSW-UHFFFAOYSA-N C[n](cc1)c2c1cc(CC(C(N(CC1)CCC1C1CCN(CC(OC)=O)CC1)=O)NC(N1CCC(CCC(CCc3ccccc3N3)C3=O)CC1)=O)cc2 Chemical compound C[n](cc1)c2c1cc(CC(C(N(CC1)CCC1C1CCN(CC(OC)=O)CC1)=O)NC(N1CCC(CCC(CCc3ccccc3N3)C3=O)CC1)=O)cc2 UUHYITULYDTBSW-UHFFFAOYSA-N 0.000 description 1
- 102000014468 Calcitonin Gene-Related Peptide Receptors Human genes 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- VLJVXMAQFYLTPQ-UHFFFAOYSA-N Cc(cc(CC(CC(N(CC1)CCC1N(CCc1ccccc1N1)C1=O)=O)C(N(CC1)CCN1C1CCN(C)CC1)=O)cc1O2)c1NC2=O Chemical compound Cc(cc(CC(CC(N(CC1)CCC1N(CCc1ccccc1N1)C1=O)=O)C(N(CC1)CCN1C1CCN(C)CC1)=O)cc1O2)c1NC2=O VLJVXMAQFYLTPQ-UHFFFAOYSA-N 0.000 description 1
- HOKUSOZBGBXWKM-UHFFFAOYSA-N Cc1cc(CC(C(N(CC2)CCC2N2CCN(C)CC2)=O)NC(N(CC2)CCC2N(CCc2ccccc2N2)C2=O)=O)cc(N2)c1NC2=O Chemical compound Cc1cc(CC(C(N(CC2)CCC2N2CCN(C)CC2)=O)NC(N(CC2)CCC2N(CCc2ccccc2N2)C2=O)=O)cc(N2)c1NC2=O HOKUSOZBGBXWKM-UHFFFAOYSA-N 0.000 description 1
- OZQWTMWCRLQWDN-UHFFFAOYSA-N Cc1cc(CC(C(N(CC2)CCC2N2CCN(C)CC2)=O)NC(N2CCC(CCC(CCc3ccccc3N3)C3=O)CC2)=O)cc2c1[nH]cc2 Chemical compound Cc1cc(CC(C(N(CC2)CCC2N2CCN(C)CC2)=O)NC(N2CCC(CCC(CCc3ccccc3N3)C3=O)CC2)=O)cc2c1[nH]cc2 OZQWTMWCRLQWDN-UHFFFAOYSA-N 0.000 description 1
- YASIQZFDWAJFMY-UHFFFAOYSA-N Cc1cc(CC(C(N(CC2)CCC2N2CCNCC2)=O)NC(N(CC2)CCC2N(CCc2ccccc2N2)C2=O)=O)cc(N2)c1NC2=O Chemical compound Cc1cc(CC(C(N(CC2)CCC2N2CCNCC2)=O)NC(N(CC2)CCC2N(CCc2ccccc2N2)C2=O)=O)cc(N2)c1NC2=O YASIQZFDWAJFMY-UHFFFAOYSA-N 0.000 description 1
- GFSRNNFHPMHQCE-UHFFFAOYSA-N Cc1cc(CC(C(N(CC2)CCN2C2CCN(C)CC2)=O)NC(N(CC2)CCC2N2N=C(c3ccccc3)NC2=O)=O)cc(N2)c1NC2=O Chemical compound Cc1cc(CC(C(N(CC2)CCN2C2CCN(C)CC2)=O)NC(N(CC2)CCC2N2N=C(c3ccccc3)NC2=O)=O)cc(N2)c1NC2=O GFSRNNFHPMHQCE-UHFFFAOYSA-N 0.000 description 1
- RHOPTHQACCXPDZ-UHFFFAOYSA-N Cc1cc(CC(CC(N(CC2)CCC2N2N=C(c3ccccc3)NC2=O)=O)C(N(CC2)CCC2N2CCCCC2)=O)cc(N2)c1NC2=O Chemical compound Cc1cc(CC(CC(N(CC2)CCC2N2N=C(c3ccccc3)NC2=O)=O)C(N(CC2)CCC2N2CCCCC2)=O)cc(N2)c1NC2=O RHOPTHQACCXPDZ-UHFFFAOYSA-N 0.000 description 1
- OJGQRTGNJZWVES-UHFFFAOYSA-N Cc1cc(CC(CC(N(CC2)CCC2N2N=C(c3ccccc3)NC2=O)=O)C(N(CC2)CCN2C2CCNCC2)=O)cc(O2)c1NC2=O Chemical compound Cc1cc(CC(CC(N(CC2)CCC2N2N=C(c3ccccc3)NC2=O)=O)C(N(CC2)CCN2C2CCNCC2)=O)cc(O2)c1NC2=O OJGQRTGNJZWVES-UHFFFAOYSA-N 0.000 description 1
- GJSURZIOUXUGAL-UHFFFAOYSA-N Clonidine Chemical compound ClC1=CC=CC(Cl)=C1NC1=NCCN1 GJSURZIOUXUGAL-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical compound [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 description 1
- XBPCUCUWBYBCDP-UHFFFAOYSA-N Dicyclohexylamine Chemical compound C1CCCCC1NC1CCCCC1 XBPCUCUWBYBCDP-UHFFFAOYSA-N 0.000 description 1
- MUXOBHXGJLMRAB-UHFFFAOYSA-N Dimethyl succinate Chemical compound COC(=O)CCC(=O)OC MUXOBHXGJLMRAB-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 238000012286 ELISA Assay Methods 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- 229940124056 Histamine H1 receptor antagonist Drugs 0.000 description 1
- 208000033830 Hot Flashes Diseases 0.000 description 1
- 206010060800 Hot flush Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- PWWVAXIEGOYWEE-UHFFFAOYSA-N Isophenergan Chemical compound C1=CC=C2N(CC(C)N(C)C)C3=CC=CC=C3SC2=C1 PWWVAXIEGOYWEE-UHFFFAOYSA-N 0.000 description 1
- UETNIIAIRMUTSM-UHFFFAOYSA-N Jacareubin Natural products CC1(C)OC2=CC3Oc4c(O)c(O)ccc4C(=O)C3C(=C2C=C1)O UETNIIAIRMUTSM-UHFFFAOYSA-N 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 108010007859 Lisinopril Proteins 0.000 description 1
- ZRVUJXDFFKFLMG-UHFFFAOYSA-N Meloxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=NC=C(C)S1 ZRVUJXDFFKFLMG-UHFFFAOYSA-N 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-XIXRPRMCSA-N Mesotartaric acid Chemical compound OC(=O)[C@@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-XIXRPRMCSA-N 0.000 description 1
- UUIQMZJEGPQKFD-UHFFFAOYSA-N Methyl butyrate Chemical compound CCCC(=O)OC UUIQMZJEGPQKFD-UHFFFAOYSA-N 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- UCHDWCPVSPXUMX-TZIWLTJVSA-N Montelukast Chemical compound CC(C)(O)C1=CC=CC=C1CC[C@H](C=1C=C(\C=C\C=2N=C3C=C(Cl)C=CC3=CC=2)C=CC=1)SCC1(CC(O)=O)CC1 UCHDWCPVSPXUMX-TZIWLTJVSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-UHFFFAOYSA-N Naproxen Natural products C1=C(C(C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- PDJOUBULRJRMKE-UHFFFAOYSA-N O=C(C(Cc(cc1Cl)cc(N2)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)N(CC1)CCC1C1CCNCC1 Chemical compound O=C(C(Cc(cc1Cl)cc(N2)c1NC2=O)NC(N(CC1)CCC1N1N=C(c2ccccc2)NC1=O)=O)N(CC1)CCC1C1CCNCC1 PDJOUBULRJRMKE-UHFFFAOYSA-N 0.000 description 1
- NXSCUEYNZXPHRH-UHFFFAOYSA-N O=C(CC(CC1)CCC1C1CCNCC1)C(CC(N1CCC(CCC(CCc2ccccc2N2)C2=O)CC1)=O)Cc(cc1)cc2c1[nH]cc2 Chemical compound O=C(CC(CC1)CCC1C1CCNCC1)C(CC(N1CCC(CCC(CCc2ccccc2N2)C2=O)CC1)=O)Cc(cc1)cc2c1[nH]cc2 NXSCUEYNZXPHRH-UHFFFAOYSA-N 0.000 description 1
- TVJXRKQRCOSGFY-UHFFFAOYSA-N O=C(CC(Cc(cc1)cc(O2)c1NC2=O)C(N(CC1)CCC1N1CCCCC1)=O)N(CC1)CCC1N1N=C(c2ccccc2)NC1=O Chemical compound O=C(CC(Cc(cc1)cc(O2)c1NC2=O)C(N(CC1)CCC1N1CCCCC1)=O)N(CC1)CCC1N1N=C(c2ccccc2)NC1=O TVJXRKQRCOSGFY-UHFFFAOYSA-N 0.000 description 1
- ZTIUCVMRKOVYOK-UHFFFAOYSA-O O=C(CC(Cc(cc1)cc2c1[nH]cc2)C(N1CCC(CCC2CCNCC2)CC1)=O)N(CC1)CCC1N1N=C(c2ccccc2)[NH2+]C1=O Chemical compound O=C(CC(Cc(cc1)cc2c1[nH]cc2)C(N1CCC(CCC2CCNCC2)CC1)=O)N(CC1)CCC1N1N=C(c2ccccc2)[NH2+]C1=O ZTIUCVMRKOVYOK-UHFFFAOYSA-O 0.000 description 1
- WDPJXJADWKSVBR-UHFFFAOYSA-N O=C(CC(Cc(cc1O2)ccc1NC2=O)C(N(CC1)CCC1N1CCNCC1)=O)N(CC1)CCC1N1N=C(c2ccccc2)NC1=O Chemical compound O=C(CC(Cc(cc1O2)ccc1NC2=O)C(N(CC1)CCC1N1CCNCC1)=O)N(CC1)CCC1N1N=C(c2ccccc2)NC1=O WDPJXJADWKSVBR-UHFFFAOYSA-N 0.000 description 1
- CXOFVDLJLONNDW-UHFFFAOYSA-N Phenytoin Chemical compound N1C(=O)NC(=O)C1(C=1C=CC=CC=1)C1=CC=CC=C1 CXOFVDLJLONNDW-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920002873 Polyethylenimine Polymers 0.000 description 1
- 229920003080 Povidone K 25 Polymers 0.000 description 1
- IWYDHOAUDWTVEP-UHFFFAOYSA-N R-2-phenyl-2-hydroxyacetic acid Natural products OC(=O)C(O)C1=CC=CC=C1 IWYDHOAUDWTVEP-UHFFFAOYSA-N 0.000 description 1
- 238000003436 Schotten-Baumann reaction Methods 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- KJADKKWYZYXHBB-XBWDGYHZSA-N Topiramic acid Chemical compound C1O[C@@]2(COS(N)(=O)=O)OC(C)(C)O[C@H]2[C@@H]2OC(C)(C)O[C@@H]21 KJADKKWYZYXHBB-XBWDGYHZSA-N 0.000 description 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- YZCKVEUIGOORGS-NJFSPNSNSA-N Tritium Chemical compound [3H] YZCKVEUIGOORGS-NJFSPNSNSA-N 0.000 description 1
- 108010057266 Type A Botulinum Toxins Proteins 0.000 description 1
- 229960004892 acemetacin Drugs 0.000 description 1
- FSQKKOOTNAMONP-UHFFFAOYSA-N acemetacin Chemical compound CC1=C(CC(=O)OCC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 FSQKKOOTNAMONP-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229960002133 almotriptan Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229960000836 amitriptyline Drugs 0.000 description 1
- KRMDCWKBEZIMAB-UHFFFAOYSA-N amitriptyline Chemical compound C1CC2=CC=CC=C2C(=CCCN(C)C)C2=CC=CC=C21 KRMDCWKBEZIMAB-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000003474 anti-emetic effect Effects 0.000 description 1
- 230000001022 anti-muscarinic effect Effects 0.000 description 1
- 229940125681 anticonvulsant agent Drugs 0.000 description 1
- 239000001961 anticonvulsive agent Substances 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 229940125683 antiemetic agent Drugs 0.000 description 1
- 239000002111 antiemetic agent Substances 0.000 description 1
- 229940125684 antimigraine agent Drugs 0.000 description 1
- 239000002282 antimigraine agent Substances 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 239000012131 assay buffer Substances 0.000 description 1
- 229960002274 atenolol Drugs 0.000 description 1
- 229950002360 avitriptan Drugs 0.000 description 1
- WRZVGHXUPBWIOO-UHFFFAOYSA-N avitriptan Chemical compound C12=CC(CS(=O)(=O)NC)=CC=C2NC=C1CCCN(CC1)CCN1C1=NC=NC=C1OC WRZVGHXUPBWIOO-UHFFFAOYSA-N 0.000 description 1
- 229960002170 azathioprine Drugs 0.000 description 1
- LMEKQMALGUDUQG-UHFFFAOYSA-N azathioprine Chemical compound CN1C=NC([N+]([O-])=O)=C1SC1=NC=NC2=C1NC=N2 LMEKQMALGUDUQG-UHFFFAOYSA-N 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 239000002876 beta blocker Substances 0.000 description 1
- 229940097320 beta blocking agent Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 229940089093 botox Drugs 0.000 description 1
- 229940098773 bovine serum albumin Drugs 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- FFGPTBGBLSHEPO-UHFFFAOYSA-N carbamazepine Chemical compound C1=CC2=CC=CC=C2N(C(=O)N)C2=CC=CC=C21 FFGPTBGBLSHEPO-UHFFFAOYSA-N 0.000 description 1
- 229960000623 carbamazepine Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 229960000590 celecoxib Drugs 0.000 description 1
- RZEKVGVHFLEQIL-UHFFFAOYSA-N celecoxib Chemical compound C1=CC(C)=CC=C1C1=CC(C(F)(F)F)=NN1C1=CC=C(S(N)(=O)=O)C=C1 RZEKVGVHFLEQIL-UHFFFAOYSA-N 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 238000011097 chromatography purification Methods 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 229960002896 clonidine Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 229940111134 coxibs Drugs 0.000 description 1
- UVKZSORBKUEBAZ-UHFFFAOYSA-N cyclizine Chemical compound C1CN(C)CCN1C(C=1C=CC=CC=1)C1=CC=CC=C1 UVKZSORBKUEBAZ-UHFFFAOYSA-N 0.000 description 1
- 229960003564 cyclizine Drugs 0.000 description 1
- 239000003255 cyclooxygenase 2 inhibitor Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229910052805 deuterium Inorganic materials 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- XLMALTXPSGQGBX-GCJKJVERSA-N dextropropoxyphene Chemical compound C([C@](OC(=O)CC)([C@H](C)CN(C)C)C=1C=CC=CC=1)C1=CC=CC=C1 XLMALTXPSGQGBX-GCJKJVERSA-N 0.000 description 1
- 229960004193 dextropropoxyphene Drugs 0.000 description 1
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 description 1
- 229960001259 diclofenac Drugs 0.000 description 1
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 1
- HUPFGZXOMWLGNK-UHFFFAOYSA-N diflunisal Chemical compound C1=C(O)C(C(=O)O)=CC(C=2C(=CC(F)=CC=2)F)=C1 HUPFGZXOMWLGNK-UHFFFAOYSA-N 0.000 description 1
- 229960000616 diflunisal Drugs 0.000 description 1
- HESHRHUZIWVEAJ-JGRZULCMSA-N dihydroergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2[C@@H](C3=CC=CC4=NC=C([C]34)C2)C1)C)C1=CC=CC=C1 HESHRHUZIWVEAJ-JGRZULCMSA-N 0.000 description 1
- 229960004704 dihydroergotamine Drugs 0.000 description 1
- HSUGRBWQSSZJOP-RTWAWAEBSA-N diltiazem Chemical compound C1=CC(OC)=CC=C1[C@H]1[C@@H](OC(C)=O)C(=O)N(CCN(C)C)C2=CC=CC=C2S1 HSUGRBWQSSZJOP-RTWAWAEBSA-N 0.000 description 1
- 229960004166 diltiazem Drugs 0.000 description 1
- UXGNZZKBCMGWAZ-UHFFFAOYSA-N dimethylformamide dmf Chemical compound CN(C)C=O.CN(C)C=O UXGNZZKBCMGWAZ-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- FGXWKSZFVQUSTL-UHFFFAOYSA-N domperidone Chemical compound C12=CC=CC=C2NC(=O)N1CCCN(CC1)CCC1N1C2=CC=C(Cl)C=C2NC1=O FGXWKSZFVQUSTL-UHFFFAOYSA-N 0.000 description 1
- 229960001253 domperidone Drugs 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000773 effect on pain Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960002472 eletriptan Drugs 0.000 description 1
- OTLDLQZJRFYOJR-LJQANCHMSA-N eletriptan Chemical compound CN1CCC[C@@H]1CC1=CN=C2[C]1C=C(CCS(=O)(=O)C=1C=CC=CC=1)C=C2 OTLDLQZJRFYOJR-LJQANCHMSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003133 ergot alkaloid Drugs 0.000 description 1
- OFKDAAIKGIBASY-VFGNJEKYSA-N ergotamine Chemical compound C([C@H]1C(=O)N2CCC[C@H]2[C@]2(O)O[C@@](C(N21)=O)(C)NC(=O)[C@H]1CN([C@H]2C(C3=CC=CC4=NC=C([C]34)C2)=C1)C)C1=CC=CC=C1 OFKDAAIKGIBASY-VFGNJEKYSA-N 0.000 description 1
- 229960004943 ergotamine Drugs 0.000 description 1
- XCGSFFUVFURLIX-UHFFFAOYSA-N ergotaminine Natural products C1=C(C=2C=CC=C3NC=C(C=23)C2)C2N(C)CC1C(=O)NC(C(N12)=O)(C)OC1(O)C1CCCN1C(=O)C2CC1=CC=CC=C1 XCGSFFUVFURLIX-UHFFFAOYSA-N 0.000 description 1
- CCIVGXIOQKPBKL-UHFFFAOYSA-M ethanesulfonate Chemical compound CCS([O-])(=O)=O CCIVGXIOQKPBKL-UHFFFAOYSA-M 0.000 description 1
- OJCSPXHYDFONPU-UHFFFAOYSA-N etoac etoac Chemical compound CCOC(C)=O.CCOC(C)=O OJCSPXHYDFONPU-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- ZPAKPRAICRBAOD-UHFFFAOYSA-N fenbufen Chemical compound C1=CC(C(=O)CCC(=O)O)=CC=C1C1=CC=CC=C1 ZPAKPRAICRBAOD-UHFFFAOYSA-N 0.000 description 1
- 229960001395 fenbufen Drugs 0.000 description 1
- 229960001419 fenoprofen Drugs 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- SMANXXCATUTDDT-QPJJXVBHSA-N flunarizine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)N1CCN(C\C=C\C=2C=CC=CC=2)CC1 SMANXXCATUTDDT-QPJJXVBHSA-N 0.000 description 1
- 229960000326 flunarizine Drugs 0.000 description 1
- 229960002390 flurbiprofen Drugs 0.000 description 1
- SYTBZMRGLBWNTM-UHFFFAOYSA-N flurbiprofen Chemical compound FC1=CC(C(C(O)=O)C)=CC=C1C1=CC=CC=C1 SYTBZMRGLBWNTM-UHFFFAOYSA-N 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000001640 fractional crystallisation Methods 0.000 description 1
- 229960002284 frovatriptan Drugs 0.000 description 1
- SIBNYOSJIXCDRI-SECBINFHSA-N frovatriptan Chemical compound C1=C(C(N)=O)[CH]C2=C(C[C@H](NC)CC3)C3=NC2=C1 SIBNYOSJIXCDRI-SECBINFHSA-N 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 229960002870 gabapentin Drugs 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000000938 histamine H1 antagonist Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 125000004531 indol-5-yl group Chemical group [H]N1C([H])=C([H])C2=C([H])C(*)=C([H])C([H])=C12 0.000 description 1
- 229960000905 indomethacin Drugs 0.000 description 1
- 229960002056 indoramin Drugs 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- XVQUOJBERHHONY-UHFFFAOYSA-N isometheptene Chemical compound CNC(C)CCC=C(C)C XVQUOJBERHHONY-UHFFFAOYSA-N 0.000 description 1
- 229960003046 isometheptene Drugs 0.000 description 1
- DKYWVDODHFEZIM-UHFFFAOYSA-N ketoprofen Chemical compound OC(=O)C(C)C1=CC=CC(C(=O)C=2C=CC=CC=2)=C1 DKYWVDODHFEZIM-UHFFFAOYSA-N 0.000 description 1
- 229960000991 ketoprofen Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- VHOGYURTWQBHIL-UHFFFAOYSA-N leflunomide Chemical compound O1N=CC(C(=O)NC=2C=CC(=CC=2)C(F)(F)F)=C1C VHOGYURTWQBHIL-UHFFFAOYSA-N 0.000 description 1
- 229960000681 leflunomide Drugs 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229960002394 lisinopril Drugs 0.000 description 1
- CZRQXSDBMCMPNJ-ZUIPZQNBSA-N lisinopril dihydrate Chemical compound O.O.C([C@H](N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(O)=O)C(O)=O)CC1=CC=CC=C1 CZRQXSDBMCMPNJ-ZUIPZQNBSA-N 0.000 description 1
- WGOPGODQLGJZGL-UHFFFAOYSA-N lithium;butane Chemical compound [Li+].CC[CH-]C WGOPGODQLGJZGL-UHFFFAOYSA-N 0.000 description 1
- 229960002202 lornoxicam Drugs 0.000 description 1
- OXROWJKCGCOJDO-JLHYYAGUSA-N lornoxicam Chemical compound O=C1C=2SC(Cl)=CC=2S(=O)(=O)N(C)\C1=C(\O)NC1=CC=CC=N1 OXROWJKCGCOJDO-JLHYYAGUSA-N 0.000 description 1
- 229940057948 magnesium stearate Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 229960002510 mandelic acid Drugs 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 229960003464 mefenamic acid Drugs 0.000 description 1
- HYYBABOKPJLUIN-UHFFFAOYSA-N mefenamic acid Chemical compound CC1=CC=CC(NC=2C(=CC=CC=2)C(O)=O)=C1C HYYBABOKPJLUIN-UHFFFAOYSA-N 0.000 description 1
- 229960001929 meloxicam Drugs 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- PIZJNPVTWMMBIP-UHFFFAOYSA-N methyl 2-(1h-indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butanoate Chemical compound C1CC2=CC=CC=C2NC(=O)N1C(CC1)CCN1C(=O)CC(C(=O)OC)CC1=CC=C(NN=C2)C2=C1 PIZJNPVTWMMBIP-UHFFFAOYSA-N 0.000 description 1
- IBBZQUWNNGSXCG-UHFFFAOYSA-N methyl 2-[(7-methyl-1h-indazol-5-yl)methyl]-4-oxo-4-[4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidin-1-yl]butanoate Chemical compound C1CC2=CC=CC=C2NC(=O)N1C(CC1)CCN1C(=O)CC(C(=O)OC)CC1=CC(C)=C(NN=C2)C2=C1 IBBZQUWNNGSXCG-UHFFFAOYSA-N 0.000 description 1
- TTWJBBZEZQICBI-UHFFFAOYSA-N metoclopramide Chemical compound CCN(CC)CCNC(=O)C1=CC(Cl)=C(N)C=C1OC TTWJBBZEZQICBI-UHFFFAOYSA-N 0.000 description 1
- 229960004503 metoclopramide Drugs 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229960005127 montelukast Drugs 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000003149 muscarinic antagonist Substances 0.000 description 1
- REPVNSJSTLRQEQ-UHFFFAOYSA-N n,n-dimethylacetamide;n,n-dimethylformamide Chemical compound CN(C)C=O.CN(C)C(C)=O REPVNSJSTLRQEQ-UHFFFAOYSA-N 0.000 description 1
- ZFRNVCFWEGWIDJ-UHFFFAOYSA-N n-[1-[4-(4-fluorophenyl)piperidin-1-yl]-3-(1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1=CC(F)=CC=C1C1CCN(C(=O)C(CC=2C=C3C=NNC3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 ZFRNVCFWEGWIDJ-UHFFFAOYSA-N 0.000 description 1
- SUZMQFRELQJARF-UHFFFAOYSA-N n-[1-[4-(4-methyl-1,4-diazepan-1-yl)piperidin-1-yl]-3-(7-methyl-1h-indazol-5-yl)-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCCN1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 SUZMQFRELQJARF-UHFFFAOYSA-N 0.000 description 1
- JPPVEJVUQJDNBV-UHFFFAOYSA-N n-[1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxo-3-[7-(trifluoromethyl)-1h-indazol-5-yl]propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=NNC3=C(C=2)C(F)(F)F)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 JPPVEJVUQJDNBV-UHFFFAOYSA-N 0.000 description 1
- XQOOGBNMFYJNCM-UHFFFAOYSA-N n-[3-(1-methylindazol-5-yl)-1-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCN1C1CCN(C(=O)C(CC=2C=C3C=NN(C)C3=CC=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 XQOOGBNMFYJNCM-UHFFFAOYSA-N 0.000 description 1
- AJAZORKSSNXTNA-UHFFFAOYSA-N n-[3-(1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(3-oxo-5-phenyl-1h-1,2,4-triazol-2-yl)piperidine-1-carboxamide Chemical compound C1CC(N2C(NC(=N2)C=2C=CC=CC=2)=O)CCN1C(=O)NC(CC=1C=C2C=NNC2=CC=1)C(=O)N(CC1)CCC1C1CCNCC1 AJAZORKSSNXTNA-UHFFFAOYSA-N 0.000 description 1
- XDISEMIVILCLQB-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)-1,4-diazepan-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CCC1 XDISEMIVILCLQB-UHFFFAOYSA-N 0.000 description 1
- QRKZBKSNVJJRSX-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-[4-(1-methylpiperidin-4-yl)piperazin-1-yl]-1-oxopropan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C1CN(C)CCC1N1CCN(C(=O)C(CC=2C=C3C=NNC3=C(C)C=2)NC(=O)N2CCC(CC2)N2C(NC3=CC=CC=C3CC2)=O)CC1 QRKZBKSNVJJRSX-UHFFFAOYSA-N 0.000 description 1
- MULHJFHQHKEYTD-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 MULHJFHQHKEYTD-UHFFFAOYSA-N 0.000 description 1
- IXNCVRYRSYWVSC-UHFFFAOYSA-N n-[3-(7-methyl-1h-indazol-5-yl)-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCN1C1=CC=NC=C1 IXNCVRYRSYWVSC-UHFFFAOYSA-N 0.000 description 1
- DJZFXLCTWGKYEO-UHFFFAOYSA-N n-[3-(7-methyl-1h-indol-5-yl)-1-oxo-1-(4-piperazin-1-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2C=CNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1N1CCNCC1 DJZFXLCTWGKYEO-UHFFFAOYSA-N 0.000 description 1
- FXYFNKBBGMINBQ-UHFFFAOYSA-N n-[3-(7-methyl-2h-benzotriazol-5-yl)-1-oxo-1-(4-piperidin-4-ylpiperidin-1-yl)propan-2-yl]-4-(2-oxo-4,5-dihydro-1h-1,3-benzodiazepin-3-yl)piperidine-1-carboxamide Chemical compound C=1C=2N=NNC=2C(C)=CC=1CC(NC(=O)N1CCC(CC1)N1C(NC2=CC=CC=C2CC1)=O)C(=O)N(CC1)CCC1C1CCNCC1 FXYFNKBBGMINBQ-UHFFFAOYSA-N 0.000 description 1
- VWPOSFSPZNDTMJ-UCWKZMIHSA-N nadolol Chemical compound C1[C@@H](O)[C@@H](O)CC2=C1C=CC=C2OCC(O)CNC(C)(C)C VWPOSFSPZNDTMJ-UCWKZMIHSA-N 0.000 description 1
- 229960004255 nadolol Drugs 0.000 description 1
- 229960002009 naproxen Drugs 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical compound C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- UNHGSHHVDNGCFN-UHFFFAOYSA-N naratriptan Chemical compound C=12[CH]C(CCS(=O)(=O)NC)=CC=C2N=CC=1C1CCN(C)CC1 UNHGSHHVDNGCFN-UHFFFAOYSA-N 0.000 description 1
- 229960005254 naratriptan Drugs 0.000 description 1
- 229940097496 nasal spray Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 235000008729 phenylalanine Nutrition 0.000 description 1
- 150000002994 phenylalanines Chemical class 0.000 description 1
- 229960002895 phenylbutazone Drugs 0.000 description 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 description 1
- 229960002036 phenytoin Drugs 0.000 description 1
- QYSPLQLAKJAUJT-UHFFFAOYSA-N piroxicam Chemical compound OC=1C2=CC=CC=C2S(=O)(=O)N(C)C=1C(=O)NC1=CC=CC=N1 QYSPLQLAKJAUJT-UHFFFAOYSA-N 0.000 description 1
- 229960002702 piroxicam Drugs 0.000 description 1
- FIADGNVRKBPQEU-UHFFFAOYSA-N pizotifen Chemical compound C1CN(C)CCC1=C1C2=CC=CC=C2CCC2=C1C=CS2 FIADGNVRKBPQEU-UHFFFAOYSA-N 0.000 description 1
- 229960004572 pizotifen Drugs 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 238000002953 preparative HPLC Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- WIKYUJGCLQQFNW-UHFFFAOYSA-N prochlorperazine Chemical compound C1CN(C)CCN1CCCN1C2=CC(Cl)=CC=C2SC2=CC=CC=C21 WIKYUJGCLQQFNW-UHFFFAOYSA-N 0.000 description 1
- 229960003111 prochlorperazine Drugs 0.000 description 1
- 229960003910 promethazine Drugs 0.000 description 1
- 229960003712 propranolol Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000006340 racemization Effects 0.000 description 1
- 238000000163 radioactive labelling Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960000425 rizatriptan Drugs 0.000 description 1
- TXHZXHICDBAVJW-UHFFFAOYSA-N rizatriptan Chemical compound C=1[C]2C(CCN(C)C)=CN=C2C=CC=1CN1C=NC=N1 TXHZXHICDBAVJW-UHFFFAOYSA-N 0.000 description 1
- 229960000371 rofecoxib Drugs 0.000 description 1
- RZJQGNCSTQAWON-UHFFFAOYSA-N rofecoxib Chemical compound C1=CC(S(=O)(=O)C)=CC=C1C1=C(C=2C=CC=CC=2)C(=O)OC1 RZJQGNCSTQAWON-UHFFFAOYSA-N 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229940086766 sodium chloride 180 mg Drugs 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- 229910000104 sodium hydride Inorganic materials 0.000 description 1
- AEQFSUDEHCCHBT-UHFFFAOYSA-M sodium valproate Chemical compound [Na+].CCCC(C([O-])=O)CCC AEQFSUDEHCCHBT-UHFFFAOYSA-M 0.000 description 1
- WGRULTCAYDOGQK-UHFFFAOYSA-M sodium;sodium;hydroxide Chemical compound [OH-].[Na].[Na+] WGRULTCAYDOGQK-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 229960001940 sulfasalazine Drugs 0.000 description 1
- NCEXYHBECQHGNR-QZQOTICOSA-N sulfasalazine Chemical compound C1=C(O)C(C(=O)O)=CC(\N=N\C=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-QZQOTICOSA-N 0.000 description 1
- NCEXYHBECQHGNR-UHFFFAOYSA-N sulfasalazine Natural products C1=C(O)C(C(=O)O)=CC(N=NC=2C=CC(=CC=2)S(=O)(=O)NC=2N=CC=CC=2)=C1 NCEXYHBECQHGNR-UHFFFAOYSA-N 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960004605 timolol Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229960004394 topiramate Drugs 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 125000004784 trichloromethoxy group Chemical group ClC(O*)(Cl)Cl 0.000 description 1
- 238000005533 tritiation Methods 0.000 description 1
- 229910052722 tritium Inorganic materials 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 229940102566 valproate Drugs 0.000 description 1
- PJDFLNIOAUIZSL-UHFFFAOYSA-N vigabatrin Chemical compound C=CC(N)CCC(O)=O PJDFLNIOAUIZSL-UHFFFAOYSA-N 0.000 description 1
- 229960005318 vigabatrin Drugs 0.000 description 1
- 229960001360 zolmitriptan Drugs 0.000 description 1
- ULSDMUVEXKOYBU-ZDUSSCGKSA-N zolmitriptan Chemical compound C1=C2C(CCN(C)C)=CNC2=CC=C1C[C@H]1COC(=O)N1 ULSDMUVEXKOYBU-ZDUSSCGKSA-N 0.000 description 1
- ZXVNMYWKKDOREA-UHFFFAOYSA-N zomepirac Chemical compound C1=C(CC(O)=O)N(C)C(C(=O)C=2C=CC(Cl)=CC=2)=C1C ZXVNMYWKKDOREA-UHFFFAOYSA-N 0.000 description 1
- 229960003414 zomepirac Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Die vorliegende Erfindung betrifft substituierte Piperidine der allgemeinen Formel, in der A, B, D, E,..., R1, R2 und X wie im Anspruch 1 definiert sind, deren Tautomere, deren Diastereomere, deren Enantiomere, deren Gemische und deren Salze, insbesondere deren physiologisch verträgliche Salze mit anorganischen oder organischen Säuren oder Basen, welche wertvolle pharmakologische Eigenschaften aufweisen, insbesondere CGRP-antagonistische Eigenschaften, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung.The present invention relates to substituted piperidines of the general formula in which A, B, D, E, ..., R 1 , R 2 and X are as defined in claim 1, their tautomers, their diastereomers, their enantiomers, their mixtures and their salts, in particular their physiologically acceptable salts with inorganic or organic acids or bases which have valuable pharmacological properties, in particular CGRP-antagonistic properties, medicaments containing these compounds, their use and processes for their preparation.
Description
Gegenstand der vorliegenden Erfindung sind ausgewählte CGRP-Antagonisten der allgemeinen Formel deren Tautomere, deren Diastereomere, deren Enantiomere, deren Hydrate, deren Gemische und deren Salze sowie die Hydrate der Salze, insbesondere deren physiologisch verträgliche Salze mit anorganischen oder organischen Säuren, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung.The present invention relates to selected CGRP antagonists of the general formula their tautomers, their diastereomers, their enantiomers, their hydrates, their mixtures and their salts, and the hydrates of the salts, in particular their physiologically acceptable salts with inorganic or organic acids, medicaments containing these compounds, their use and processes for their preparation.
In
der obigen allgemeinen Formel bedeuten in einer ersten Ausführungsform
A
ein Stickstoff- oder Sauerstoffatom oder eine CH-Gruppe,
B
ein Stickstoffatom, eine CH- oder eine Carbonyl-Gruppe,
D ein
Wasserstoffatom oder eine Methylgruppe,
E ein Wasserstoff-,
Fluor- Chlor- oder Bromatom, eine Methyl-, Ethyl- oder Trifluormethylgruppe,
X
eine Methylen- oder NH-Gruppe,
---- eine Einfachbindung, wenn
A ein Sauerstoffatom darstellt, oder
R1 einen
Rest der Formel und
R2 einen Rest der Formel In the above general formula, in a first embodiment
A is a nitrogen or oxygen atom or a CH group,
B is a nitrogen atom, a CH or a carbonyl group,
D is a hydrogen atom or a methyl group,
E is a hydrogen, fluorine, chlorine or bromine atom, a methyl, ethyl or trifluoromethyl group,
X is a methylene or NH group,
---- a single bond, if A represents an oxygen atom, or
R 1 is a radical of the formula and
R 2 is a radical of the formula
Eine
zweite Ausführungsform
der vorliegenden Erfindung umfasst diejenigen Verbindungen der allgemeinen
Formel I, in denen
die Kombination von A, B, D, E und ----
eine Gruppe der Formel R1 einen Rest der Formel und
R2 einen Rest der Formel deren
Tautomere, deren Diastereomere, deren Enantiomere, deren Hydrate,
deren Gemische und deren Salze sowie die Hydrate der Salze.A second embodiment of the present invention comprises those compounds of general formula I in which
the combination of A, B, D, E and ---- a group of the formula R 1 is a radical of the formula and
R 2 is a radical of the formula their tautomers, their diastereomers, their enantiomers, their hydrates, their mixtures and their salts, and the hydrates of the salts.
Beispielsweise seien folgende bevorzugte Verbindungen der allgemeinen Formel I erwähnt:
- (1) 1-1,4'-Bipiperidinyl-1'-yl-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (2) 2-(1H-Indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (3) 1-4,4'-Bipiperidinyl-1-yl-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (4) 1-(4-Dimethylamino-piperidin-1-yl)-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (5) (S)-2-(1H-Indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (6) 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (7) 2-(1H-Indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (8) 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (9) 2-(1H-Indazol-5-ylmethyl)-1-[4-(4-methyl-perhydro-1,4-diazepin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (10) 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (11) 2-(1H-Indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-perhydro-1,4-diazepin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (12) 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl)-butan-1,4- dion,
- (13) 1-[4-(4-fluor-phenyl)-piperazin-1-yl]-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (14) 1-[4-(4-fluor-phenyl)-piperidin-1-yl]-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (15) 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-pyridin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (16) (1'-{2-(1H-Indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butyryl}-4,4'-bipiperidinyl-1-yl)-essigsäure-methylester,
- (17) 2-(1H-Indazol-5-ylmethyl)-1-(1'-methanesulfonyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (18) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-1,4'-bipiperidinyl-1'-yl-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (19) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (20) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (21) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(4-dimethylamino-piperidin-1-yl)-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (22) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (23) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (24) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (25) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (26) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(4-methyl-perhydro-1,4-diazepin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (27) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (28) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-perhydro-1,4-diazepin-1-yl]-2-oxo-ethyl}-amid,
- (29) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl)-ethyl]-amid,
- (30) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-fluor-phenyl)-piperazin-1-yl]-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (31) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-fluor-phenyl)-piperidin-1-yl]-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (32) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-pyridin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (33) [1'-(3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonyl]-amino}-propionyl)-4,4'-bipiperidinyl-1-yl]-essigsäure-methylester,
- (34) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-(1'-methanesulfonyl-4,4'-bipiperidinyl-1-yl)-2-oxo- ethyl]-amid,
- (35) 1-1,4'-Bipiperidinyl-1'-yl-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (36) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (37) 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (38) 1-(4-Dimethylamino-piperidin-1-yl)-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (39) 2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (40) 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (41) 2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (42) 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (43) 2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-perhydro-1,4-diazepin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (44) 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (45) 2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-perhydro-1,4-diazepin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (46) 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl)-butan-1,4-dion,
- (47) 1-[4-(4-fluor-phenyl)-piperazin-1-yl]-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (48) 1-[4-(4-fluor-phenyl)-piperidin-1-yl]-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (49) 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-pyridin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (50) (1'-{2-(7-Methyl-1H-indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butyryl}-4,4'-bipiperidinyl-1-yl)-essigsäure-methylester,
- (51) 1-(1'-Methanesulfonyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (52) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-1,4'-bipiperidinyl-1'-yl-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (53) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (54) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (55) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(4-dimethylamino-piperidin-1-yl)-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (56) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1- yl]-2-oxo-ethyl}-amid,
- (57) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (58) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (59) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (60) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-perhydro-1,4-diazepin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (61) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (62) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-perhydro-1,4-diazepin-1-yl]-2-oxo-ethyl}-amid,
- (63) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl)-ethyl]-amid,
- (64) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-fluor-phenyl)-piperazin-1-yl]-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (65) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-fluor-phenyl)-piperidin-1-yl]-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (66) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-pyridin-4-yl-piperazin-1-yl)- ethyl]-amid,
- (67) [1'-(3-(7-Methyl-1H-indazol-5-yl)-2-{[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonyl]-amino}-propionyl)-4,4'-bipiperidinyl-1-yl]-essigsäure-methylester,
- (68) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methanesulfonyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (69) 2-(1H-Indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (70) 1-4,4'-Bipiperidinyl-1-yl-2-(1H-indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (71) 2-(1H-Indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (72) 2-(1H-Indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (73) 2-(1H-Indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (74) 2-(1H-Indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (75) 1-1,4'-Bipiperidinyl-1'-yl-2-(1H-indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (76) 1-(4-Dimethylamino-piperidin-1-yl)-2-(1H-indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (77) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (78) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (79) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo- ethyl}-amid,
- (80) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (81) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (82) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (83) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (84) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (85) 2-(7-Ethyl-1H-indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (86) 1-4,4'-Bipiperidinyl-1-yl-2-(7-ethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (87) 2-(7-Ethyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (88) 2-(7-Ethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (89) 2-(7-Ethyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (90) 2-(7-Ethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (91) 2-(7-Chlor-1H-indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (92) 1-4,4'-Bipiperidinyl-1-yl-2-(7-chlor-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (93) 2-(7-Chlor-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (94) 2-(7-Chlor-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (95) 2-(7-chlor-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (96) 2-(7-Chlor-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (97) 2-(7-Brom-1H-indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (98) 1-4,4'-Bipiperidinyl-1-yl-2-(7-brom-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (99) 2-(7-Brom-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (100) 2-(7-Brom-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (101) 2-(7-Brom-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (102) 2-(7-Brom-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (103) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion,
- (104) 1-4,4'-Bipiperidinyl-1-yl-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion,
- (105) 2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (106) 4-[4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion,
- (107) 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion,
- (108) 4-[4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion,
- (109) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(1-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (110) 1-4,4'-Bipiperidinyl-1-yl-2-(1-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (111) 2-(1-Methyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (112) 2-(1-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (113) 2-(1-Methyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (114) 2-(1-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (115) 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (116) 1-4,4'-Bipiperidinyl-1-yl-2-(1,7-dimethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (117) 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (118) 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (119) 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (120) 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (121) 2-(1H-Benzotriazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (122) 2-(1H-Benzotriazol-5-ylmethyl)-1-4,4'-bipiperidinyl-1-yl-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (123) 2-(1H-Benzotriazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (124) 2-(1H-Benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (125) 2-(1H-Benzotriazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (126) 2-(1H-Benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (127) 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (128) 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-1H-benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (129) 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (130) 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (131) 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (132) 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (133) 2-(1H-Indol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (134) 1-4,4'-Bipiperidinyl-1-yl-2-(1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (135) 2-(1H-Indol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (136) 2-(1H-Indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3- yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (137) 2-(1H-Indol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (138) 2-(1H-Indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (139) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (140) 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (141) 2-(7-Methyl-1H-indol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (142) 2-(7-Methyl-1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (143) 2-(7-Methyl-1H-indol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (144) 2-(7-Methyl-1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (145) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-ethyl-1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (146) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-ethyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (147) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-ethyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (148) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-ethyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (149) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-ethyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (150) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-ethyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (151) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-chlor-1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (152) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-chlor-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (153) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-chlor-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (154) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-chlor-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (155) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-chlor-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (156) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-chlor-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (157) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-brom-1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (158) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-brom-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (159) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-brom-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (160) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-brom-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (161) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-brom-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (162) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-brom-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (163) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid,
- (164) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid,
- (165) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid,
- (166) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid,
- (167) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid,
- (168) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid,
- (169) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(1-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (170) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(1-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (171) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1-methyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (172) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (173) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1-methyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (174) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (175) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (176) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (177) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (178) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (179) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (180) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (181) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-benzotriazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (182) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure (1-(1H-benzotriazol-5-ylmethyl)-2-4,4'-bipiperidinyl-1-yl-2-oxo-ethyl]-amid,
- (183) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-benzotriazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (184) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-benzotriazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (185) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-benzotriazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (186) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-benzotriazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (187) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (188) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (189) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)- piperidin-1-yl]-2-oxo-ethyl}-amid,
- (190) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (191) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (192) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (193) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (194) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(1H-indol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (195) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (196) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (197) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (198) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (199) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-1H-indol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (200) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-1H-indol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (201) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (202) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (203) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (204) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (205) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (206) 1-4,4'-Bipiperidinyl-1-yl-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (207) 1-[4-(4-Methyl-piperazin-1-yl)-piperidin-1-yl]-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (208) 2-(2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (209) 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (210) 2-(2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (211) 1-1,4'-Bipiperidinyl-1'-yl-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (212) 1-(4-Dimethylamino-piperidin-1-yl)-2-(2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (213) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (214) 1-4,4'-Bipiperidinyl-1-yl-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (215) 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (216) 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (217) 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (218) 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (219) 1-1,4'-Bipiperidinyl-1'-yl-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (220) 1-(4-Dimethylamino-piperidin-1-yl)-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (221) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (222) 1-4,4'-Bipiperidinyl-1-yl-2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (223) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (224) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (225) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (226) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (227) 1-1,4'-Bipiperidinyl-1'-yl-2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (228) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-(4-dimethylamino-piperidin-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (229) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (230) 1-4,4'-Bipiperidinyl-1-yl-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (231) 1-[4-(4-Methyl-piperazin-1-yl)-piperidin-1-yl]-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (232) 2-(2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-di hydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (233) 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (234) 2-(2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (235) 1-1,4'-Bipiperidinyl-1'-yl-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (236) 1-(4-Dimethylamino-piperidin-1-yl)-2-(2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (237) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (238) 1-4,4'-Bipiperidinyl-1-yl-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (239) 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (240) 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (241) 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (242) 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)- butan-1,4-dion,
- (243) 1-1,4'-Bipiperidinyl-1'-yl-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl)-butan-1,4-dion,
- (244) 1-(4-Dimethylamino-piperidin-1-yl)-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (245) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (246) 1-4,4'-Bipiperidinyl-1-yl-2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (247) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (248) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (249) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (250) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (251) 1-1,4'-Bipiperidinyl-1'-yl-2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (252) 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-(4-dimethylamino-piperidin-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin- 1-yl]-butan-1,4-dion,
- (253) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (254) 1-4,4'-Bipiperidinyl-1-yl-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (255) 1-[4-(4-Methyl-piperazin-1-yl)-piperidin-1-yl]-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (256) 2-(2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (257) 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (258) 2-(2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (259) 1-1,4'-Bipiperidinyl-1'-yl-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (260) 1-(4-Dimethylamino-piperidin-1-yl)-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (261) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (262) 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]- butan-1,4-dion,
- (263) 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (264) 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (265) 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (266) 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (267) 1-1,4'-Bipiperidinyl-1'-yl-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (268) 1-(4-Dimethylamino-piperidin-1-yl)-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (269) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (270) 1-4,4'-Bipiperidinyl-1-yl-2-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (271) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (272) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl- piperidin-1-yl)-butan-1,4-dion,
- (273) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (274) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (275) 1-1,4'-Bipiperidinyl-1'-yl-2-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (276) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-(4-dimethylamino-piperidin-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (277) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (278) 1-4,4'-Bipiperidinyl-1-yl-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (279) 1-[4-(4-Methyl-piperazin-1-yl)-piperidin-1-yl]-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (280) 2-(2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (281) 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (282) 2-(2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)- butan-1,4-dion,
- (283) 1-1,4'-Bipiperidinyl-1'-yl-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (284) 1-(4-Dimethylamino-piperidin-1-yl)-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (285) 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (286) 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (287) 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (288) 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (289) 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (290) 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (291) 1-1,4'-Bipiperidinyl-1'-yl-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (292) 1-(4-Dimethylamino-piperidin-1-yl)-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)- piperidin-1-yl]-butan-1,4-dion,
- (293) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (294) 1-4,4'-Bipiperidinyl-1-yl-2-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (295) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (296) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (297) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (298) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion,
- (299) 1-1,4'-Bipiperidinyl-1'-yl-2-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (300) 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-(4-dimethylamino-piperidin-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion,
- (301) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (302) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)- ethyl]-amid,
- (303) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (304) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (305) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (306) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (307) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (308) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (309) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (310) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (311) 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion,
- (312) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperazin- 1-yl-piperidin-1-yl)-ethyl]-amid,
- (313) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure{1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (314) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (315) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (316) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (317) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (318) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (319) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure{1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (320) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (321) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure{1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (322) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperidin- 4-yl-piperazin-1-yl)-ethyl]-amid,
- (323) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (324) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-dimethylaminopiperidin-1-yl)-2-oxo-ethyl]-amid,
- (325) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (326) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (327) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (328) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (329) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (330) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (331) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid,
- (332) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol- 6-ylmethyl)-ethyl]-amid,
- (333) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (334) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (335) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (336) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (337) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (338) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (339) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure(2-1,4'-bipiperidinyl-1'-yl-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (340) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (341) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (342) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)- 2-oxo-ethyl]-amid,
- (343) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (344) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (345) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (346) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (347) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid,
- (348) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-dimethylamino-piperidin-1-yl)-2-oxo-ethyl]-amid,
- (349) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (350) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (351) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (352) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-piperazin-1-yl- piperidin-1-yl)-ethyl]-amid,
- (353) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (354) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (355) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (356) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (357) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl)-amid,
- (358) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (359) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure{1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (360) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (361) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure{1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (362) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4- piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (363) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (364) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (365) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (366) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (367) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure{1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (368) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (369) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure{1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (370) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (371) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (372) 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-dimethyl amino-piperidin-1-yl)-2-oxo-ethyl]-amid,
- (373) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (374) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (375) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (376) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (377) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (378) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (379) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (380) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid,
- (381) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (382) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-yl methyl)-2-oxo-ethyl]-amid,
- (383) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(4-methylpiperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (384) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazal-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (385) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (386) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (387) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (388) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (389) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid,
- (390) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (391) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid,
- (392) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-pipera zin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (393) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid,
- (394) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid,
- (395) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid,
- (396) 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-dimethylamino-piperidin-1-yl)-2-oxo-ethyl]-amid,
- (397) 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-1-(4-pyrrolidin-1-yl-piperidin-1-yl)-butan-1,4-dion,
- (398) 4-(2-Oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carbonsäure-[1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-pyrrolidin-1-yl-piperidin-1-yl)-ethyl]-amid,
- (1) 1-1,4'-bipiperidinyl-1'-yl-2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (2) 2- (1H-Indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4 , 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (3) 1-4,4'-bipiperidinyl-1-yl-2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1, 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (4) 1- (4-Dimethylamino-piperidin-1-yl) -2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (5) (S) -2- (1H-Indazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (6) 2- (1H-Indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 yl] 1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (7) 2- (1H-Indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (8) 2- (1H-Indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 yl] -1- (4-piperi din-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (9) 2- (1H-Indazol-5-ylmethyl) -1- [4- (4-methyl-perhydro-1,4-diazepin-1-yl) -piperidin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (10) 2- (1H-Indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1] yl] -1- (4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (11) 2- (1H-indazol-5-ylmethyl) -1- [4- (1-methylpiperidin-4-yl) -perhydro-1,4-diazepin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (12) 2- (1H-Indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1] yl] -1- (4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl) -butane-1,4-dione,
- (13) 1- [4- (4-fluoro-phenyl) -piperazin-1-yl] -2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4 , 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (14) 1- [4- (4-fluoro-phenyl) -piperidin-1-yl] -2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4 , 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (15) 2- (1H-Indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1] yl] -1- (4-pyridin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (16) (1 '- {2- (1H-Indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine] 3-yl) -piperidin-1-yl] -butyryl} -4,4'-bipiperidinyl-1-yl) -acetic acid methylester,
- (17) 2- (1H-Indazol-5-ylmethyl) -1- (1'-methanesulfonyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4 , 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (18) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl -1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (19) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2 - (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (20) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (21) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (22) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2 - [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (23) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2 -oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (24) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2 - [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (25) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2 -oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (26) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2 - [4- (4-methyl-perhydro-1,4-diazepin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (27) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2 -oxo-2- (4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (28) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2 - [4- (1-methyl-piperidin-4-yl) -perhydro-1,4-diazepin-1-yl] -2-oxo-ethyl} -amide,
- (29) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2 -oxo-2- (4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl) -ethyl] -amide,
- (30) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-fluoro-phenyl) -] piperazin-1-yl] -1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (31) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-fluoro-phenyl) -] piperidin-1-yl] -1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (32) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2 -oxo-2- (4-pyridin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (33) [1 '- (3- (1H-Indazol-5-yl) -2 - {[4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl ) -piperidine-1-carbonyl] -amine o} -propionyl) -4,4'-bipiperidinyl-1-yl] -acetic acid methylester,
- (34) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2 - (1'-methanesulfonyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (35) 1-1,4'-bipiperidinyl-1'-yl-2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5 tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (36) 1- (1'-Methyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (37) 1-4,4'-bipiperidinyl-1-yl-2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5- tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (38) 1- (4-Dimethylamino-piperidin-1-yl) -2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5 tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (39) 2- (7-Methyl-1H-indazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (40) 2- (7-Methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (41) 2- (7-Methyl-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (42) 2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (43) 2- (7-Methyl-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-perhydro-1,4-diazepin-1-yl) -piperidin-1-yl] -4 - [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (44) 2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (45) 2- (7-Methyl-1H-indazol-5-ylmethyl) -1- [4- (1-methylpiperidin-4-yl) -perhydro-1,4-diazepin-1-yl] -4 - [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (46) 2- (7-Methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4- piperidin-4-yl-perhydro-1,4-diazepin-1-yl) -butan-1,4-dione,
- (47) 1- [4- (4-fluoro-phenyl) -piperazin-1-yl] -2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (48) 1- [4- (4-fluoro-phenyl) -piperidin-1-yl] -2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (49) 2- (7-Methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-pyridin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (50) (1 '- {2- (7-methyl-1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1, 3-benzodiazepin-3-yl) -piperidin-1-yl] -butyryl} -4,4'-bipiperidinyl-1-yl) -acetic acid methylester,
- (51) 1- (1'-Methanesulfonyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (52) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (53) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'- bipiperidinyl-1-yl) -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (54) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (55) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (56) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indazole-5-) ylmethyl) -2- [4- (4-methyl-1-piperazin-1-yl) -piperidin-1-yl] -2-oxo-ethyl} -amide,
- (57) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazole-5- ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (58) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indazole-5-) ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (59) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazole-5- ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (60) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indazol-5-) ylmethyl) -2- [4- (4-methyl-perhydro-1,4-diazepin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (61) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazole-5-one] ylmethyl) -2-oxo-2- (4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (62) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indazole-5- ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) -perhydro-1,4-diazepin-1-yl] -2-oxo-ethyl} -amide,
- (63) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazole-5- ylmethyl) -2-oxo-2- (4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl) -ethyl] -amide,
- (64) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-fluoro-phenyl) -] piperazin-1-yl] -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (65) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-fluoro-phenyl) -] piperidin-1-yl] -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (66) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazole-5-one] ylmethyl) -2-oxo-2- (4-pyridin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (67) [1 '- (3- (7-Methyl-1H-indazol-5-yl) -2 - {[4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine -3-yl) -piperidine-1-carbonyl] -amino} -propionyl) -4,4'-bipiperidinyl-1-yl] -acetic acid methylester,
- (68) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methanesulfonyl-4,4'- bipiperidinyl-1-yl) -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (69) 2- (1H-Indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (5-oxo-3-phenyl-4 , 5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (70) 1-4,4'-bipiperidinyl-1-yl-2- (1H-indazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1, 2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (71) 2- (1H-Indazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (5-oxo-3 -phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (72) 2- (1H-Indazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine 1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (73) 2- (1H-Indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (5-oxo-3 -phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (74) 2- (1H-Indazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine 1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (75) 1-1,4'-bipiperidinyl-1'-yl-2- (1H-indazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1 , 2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (76) 1- (4-Dimethylamino-piperidin-1-yl) -2- (1H-indazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1 , 2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (77) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (78) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-one yl-1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (79) 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2- [4- (4-methylpiperazin-1-yl) piperidin-1-yl] -2-oxoethyl} -amide,
- (80) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (81) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (82) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (83) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1 ' -yl-1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (84) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidine-1-) yl) -1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (85) 2- (7-Ethyl-1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (86) 1-4,4'-bipiperidinyl-1-yl-2- (7-ethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5- tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (87) 2- (7-Ethyl-1H-indazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (88) 2- (7-Ethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (89) 2- (7-Ethyl-1H-indazol-5-ylmethyl) -1- [4- (1-methylpiperidin-4-yl) -piperazin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (90) 2- (7-Ethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (91) 2- (7-Chloro-1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1yl] -butan-1,4-dione,
- (92) 1-4,4'-bipiperidinyl-1-yl-2- (7-chloro-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5- tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (93) 2- (7-Chloro-1H-indazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (94) 2- (7-chloro-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (95) 2- (7-chloro-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (96) 2- (7-chloro-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (97) 2- (7-Bromo-1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (98) 1-4,4'-bipiperidinyl-1-yl-2- (7-bromo-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5- tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (99) 2- (7-bromo-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (100) 2- (7-Bromo-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (101) 2- (7-Bromo-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (102) 2- (7-Bromo-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (103) 1- (1'-Methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine-3 -yl) piperidin-1-yl] -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione,
- (104) 1-4,4'-bipiperidinyl-1-yl-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione,
- (105) 2- (7-Methyl-1H-indazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (106) 4- [4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperazine-1) yl-piperidin-1-yl) -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione,
- (107) 1- [4- (1-Methylpiperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3 benzodiazepine-3-yl) -piperidin-1-yl] -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione,
- (108) 4- [4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperidine-4-) yl-piperazin-1-yl) -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione,
- (109) 1- (1'-Methyl-4,4'-bipiperidinyl-1-yl) -2- (1-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (110) 1-4,4'-bipiperidinyl-1-yl-2- (1-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5- tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (111) 2- (1-Methyl-1H-indazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (112) 2- (1-Methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (113) 2- (1-Methyl-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (114) 2- (1-Methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (115) 2- (1,7-Dimethyl-1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo -1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (116) 1-4,4'-bipiperidinyl-1-yl-2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4, 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (117) 2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (118) 2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl ) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (119) 2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2- oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (120) 2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl ) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (121) 2- (1H-Benzotriazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4 , 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (122) 2- (1H-Benzotriazol-5-ylmethyl) -1,4,4'-bipiperidinyl-1-yl-4- [4- (2-oxo-1,2,4,5-tetrahydro-1, 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (123) 2- (1H-Benzotriazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (124) 2- (1H-Benzotriazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1] yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (125) 2- (1H-Benzotriazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (126) 2- (1H-Benzotriazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1] yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (127) 2- (7-Methyl-1H-benzotriazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (128) 1-4,4'-bipiperidinyl-1-yl-2- (7-methyl-1H-benzotriazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5- tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (129) 2- (7-Methyl-1H-benzotriazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (130) 2- (7-Methyl-1H-benzotriazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (131) 2- (7-Methyl-1H-benzotriazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (132) 2- (7-Methyl-1H-benzotriazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (133) 2- (1H-Indol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4 , 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (134) 1-4,4'-bipiperidinyl-1-yl-2- (1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1, 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (135) 2- (1H-Indol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (136) 2- (1H-Indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (137) 2- (1H-Indol-5-ylmethyl) -1- [4- (1-methylpiperidin-4-yl) -piperazin-1-yl] -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (138) 2- (1H-Indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (139) 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (140) 1-4,4'-bipiperidinyl-1-yl-2- (7-methyl-1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5- tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (141) 2- (7-Methyl-1H-indol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (142) 2- (7-Methyl-1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (143) 2- (7-Methyl-1H-indol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (144) 2- (7-Methyl-1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) - piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (145) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-ethyl-1H-indazole-5- ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (146) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (7-ethyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (147) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-ethyl-1H-indazole-5- ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (148) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-ethyl-1H-indazole-5- ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (149) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-ethyl-1H-indazole-5- ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (150) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-ethyl-1H-indazole-5- ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (151) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-1H-indazole-5- ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (152) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (7-chloro-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (153) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-chloro-1H-indazole-5- ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (154) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-1H-indazole-5- ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (155) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-chloro-1H-indazole-5- ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (156) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-1H-indazole-5- ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (157) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-bromo-1H-indazole-5- ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (158) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (7-bromo-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (159) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-bromo-1H-indazole-5- ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (160) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-bromo-1H-indazole-5- ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (161) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-bromo-1H-indazole-5- ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (162) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-bromo-1H-indazole-5- ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (163) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'- bipiperidinyl-1-yl) -2-oxo-1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide,
- (164) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 2-oxo-1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide,
- (165) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-methyl-piperazine-1 -yl) piperidin-1-yl] -2-oxo-1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide,
- (166) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-2- (4-pipera zin-1-yl-piperidin-1-yl) -1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide,
- (167) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (1-methyl-piperidine-4 yl) piperazin-1-yl] -2-oxo-1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide,
- (168) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-2- (4-piperidine-4-) yl-piperazin-1-yl) -1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide,
- (169) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'- bipiperidinyl-1-yl) -1- (1-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (170) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (1-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (171) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1-methyl-1H-indazole-5-) ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (172) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1-methyl-1H-indazole-5-one] ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (173) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1-methyl-1H-indazole-5- ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (174) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1-methyl-1H-indazole-5-one] ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (175) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1,7-dimethyl-1H-indazole) 5-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (176) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (1,7-dimethyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (177) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1,7-dimethyl-1H-indazole) 5-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (178) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1,7-dimethyl-1H-indazole) 5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (179) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1,7-dimethyl-1H-indazole) 5-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (180) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1,7-dimethyl-1H-indazole) 5-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (181) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-benzotriazol-5-ylmethyl) -2 - (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (182) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid (1- (1H-benzotriazol-5-ylmethyl) -2 -4,4'-bipiperidinyl-1-yl-2-oxo-ethyl] -amide,
- (183) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-benzotriazol-5-ylmethyl) -2 - [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (184) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-benzotriazol-5-ylmethyl) -2 -oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (185) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-benzotriazol-5-ylmethyl) -2 - [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (186) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-benzotriazol-5-ylmethyl) -2 -oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (187) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-benzotriazole-5- ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (188) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (7-methyl-1H-benzotriazole-5-ylmethyl) -2-oxo-ethyl] -amide,
- (189) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-benzotriazole-5- ylmethyl) -2- [4- (4-methylpiperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (190) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-benzotriazole-5- ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (191) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-benzotriazole-5- ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (192) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-benzotriazole-5- ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (193) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indol-5-ylmethyl) -2 - (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (194) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (1H-indol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (195) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indol-5-ylmethyl) -2 - [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (196) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indol-5-yl thyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (197) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indol-5-ylmethyl) -2 - [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (198) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indol-5-ylmethyl) -2 -oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (199) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'- bipiperidinyl-1-yl) -1- (7-methyl-1H-indol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (200) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (7-methyl-1H-indol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (201) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indole-5-) ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (202) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indole-5-) ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (203) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indole-5-) ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (204) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indole-5-) ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (205) 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (206) 1-4,4'-bipiperidinyl-1-yl-2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (207) 1- [4- (4-Methylpiperazin-1-yl) -piperidin-1-yl] -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [ 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (208) 2- (2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine-3 -yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (209) 1- [4- (1-Methylpiperidin-4-yl) piperazin-1-yl] -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [ 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (210) 2- (2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine-3 -yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (211) 1-1,4'-bipiperidinyl-1'-yl-2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2 , 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (212) 1- (4-Dimethylamino-piperidin-1-yl) -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (213) 1- (1'-Methyl-4,4'-bipiperidinyl-1-yl) -2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [ 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (214) 1-4,4'-bipiperidinyl-1-yl-2- (4-methyl-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -4- [4- (2-yl) oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (215) 2- (4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (216) 2- (4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3 benzodiazepine-3-yl) -piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (217) 2- (4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (218) 2- (4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3 benzodiazepine-3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (219) 1-1,4'-Bipiperidinyl-1'-yl-2- (4- methyl-2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl) -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (220) 1- (4-Dimethylamino-piperidin-1-yl) -2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo -1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (221) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [ 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (222) 1-4,4'-bipiperidinyl-1-yl-2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo) 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (223) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (224) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3 benzodiazepine-3-yl) -piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (225) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (226) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3 benzodiazepine-3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (227) 1-1,4'-Bipiperidinyl-1'-yl-2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo -1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (228) 2- (4-Chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- (4-dimethylamino-piperidin-1-yl) -4- [4- (2-oxo -1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (229) 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (230) 1-4,4'-bipiperidinyl-1-yl-2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl) 4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (231) 1- [4- (4-Methylpiperazin-1-yl) -piperidin-1-yl] -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [ 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (232) 2- (2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4- triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (233) 1- [4- (1-Methylpiperidin-4-yl) piperazin-1-yl] -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [ 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (234) 2- (2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazole -1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (235) 1-1,4'-Bipiperidinyl-1'-yl-2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl -4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (236) 1- (4-Dimethylamino-piperidin-1-yl) -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3 -phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (237) 1- (1'-Methyl-4,4'-bipiperidinyl-1-yl) -2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [ 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (238) 1-4,4'-bipiperidinyl-1-yl-2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5- oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (239) -2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (240) 2- (4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2 , 4-triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (241) 2- (4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (1-methylpiperidin-4-yl) -piperazin-1-yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (242) 2- (4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2 , 4-triazol-1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butane-1,4-dione,
- (243) 1-1,4'-Bipiperidinyl-1'-yl-2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl) -4- [4- (5 -oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl) -butan-1,4-dione,
- (244) 1- (4-Dimethylamino-piperidin-1-yl) -2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo -3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (245) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [ 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (246) 1-4,4'-bipiperidinyl-1-yl-2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo) 3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (247) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (248) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2 , 4-triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (249) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (250) 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2 , 4-triazol-1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (251) 1-1,4'-Bipiperidinyl-1'-yl-2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo -3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (252) 2- (4-Chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- (4-dimethylamino-piperidin-1-yl) -4- [4- (5-oxo 3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidin-1-yl] -butane-1,4-dione,
- (253) 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (254) 1-4,4'-bipiperidinyl-1-yl-2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1, 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (255) 1- [4- (4-Methylpiperazin-1-yl) -piperidin-1-yl] -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4 - [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (256) 2- (2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine -3-yl) -piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (257) 1- [4- (1-Methylpiperidin-4-yl) piperazin-1-yl] -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4 - [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (258) 2- (2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine -3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (259) 1-1,4'-Bipiperidinyl-1'-yl-2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (260) 1- (4-Dimethylamino-piperidin-1-yl) -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (261) 1- (1'-Methyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4 - [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (262) 1-4,4'-Bipiperidinyl-1-yl-2- (7-methyl-2-oxo-2,3-dihydro-1 H -benzimidazol-5-ylmethyl) -4- [4- (2- oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butane-1,4-dione,
- (263) 2- (7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidine-1 yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (264) 2- (7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (265) 2- (7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazine-1] yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (266) 2- (7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (267) 1-1,4'-bipiperidinyl-1'-yl-2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (268) 1- (4-Dimethylamino-piperidin-1-yl) -2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (269) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4 - [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (270) 1-4,4'-bipiperidinyl-1-yl-2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2- oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (271) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidine-1] yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (272) 2- (7-Chloro-2-oxo-2,3-dihydro-1 H -benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butane-1,4-dione,
- (273) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazine-1] yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (274) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (275) 1-1,4'-bipiperidinyl-1'-yl-2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (276) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- (4-dimethylamino-piperidin-1-yl) -4- [4- (2 oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (277) 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (278) 1-4,4'-Bipiperidinyl-1-yl-2- (2-oxo-2,3-dihydro-1 H -benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-) phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (279) 1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4 - (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione;
- (280) 2- (2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4 triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (281) 1- [4- (1-Methylpiperidin-4-yl) piperazin-1-yl] -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4 - [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (282) 2- (2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4 -triazol-1-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butane-1,4-dione,
- (283) 1-1,4'-Bipiperidinyl-1'-yl-2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3 -phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (284) 1- (4-Dimethylamino-piperidin-1-yl) -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3 -phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (285) 1- (1'-Methyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4 - [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (286) 1-4,4'-bipiperidinyl-1-yl-2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5- oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (287) 2- (7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidine-1] yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione .
- (288) 2- (7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1 , 2,4-triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (289) 2- (7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazine-1] yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione .
- (290) 2- (7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1 , 2,4-triazol-1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (291) 1-1,4'-bipiperidinyl-1'-yl-2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5 -oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (292) 1- (4-Dimethylamino-piperidin-1-yl) -2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5 oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidin-1-yl] -butane-1,4-dione,
- (293) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4 - [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (294) 1-4,4'-bipiperidinyl-1-yl-2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5- oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (295) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidine-1] yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione .
- (296) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1 , 2,4-triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (297) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazine-1] yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione .
- (298) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1 , 2,4-triazol-1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione,
- (299) 1-1,4'-Bipiperidinyl-1'-yl-2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo- 3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (300) 2- (7-Chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- (4-dimethylamino-piperidin-1-yl) -4- [4- (5 -oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione,
- (301) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'- bipiperidinyl-1-yl) -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (302) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (303) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-methyl-piperazine-1 -yl) piperidin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (304) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (305) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (1-methyl-piperidine-4 yl) piperazin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (306) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (307) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (308) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (309) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'- bipiperidinyl-1-yl) -1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (310) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (311) 2- (4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) -piperidin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione,
- (312) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-methyl-2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (313) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (4-methyl-2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (314) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-methyl-2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (315) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl -1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (316) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (317) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (318) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (319) 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (4-chloro-2-oxo-2,3-dihydro benzoxazol-6-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (320) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (321) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (4-chloro-2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (322) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (323) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl -1- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (324) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2, 3-dihydro-benzoxazol-6-ylmethyl) -2- (4-dimethylaminopiperidine-1-yl) -2-oxo-ethyl] -amide,
- (325) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4 '-bipiperidinyl-1-yl) -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (326) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-one yl-2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (327) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- [4- (4-methyl-piperazine -1-yl) piperidin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (328) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (329) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- [4- (1-methyl-piperidine -4-yl) piperazine-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (330) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (331) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1 ' -yl-2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (332) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidine-1-) yl) -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide,
- (333) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4 '-bipiperidinyl-1-yl) -1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (334) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-one yl-1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (335) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (4-methyl-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (336) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-methyl-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (337) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (4-methyl-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (338) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-methyl-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (339) 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid (2-1,4'-bipiperidinyl-1'-yl 1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (340) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidine-1-) yl) -1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (341) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (342) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-one yl-1- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (343) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (4-chloro-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (344) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (345) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (4-chloro-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (346) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (347) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1 ' -yl-1- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide,
- (348) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo) 2,3-dihydro-benzoxazol-6-ylmethyl) -2- (4-dimethylamino-piperidin-1-yl) -2-oxo-ethyl] -amide,
- (349) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'- bipiperidinyl-1-yl) -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (350) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (351) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-methyl-piperazine-1 -yl) piperidin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (352) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (353) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (1-methyl-piperidine-4 yl) piperazin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (354) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (355) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (356) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (357) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'- bipiperidinyl-1-yl) -1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl) -amide,
- (358) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (359) 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-2-oxo-2,3-dihydro -1H-benzimidazol-5-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (360) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (361) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (362) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (363) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl -1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (364) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (365) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (366) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl] 1- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (367) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-chloro-2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (368) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (369) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-chloro-2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (370) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (371) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl -1- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (372) 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2, 3-dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-dimethylamino-piperidin-1-yl) -2-oxo-ethyl] -amide,
- (373) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4 '-bipiperidinyl-1-yl) -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (374) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-one yl-2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (375) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- [4- (4-methyl-piperazine -1-yl) piperidin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (376) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (377) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- [4- (1-methyl-piperidine -4-yl) piperazine-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (378) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (379) 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl 2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (380) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidine-1-) yl) -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide,
- (381) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4 '-bipiperidinyl-1-yl) -1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (382) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-one yl-1- (7-methyl-2-oxo-2,3-dihydro-1 H -benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (383) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (7-methyl-2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (4-methylpiperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (384) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-methyl-2-oxo) 2,3-dihydro-1H-benzimidazal-5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (385) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (7-methyl-2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (386) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-methyl-2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (387) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1 ' -yl-1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (388) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidine-1-) yl) -1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (389) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide,
- (390) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-one yl-1- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (391) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (7-chloro-2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide,
- (392) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide,
- (393) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (7-chloro-2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide,
- (394) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide,
- (395) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1 ' -yl-1- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide,
- (396) 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo) 2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-dimethylamino-piperidin-1-yl) -2-oxo-ethyl] -amide,
- (397) 2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydrobenzo [d] [1,3] diazepin-3-yl) piperidin-1-yl] -1- (4-pyrrolidin-1-yl-piperidin-1-yl) -butan-1,4-dione,
- (398) 4- (2-Oxo-1,2,4,5-tetrahydro-benzo [d] [1,3] diazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazole) 5-ylmethyl) -2-oxo-2- (4-pyrrolidin-1-yl-piperidin-1-yl) -ethyl] -amide,
Die Verbindungen der allgemeinen Formel (I) werden nach prinzipiell bekannten Methoden hergestellt. Die folgenden Verfahren haben sich zur Herstellung der erfindungsgemäßen Verbindungen der allgemeinen Formel (I) besonders bewährt:
- (a) Zur Herstellung von Verbindungen der allgemeinen Formel (I), in der X die NH-Gruppe bedeutet und A, B, D, E, ----, R1 und R2 wie eingangs erwähnt definiert sind: Umsetzung von Piperidinen der allgemeinen Formel in der R1 wie eingangs erwähnt definiert ist, mit Kohlensäurederivaten der allgemeinen Formel in der G eine nucleofuge Gruppe, bevorzugt die Phenoxy-, 1H-Imidazol-1-yl-, 1H-1,2,4-Triazol-1-yl-, Trichlormethoxy- oder die 2,5-Dioxopyrrolidin-1-yloxy-Gruppe bedeutet, und mit primären Aminen der allgemeinen Formel in der A, B, D, E, ---- und R2 wie eingangs erwähnt definiert ist, mit der Maßgabe, dass diese Gruppen keine weitere freie primäre oder sekundäre aliphatische Aminofunktion enthalten.
- (A) For the preparation of compounds of the general formula (I) in which X is the NH group and A, B, D, E, ----, R 1 and R 2 are defined as mentioned above: reaction of piperidines the general formula in which R 1 is defined as mentioned above, with carbonic acid derivatives of the general formula in the G is a nucleofugic group, preferably the phenoxy, 1H-imidazol-1-yl, 1H-1,2,4-triazol-1-yl, trichloromethoxy or the 2,5-dioxopyrrolidin-1-yloxy- Group means, and with primary amines of the general formula in which A, B, D, E, ---- and R 2 are defined as mentioned above, with the proviso that these groups contain no further free primary or secondary aliphatic amino function.
Die im Prinzip zweistufigen Reaktionen werden in der Regel als Eintopfverfahren durchgeführt, und zwar bevorzugt in der Weise, dass man in der ersten Stufe eine der beiden Komponenten (III) oder (V) mit äquimolaren Mengen des Kohlensäurederivates der allgemeinen Formel (IV) in einem geeigneten Lösungsmittel bei tieferer Temperatur zur Reaktion bringt, anschließend wenigstens äquimolare Mengen der anderen Komponente (III) oder (V) zugibt und die Umsetzung bei höherer Temperatur beendet. Die Umsetzungen mit Bis-(trichlormethyl)-carbonat werden bevorzugt in Gegenwart von wenigstens 2 Äquivalenten (bezogen auf Bis-(trichlormethyl)-carbonat) einer tertiären Base, beispielsweise von Triethylamin, N-Ethyldiisopropylamin, Pyridin, 1,5-Diaza-bicyclo-[4,3,0]-non-5-en, 1,4-Diazabicyclo[2,2,2]octan oder 1,8-Diazabicyclo-[5,4,0]-un-dec-7-en, durchgeführt. Als Lösungsmittel, die wasserfrei sein sollten, kommen beispielsweise Tetrahydrofuran, Dioxan, Dimethylformamid, Dimethylacetamid, N-Methyl-2-pyrrolidon, 1,3-Dimethyl-2-imidazolidinon oder Acetonitril in Betracht, bei Verwendung von Bis-(trichlormethyl)-carbonat als Carbonylkomponente werden wasserfreie Chlorkohlenwasserstoffe, beispielsweise Dichlormethan, 1,2-Dichlorethan oder Trichlorethylen, bevorzugt. Die Reaktionstemperaturen liegen für die erste Reaktionsstufe zwischen –30°C und +25°C, bevorzugt –5°C und +10°C, für die zweite Reaktionsstufe zwischen +15°C und der Siedetemperatur des verwendeten Lösungsmittels, bevorzugt zwischen +20°C und +70°C (Siehe auch: H. A. Staab und W. Rohr, "Synthesen mit heterocyclischen Amiden (Azoliden)", Neuere Methoden der Präparativen Organischen Chemie, Band V, S. 53-93, Verlag Chemie, Weinheim/Bergstr., 1967; P. Majer und R.S. Randad, J. Org. Chem. 59, S. 1937-1938 (1994); K. Takeda, Y. Akagi, A. Saiki, T. Sukahara und H. Ogura, Tetrahedron Letters 24 (42), 4569-4572 (1983)).
- (b) Zur Herstellung von Verbindungen der allgemeinen Formel (I), in der X die Methylengruppe bedeutet und A, B, D, E, ----, R1 und R2 wie eingangs erwähnt definiert sind, mit der Maßgabe, dass diese Gruppen keine weitere freie primäre oder sekundäre aliphatische Aminofunktion enthalten: Kupplung einer Carbonsäure der allgemeinen Formel in der A, B, D, E, ---- und R2 wie eingangs erwähnt definiert sind, mit einem Piperidin der allgemeinen Formel in der R1 die eingangs erwähnten Bedeutungen besitzt.
- (b) For the preparation of compounds of general formula (I) in which X represents the methylene group and A, B, D, E, ----, R 1 and R 2 are as defined above, with the proviso that these groups contain no further free primary or secondary aliphatic amino function: Coupling of a carboxylic acid of the general formula in which A, B, D, E, ---- and R 2 are defined as mentioned above, with a piperidine of the general formula in which R 1 has the meanings mentioned above.
Die Kupplung wird bevorzugt unter Verwendung von aus der Peptidchemie bekannten Verfahren (siehe z. B. Houben-Weyl, Methoden der Organischen Chemie, Bd. 15/2) durchgeführt, wobei zum Beispiel Carbodiimide, wie z.B. Dicyclohexylcarbodiimid (DCC), Diisopropylcarbodiimid (DIC) oder Ethyl-(3-dimethylaminopropyl)-carbodiimid, O-(1H-Benzotriazol-1-yl)-N,N-N',N'-tetramethyluronium-hexafluorphosphat (HBTU) oder -tetrafluorborat (TBTU) oder 1H-Benzotriazol-1-yl-oxytris-(dimethylamino)-phosphoniumhexafluorphosphat (BOP) eingesetzt werden. Durch Zugabe von 1-Hydroxybenzotriazol (HOBt) oder von 3-Hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazin (HOObt) kann die Reaktionsgeschwindigkeit gesteigert werden. Die Kupplungen werden normalerweise mit äquimolaren Anteilen der Kupplungskomponenten sowie des Kupplungsreagenz in Lösungsmitteln wie Dichlormethan, Tetrahydrofuran, Acetonitril, Dimethylformamid (DMF), Dimethylacetamid (DMA), N-Methylpyrrolidon (NMP) oder Gemischen aus diesen und bei Temperaturen zwischen –30°C und +30°C, bevorzugt –20°C und +25°C, durchgeführt. Sofern erforderlich, wird als zusätzliche Hilfsbase N-Ethyldiisopropylamin (DIEA) (Hünig-Base) bevorzugt.The Coupling is preferred using peptide chemistry known processes (see, for example, Houben-Weyl, Methoden der Organischen Chemie, Vol. 15/2), for example, carbodiimides, e.g. dicyclohexylcarbodiimide (DCC), diisopropylcarbodiimide (DIC) or ethyl (3-dimethylaminopropyl) carbodiimide, O- (1H-benzotriazol-1-yl) -N, N-N ', N'-tetramethyluronium hexafluorophosphate (HBTU) or tetrafluoroborate (TBTU) or 1H-benzotriazol-1-yl-oxytris- (dimethylamino) phosphonium hexafluorophosphate (BOP) are used. By addition of 1-hydroxybenzotriazole (HOBt) or 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazine (HOObt) the reaction rate can be increased. The couplings are usually equimolar Proportions of Coupling Components and Coupling Reagent in solvents such as dichloromethane, tetrahydrofuran, acetonitrile, dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidone (NMP) or mixtures from these and at temperatures between -30 ° C and + 30 ° C, preferably -20 ° C and + 25 ° C performed. Provided required, as an additional auxiliary base N-ethyldiisopropylamine (DIEA) (Hünig base) prefers.
Als weiteres Kupplungsverfahren zur Synthese von Verbindungen der allgemeinen Formel (I) wird das sogenannte "Anhydridverfahren" (siehe auch: M. Bodanszky, "Peptide Chemistry", Springer-Verlag 1988, S. 58-59; M. Bodanszky, "Principles of Peptide Synthesis", Springer-Verlag 1984, S. 21-27) eingesetzt. Bevorzugt wird das "gemischte Anhydridverfahren" in der Variante nach Vaughan (J.R. Vaughan Jr., J. Amer. Chem. Soc. 73, 3547 (1951)), bei der unter Verwendung von Chlorkohlensäureisobutylester in Gegenwart von Basen, wie 4-Methylmorpholin oder 4-Ethylmorpholin, das gemischte Anhydrid aus der zu kuppelnden Carbonsäure der allgemeinen Formel (VI) und dem Kohlensäure-monoisobutylester erhalten wird. Die Herstellung dieses gemischten Anhydrids und die Kupplung mit Aminen erfolgt im Eintopfverfahren, unter Verwendung der vorstehend genannten Lösungsmittel und bei Temperaturen zwischen –20 und +25°C, bevorzugt 0°C und +25°C.
- (c) Zur Herstellung von Verbindungen der allgemeinen Formel (I), in der X die Methylengruppe bedeutet und A, B, D, E, ----, R1 und R2 wie eingangs erwähnt definiert sind, mit der Maßgabe, dass diese Gruppen kein freies primäres oder sekundäres Amin enthalten: Kupplung einer Verbindung der allgemeinen Formel in der A, B, D, E, ----, und R2 wie eingangs erwähnt definiert sind, mit der Maßgabe, dass R2 kein primäres oder sekundäres Amin enthält, und Nu eine Austrittsgruppe, beispielsweise ein Halogenatom, wie das Chlor-, Brom- oder Iodatom, eine Alkylsulfonyloxygruppe mit 1 bis 10 Kohlenstoffatomen im Alkylteil, eine gegebenenfalls durch Chlor- oder Bromatome, durch Methyl- oder Nitrogruppen mono-, di- oder trisubstituierte Phenylsulfonyloxy- oder Naphthylsulfonyloxygruppe, wobei die Substituenten gleich oder verschieden sein können, eine 1H-Imidazol-1-yl-, eine gegebenenfalls durch eine oder zwei Methylgruppen im Kohlenstoffgerüst substituierte 1H-Pyrazol-1-yl-, eine 1H-1,2,4-Triazol-1-yl-, 1H-1,2,3-Triazol-1-yl-, 1H-1,2,3,4-Tetrazol-1-yl-, eine Vinyl-, Propargyl-, p-Nitrophenyl-, 2,4-Dinitrophenyl-, Trichlorphenyl-, Pentachlorphenyl-, Pentafluorphenyl-, Pyranyl- oder Pyridinyl-, eine Dimethylaminyloxy-, 2(1H)-Oxopyridin-1-yl-oxy-, 2,5-Dioxopyrrolidin-1-yloxy-, Phthalimidyloxy-, 1H-Benzo-triazol-1-yloxy- oder Azidgruppe bedeutet, mit einem Piperidin der allgemeinen Formel in der R1 wie eingangs erwähnt definiert ist.
- (C) For the preparation of compounds of general formula (I), in which X represents the methylene group and A, B, D, E, ----, R 1 and R 2 are defined as mentioned above, with the proviso that these groups do not contain a free primary or secondary amine: Coupling of a compound of the general formula in which A, B, D, E, ----, and R 2 are defined as mentioned above, with the proviso that R 2 is not a primary one or Nu is a leaving group, for example a halogen atom, such as the chlorine, bromine or iodine atom, an alkylsulfonyloxy group having 1 to 10 carbon atoms in the alkyl moiety, one optionally substituted by chlorine or bromine atoms, by methyl or nitro mono-, di- or trisubstituted phenylsulfonyloxy or naphthylsulfonyloxy group, where the substituents may be identical or different, a 1H-imidazol-1-yl, a 1H-pyrazol-1-yl, optionally substituted by one or two methyl groups in the carbon skeleton, a 1H- 1,2,4-triazol-1-yl, 1H-1,2,3-triazol-1-yl, 1H-1,2,3,4-tetrazol-1-yl, a vinyl, propargyl -, p-nitrophenyl, 2,4-dinitrophenyl, trichlorophenyl, pentachlorophenyl, pentafluorophenyl, pyranyl or pyridinyl, a Dimethylaminyloxy-, 2 (1H) -oxopyridin-1-yl-oxy-, 2.5 Dioxopyrrolidin-1-yloxy, phthalimidyloxy, 1H-benzo-triazol-1-yloxy or azide group, with a piperidine of the general formula in which R 1 is defined as mentioned above.
Die Umsetzung wird unter Schotten-Baumann- oder Einhorn-Bedingungen durchgeführt, das heißt die Komponenten werden in Gegenwart von wenigstens einem Äquivalent einer Hilfsbase bei Temperaturen zwischen –50°C und +120°C, bevorzugt –10°C und +30°C, und gegebenenfalls in Gegenwart von Lösungsmitteln zur Reaktion gebracht. Als Hilfsbasen kommen bevorzugt Alkali- und Erdalkalihydroxide, beispielsweise Natriumhydroxid, Kaliumhydroxid oder Bariumhydroxid, Alkalicarbonate, z. B. Natriumcarbonat, Kaliumcarbonat oder Cäsiumcarbonat, Alkaliacetate, z.B. Natrium- oder Kaliumacetat, sowie tertiäre Amine, beispielsweise Pyridin, 2,4,6-Tri-methylpyridin, Chinolin, Triethylamin, N-Ethyl-diisopropylamin, N-Ethyl-dicyclohexylamin, 1,4-Di-azabicyclo[2,2,2]octan oder 1,8-Diazabicyclo[5,4,0]-undec-7-en, als Lösungsmittel beispielsweise Dichlormethan, Tetrahydrofuran, 1,4-Dioxan, Acetonitril, Dimethylformamid, Dimethylacetamid, N-Methylpyrrolidon oder Gemische davon in Betracht; werden als Hilfsbasen Alkali- oder Erdalkalihydroxide, Alkalicarbonate oder -acetate verwendet, kann dem Reaktionsgemisch auch Wasser als Cosolvens zugesetzt werden.
- (d) Zur Herstellung von Verbindungen der allgemeinen Formel (I), in der alle Reste wie eingangs erwähnt definiert sind: Kupplung einer Carbonsäure der allgemeinen Formel in der A, B, D, E, ----, R1 und X wie eingangs erwähnt definiert sind, mit einem Amin R2 mit der Maßgabe, dass keine weitere freie primäre oder sekundäre, aliphatische Aminofunktion enthalten ist.
- (d) For the preparation of compounds of the general formula (I) in which all radicals are defined as mentioned above: coupling of a carboxylic acid of the general formula in which A, B, D, E, ----, R 1 and X are as defined above, with an amine R 2 with the proviso that no further free primary or secondary, aliphatic amino function is included.
Die Kupplung wird bevorzugt unter Verwendung von aus der Peptidchemie bekannten Verfahren (siehe z. B. Houben-Weyl, Methoden der Organischen Chemie, Bd. 15/2) durchgeführt, wobei zum Beispiel Carbodiimide, wie z.B. Dicyclohexylcarbodiimid (DCC), Diisopropylcarbodiimid (DIC) oder Ethyl-(3-dimethylamino-propyl)carbodiimid, O-(1H-Benzotriazol-1-yl)-N,N-N',N'-tetramethyluronium-hexa-fluorphosphat (HBTU) oder -tetrafluorborat (TBTU) oder 1H-Benzotriazol-1-yl-oxytris-(dimethylamino)-phosphoniumhexafluorphosphat (BOP) eingesetzt werden. Durch Zugabe von 1-Hydroxybenzotriazol (HOBt) oder von 3-Hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazin (HOObt) kann die Reaktionsgeschwindigkeit gesteigert werden. Die Kupplungen werden normalerweise mit äquimolaren Anteilen der Kupplungskomponenten sowie des Kupplungsreagenz in Lösungsmitteln wie Dichlormethan, Tetrahydrofuran, Acetonitril, Dimethylformamid (DMF), Dimethylacetamid (DMA), N-Methylpyrrolidon (NMP) oder Gemischen aus diesen und bei Temperaturen zwischen –30 und +30°C, bevorzugt –20 und +25°C, durchgeführt. Sofern erforderlich wird als zusätzliche Hilfsbase N-Ethyldiisopropylamin (DIEA) (Hünig-Base) bevorzugt.The Coupling is preferred using peptide chemistry known processes (see, for example, Houben-Weyl, Methoden der Organischen Chemie, Vol. 15/2), for example, carbodiimides, e.g. dicyclohexylcarbodiimide (DCC), diisopropylcarbodiimide (DIC) or ethyl (3-dimethylamino-propyl) carbodiimide, O- (1H-benzotriazol-1-yl) -N, N-N ', N'-tetramethyluronium hexa-fluorophosphate (HBTU) or tetrafluoroborate (TBTU) or 1H-benzotriazol-1-yl-oxytris- (dimethylamino) phosphonium hexafluorophosphate (BOP) are used. By addition of 1-hydroxybenzotriazole (HOBt) or 3-hydroxy-4-oxo-3,4-dihydro-1,2,3-benzotriazine (HOObt), the reaction rate can be increased. The couplings are usually equimolar Proportions of Coupling Components and Coupling Reagent in solvents such as dichloromethane, tetrahydrofuran, acetonitrile, dimethylformamide (DMF), dimethylacetamide (DMA), N-methylpyrrolidone (NMP) or mixtures from these and at temperatures between -30 and + 30 ° C, preferably -20 and + 25 ° C, performed. Provided is required as additional Auxiliary base N-ethyldiisopropylamine (DIEA) (Hünig base) is preferred.
Als weiteres Kupplungsverfahren zur Synthese von Verbindungen der allgemeinen Formel (I) wird das sogenannte "Anhydridverfahren" (siehe auch: M. Bodanszky, "Peptide Chemistry", Springer-Verlag 1988, S. 58-59; M. Bodanszky, "Principles of Peptide Synthesis", Springer-Verlag 1984, S. 21-27) eingesetzt. Bevorzugt wird das "gemischte Anhydridverfahren" in der Variante nach Vaughan (J.R. Vaughan Jr., J. Amer. Chem. Soc. 73, 3547 (1951)), bei der unter Verwendung von Chlorkohlensäureisobutylester in Gegenwart von Basen, wie 4-Methylmorpholin oder 4-Ethylmorpholin, das gemischte Anhydrid aus der zu kuppelnden Carbonsäure der allgemeinen Formel (VIII) und dem Kohlensäure-monoisobutylester erhalten wird. Die Herstellung dieses gemischten Anhydrids und die Kupplung mit den Aminen R2 erfolgt im Eintopfverfahren, unter Verwendung der vorstehend genannten Lösungsmittel und bei Temperaturen zwischen –20°C und +25°C, bevorzugt zwischen 0°C und +25°C.
- (e) Zur Herstellung von Verbindungen der allgemeinen Formel (I), in der alle Reste wie eingangs erwähnt definiert sind: Kupplung einer Verbindung der allgemeinen Formel in der A, B, D, E, ----, R1 und X wie eingangs erwähnt definiert sind und Nu eine Austrittsgruppe, beispielsweise ein Halogenatom, wie das Chlor-, Brom- oder Iodatom, eine Alkylsulfonyloxygruppe mit 1 bis 10 Kohlenstoffatomen im Alkylteil, eine gegebenenfalls durch Chlor- oder Bromatome, durch Methyl- oder Nitrogruppen mono-, di- oder trisubstituierte Phenylsulfonyloxy- oder Naphthylsulfonyloxygruppe, wobei die Substituenten gleich oder verschieden sein können, eine 1H-Imidazol-1-yl-, eine gegebenenfalls durch eine oder zwei Methylgruppen im Kohlenstoffgerüst substituierte 1H-Pyrazol-1-yl-, eine 1H-1,2,4-Triazol-1-yl-, 1H-1,2,3-Triazol-1-yl-, 1H-1,2,3,4-Tetrazol-1-yl-, eine Vinyl-, Propargyl-, p-Nitrophenyl-, 2,4-Dinitrophenyl-, Trichlorphenyl-, Pentachlorphenyl-, Pentafluorphenyl-, Pyranyl- oder Pyridinyl-, eine Dimethylaminyloxy-, 2(1H)-Oxopyridin-1-yl-oxy-, 2,5-Dioxopyrrolidin-1-yloxy-, Phthalimidyloxy-, 1H-Benzo-triazol-1-yloxy- oder Azidgruppe bedeutet, mit einem Amin R2, mit der Maßgabe, dass keine weitere freie primäre oder sekundäre aliphatische Aminofunktion enthalten ist.
- (E) For the preparation of compounds of the general formula (I) in which all radicals are defined as mentioned above: coupling of a compound of the general formula in which A, B, D, E, ----, R 1 and X are defined as mentioned above and Nu is a leaving group, for example a halogen atom, such as the chlorine, bromine or iodine atom, an alkylsulfonyloxy group having 1 to 10 carbon atoms in the alkyl moiety, an optionally substituted by chlorine or bromine atoms, by methyl or nitro groups mono-, di- or trisubstituted Phenylsulfonyloxy- or Naphthylsulfonyloxygruppe, where the substituents may be identical or different, a 1H-imidazol-1-yl, optionally by 1H-pyrazol-1-yl substituted in the carbon skeleton by one or two methyl groups, 1H-1,2,4-triazol-1-yl, 1H-1,2,3-triazol-1-yl, 1H-1 , 2,3,4-tetrazol-1-yl, a vinyl, propargyl, p-nitrophenyl, 2,4-dinitrophenyl, trichlorophenyl, pentachlorophenyl, pentafluorophenyl, pyranyl or pyridinyl, a dimethylaminyloxy -, 2 (1H) -oxopyridin-1-yl-oxy, 2,5-dioxopyrrolidin-1-yloxy, phthalimidyloxy, 1H-benzo-triazol-1-yloxy or azide group, with an amine R 2 , Wed. t with the proviso that no further free primary or secondary aliphatic amino function is included.
Die Umsetzung wird unter Schotten-Baumann- oder Einhorn-Bedingungen durchgeführt, das heißt, die Komponenten werden in Gegenwart von wenigstens einem Äquivalent einer Hilfsbase bei Temperaturen zwischen –50°C und +120°C, bevorzugt –10°C und +30°C, und gegebenenfalls in Gegenwart von Lösungsmitteln zur Reaktion gebracht. Als Hilfsbasen kommen bevorzugt Alkali- und Erdalkalihydroxide, beispielsweise Natriumhydroxid, Kaliumhydroxid oder Bariumhydroxid, Alkalicarbonate, z.B. Natriumcarbonat, Kaliumcarbonat oder Cäsiumcarbonat, Alkaliacetate, z.B. Natrium- oder Kaliumacetat, sowie tertiäre Amine, beispielsweise Pyridin, 2,4,6-Trimethylpyridin, Chinolin, Triethylamin, N-Ethyldiisopropylamin, N-Ethyldicyclohexylamin, 1,4-Di-azabicyclo[2,2,2]octan oder 1,8-Diaza-bicyclo[5,4,0]undec-7-en, als Lösungsmittel beispielsweise Dichlormethan, Tetrahydrofuran, 1,4-Dioxan, Acetonitril, Dimethylformamid, Dimethylacetamid, N-Methylpyrrolidon oder Gemische davon in Betracht; werden als Hilfsbasen Alkali- oder Erdalkalihydroxide, Alkalicarbonate oder -acetate verwendet, kann dem Reaktionsgemisch auch Wasser als Cosolvens zugesetzt werden.The Implementation will be under bulkhead Baumann or unicorn conditions carried out, that is, the Components become in the presence of at least one equivalent an auxiliary base at temperatures between -50 ° C and + 120 ° C, preferably -10 ° C and + 30 ° C, and optionally in the presence of solvents reacted. As auxiliary bases are preferred alkali and Alkaline earth hydroxides, for example sodium hydroxide, potassium hydroxide or barium hydroxide, alkali carbonates, e.g. Sodium carbonate, potassium carbonate or cesium carbonate, Alkali acetates, e.g. Sodium or potassium acetate, as well as tertiary amines, for example, pyridine, 2,4,6-trimethylpyridine, quinoline, triethylamine, N-ethyldiisopropylamine, N-ethyldicyclohexylamine, 1,4-di-azabicyclo [2,2,2] octane or 1,8-diazabicyclo [5,4,0] undec-7-ene, as a solvent, for example Dichloromethane, tetrahydrofuran, 1,4-dioxane, acetonitrile, dimethylformamide, Dimethylacetamide, N-methylpyrrolidone or mixtures thereof; are used as auxiliary bases alkali or alkaline earth metal hydroxides, alkali metal carbonates or Acetate used, the reaction mixture can also be water as cosolvent be added.
Die erfindungsgemäßen neuen Verbindungen der allgemeinen Formel (I) enthalten ein oder mehrere Chiralitätszentren. Sind beispielsweise zwei Chiralitätszentren vorhanden, dann können die Verbindungen in Form zweier diastereomerer Antipodenpaare auftreten. Die Erfindung umfasst die einzelnen Isomeren ebenso wie ihre Gemische.The new invention Compounds of general formula (I) contain one or more chiral centers. For example, if there are two chirality centers, then the Compounds in the form of two diastereomeric antipode pairs occur. The invention includes the individual isomers as well as their mixtures.
Die Trennung der jeweiligen Diastereomeren gelingt auf Grund ihrer unterschied lichen physikochemischen Eigenschaften, z.B. durch fraktionierte Kristallisation aus geeigneten Lösungsmitteln, durch Hochdruckflüssigkeits- oder Säulenchromatographie unter Verwendung chiraler oder bevorzugt achiraler stationärer Phasen.The separation of the respective diastereomers succeeds on the basis of their different physicochemical properties, for example by fractional crystallization from suitable solvents, by high pressure liquid or column chromatography using chiral or preferably achiral stationary Pha sen.
Die Trennung von unter die allgemeine Formel (I) fallenden Racematen gelingt beispielsweise durch HPLC an geeigneten chiralen stationären Phasen (z. B. Chiral AGP, Chiralpak AD). Racemate, die eine basische oder saure Funktion enthalten, lassen sich auch über die diastereomeren, optisch aktiven Salze trennen, die bei Umsetzung mit einer optisch aktiven Säure, beispielsweise (+)- oder (–)-Weinsäure, (+)- oder (–)-Diacetylweinsäure, (+)- oder (–)-Monomethyltartrat oder (+)- oder (–)-Camphersulfonsäure, bzw. einer optisch aktiven Base, beispielsweise mit (R)-(+)-1-Phenylethylamin, (S)-(–)-1-Phenylethylamin oder (S)-Brucin, entstehen.The Separation of racemates covered by the general formula (I) succeeds for example by HPLC on suitable chiral stationary phases (eg Chiral AGP, Chiralpak AD). Racemates, which is a basic or acidic function can also be visualized via the diastereomers active salts which, when reacted with an optically active Acid, for example, (+) - or (-) - tartaric acid, (+) - or (-) - diacetyltartaric acid, (+) - or (-) - monomethyl tartrate or (+) - or (-) - camphorsulfonic acid, or an optically active base, for example with (R) - (+) - 1-phenylethylamine, (S) - (-) - 1-phenylethylamine or (S) -Brucine, arise.
Nach einem üblichen Verfahren zur Isomerentrennung wird das Racemat einer Verbindung der allgemeinen Formel (I) mit einer der vorstehend angegebenen optisch aktiven Säuren bzw. Basen in äquimolarer Menge in einem Lösungsmittel umgesetzt und die erhaltenen kristallinen, diastereomeren, optisch aktiven Salze unter Ausnutzung ihrer verschiedenen Löslichkeit getrennt. Diese Umsetzung kann in jeder Art von Lösungsmitteln durchgeführt werden, solange sie einen ausreichenden Unterschied hinsichtlich der Löslichkeit der Salze aufweisen. Vorzugsweise werden Methanol, Ethanol oder deren Gemische, beispielsweise im Volumenverhältnis 50:50, verwendet. Sodann wird jedes der optisch aktiven Salze in Wasser gelöst, mit einer Base, wie Natriumcarbonat oder Kaliumcarbonat, oder mit einer geeigneten Säure, beispielsweise mit verdünnter Salzsäure oder wässeriger Methansulfonsäure, vorsichtig neutralisiert und dadurch die entsprechende freie Verbindung in der (+)- oder (–)-Form erhalten.To a usual one Isomer separation process becomes the racemate of a compound of the general formula (I) with one of the abovementioned optically active acids or bases in equimolar amount in a solvent reacted and the resulting crystalline diastereomers, optically active salts taking advantage of their different solubility separated. This implementation can be in any kind of solvents carried out be as long as they make a sufficient difference the solubility of the Have salts. Preferably, methanol, ethanol or their Mixtures, for example, in the volume ratio 50:50 used. thereupon each of the optically active salts is dissolved in water, with a base, such as sodium carbonate or potassium carbonate, or with a suitable acid, for example, with dilute hydrochloric acid or aqueous methane, carefully neutralized and thus the corresponding free compound in the (+) - or (-)-Shape receive.
Jeweils nur das (R)- oder (S)-Enantiomer bzw. ein Gemisch zweier optisch aktiver, unter die allgemeine Formel (I) fallender diastereomerer Verbindungen wird auch dadurch erhalten, dass man die oben beschriebenen Synthesen mit jeweils einer geeigneten (R)- bzw. (S)-konfigurierten Reaktionskomponente durchführt.Each only the (R) - or (S) -enantiomer or a mixture of two optical active, under the general formula (I) falling diastereomeric Compounds are also obtained by using the ones described above Syntheses each with a suitable (R) or (S) -configured Reaction component performs.
Die
Ausgangsverbindungen der allgemeinen Formel (III) erhält man,
soweit sie nicht literaturbekannt oder gar käuflich sind, entsprechend den
in WO 98/11128 und
Die erhaltenen Verbindungen der allgemeinen Formel (I) können, sofern sie geeignete basische Funktionen enthalten, insbesondere für pharmazeutische Anwendungen in ihre physiologisch verträglichen Salze mit anorganischen oder organischen Säuren übergeführt werden. Als Säuren kommen hierfür beispielsweise Salzsäure, Bromwasserstoffsäure, Phosphorsäure, Salpetersäure, Schwefelsäure, Methansulfonsäure, Ethansulfonsäure, Benzolsulfonsäure, p-Toluolsulfonsäure, Essigsäure, Fumarsäure, Bernsteinsäure, Milchsäure, Mandelsäure, Äpfelsäure, Zitronensäure, Weinsäure oder Maleinsäure in Betracht.The obtained compounds of general formula (I), if they contain suitable basic functions, in particular for pharmaceutical Applications in their physiologically acceptable salts with inorganic or organic acids are converted. As acids come for this for example, hydrochloric acid, hydrobromic, Phosphoric acid, Nitric acid, Sulfuric acid, Methanesulfonic acid, ethanesulfonic acid, benzenesulfonic acid, p-toluenesulfonic acid, acetic acid, fumaric acid, succinic acid, lactic acid, mandelic acid, malic acid, citric acid, tartaric acid or maleic into consideration.
Außerdem lassen sich die neuen Verbindungen der Formel (I), falls sie Carbonsäurefunktion enthalten, gewünschtenfalls in ihre Additionssalze mit anorganischen oder organischen Basen, insbesondere für die pharmazeutische Anwendung in ihre physiologisch verträglichen Additionssalze überführen. Als Basen kommen hierfür beispielsweise Natriumhydroxid, Kaliumhydroxid, Ammoniak, Cyclohexylamin, Dicyclohexylamin, Ethanolamin, Diethanolamin und Triethanolamin in Betracht.In addition, let the new compounds of the formula (I), if they carboxylic acid function included, if desired in their addition salts with inorganic or organic bases, especially for the pharmaceutical application in its physiologically acceptable Transfer addition salts. When Bases come for this for example, sodium hydroxide, potassium hydroxide, ammonia, cyclohexylamine, Dicyclohexylamine, ethanolamine, diethanolamine and triethanolamine into consideration.
Die vorliegende Erfindung betrifft Racemate, sofern die Verbindungen der allgemeinen Formel (I) nur ein Chiralitätselement besitzen. Die Anmeldung umfasst jedoch auch die einzelnen diastereomeren Antipodenpaare oder deren Gemische, die dann vorliegen, wenn mehr als ein Chiralitätselement in den Verbindungen der allgemeinen Formel (I) vorhanden ist, sowie die einzelnen optisch aktiven Enantiomeren, aus denen sich die erwähnten Racemate zusammensetzen.The The present invention relates to racemates, as far as the compounds of the general formula (I) have only one chiral element. The registration however, also encompasses the individual diastereomeric antipode pairs or their mixtures, which are present when more than one chiral element is present in the compounds of general formula (I), as well as the individual optically active enantiomers that make up the mentioned racemates put together.
Ebenfalls mit vom Gegenstand dieser Erfindung umfasst sind die erfindungsgemäßen Verbindungen, einschließlich deren Salze, in denen ein oder mehrere Wasserstoffatome durch Deuterium ausgetauscht sind.Also included in the subject matter of this invention are the compounds according to the invention, including their salts, in which one or more hydrogen atoms are replaced by deuterium.
Die neuen Verbindungen der allgemeinen Formel (I) und deren physiologisch verträgliche Salze weisen wertvolle pharmakologische Eigenschaften auf, die auf ihre selektiven CGRP-antagonistischen Eigenschaften zurückgehen. Ein weiterer Gegenstand der Erfindung sind diese Verbindungen enthaltende Arzneimittel, deren Verwendung und deren Herstellung.The new compounds of general formula (I) and their physiological compatible Salts have valuable pharmacological properties their selective CGRP antagonistic properties decline. Another object of the invention are those compounds containing Medicines, their use and their manufacture.
Die voranstehend genannten neuen Verbindungen und deren physiologisch verträgliche Salze besitzen CGRP-antagonistische Eigenschaften und zeigen gute Affinitäten in CGRP-Rezeptorbindungsstudien. Die Verbindungen weisen in den nachstehend beschriebenen pharmakologischen Testsystemen CGRP-antagonistische Eigenschaften auf.The above-mentioned new compounds and their physiological compatible Salts have CGRP antagonistic properties and show good affinities in CGRP receptor binding studies. The compounds have in the CGRP antagonistic pharmacological test systems described below Properties on.
Zum Nachweis der Affinität der voranstehend genannten Verbindungen zu humanen CGRP-Rezeptoren und ihrer antagonistischen Eigenschaften wurden die folgenden Versuche durchgeführt:To the Proof of affinity the above compounds to human CGRP receptors and their antagonistic properties were the following experiments carried out:
A. Bindungsstudien mit (den humanen CGRP-Rezeptor exprimierenden) SK-N-MC-ZellenA. Binding studies with (the human CGRP receptor expressing) SK-N-MC cells
SK-N-MC-Zellen werden in "Dulbecco's modified Eagle Medium" kultiviert. Das Medium konfluenter Kulturen wird entfernt. Die Zellen werden zweimal mit PBS- Puffer (Gibco 041-04190 M) gewaschen, durch Zugabe von PBS-Puffer, versetzt mit 0.02% EDTA, abgelöst und durch Zentrifugation isoliert. Nach Resuspension in 20 ml "Balanced Salts Solution" [BSS (in mM): NaCl 120, KCl 5.4, NaHCO3 16.2, MgSO4 0.8, NaHPO4 1.0, CaCl2 1.8, D-Glucose 5.5, HEPES 30, pH 7.40] werden die Zellen zweimal bei 100 × g zentrifugiert und in BSS resuspendiert. Nach Bestimmung der Zellzahl werden die Zellen mit Hilfe eines Ultra-Turrax homogenisiert und für 10 Minuten bei 3000 × g zentrifugiert. Der Überstand wird verworfen und das Pellet in Tris-Puffer (10 mM Tris, 50 mM NaCl, 5 mM MgCl2, 1 mM EDTA, pH 7.40), angereichert mit 1 % Rinderserum-Albumin und 0.1 % Bacitracin, rezentrifugiert und resuspendiert (1 ml/1000000 Zellen). Das Homogenat wird bei –80°C eingefroren. Die Membranpräparationen sind bei diesen Bedingungen für mehr als 6 Wochen stabil.SK-N-MC cells are cultured in "Dulbecco's modified Eagle Medium". The medium of confluent cultures is removed. The cells are washed twice with PBS buffer (Gibco 041-04190 M), removed by addition of PBS buffer, mixed with 0.02% EDTA, and isolated by centrifugation. After resuspension in 20 ml of Balanced Salts Solution [BSS (in mM): NaCl 120, KCl 5.4, NaHCO 3 16.2, MgSO 4 0.8, NaHPO 4 1.0, CaCl 2 1.8, D-glucose 5.5, HEPES 30, pH 7.40] The cells are centrifuged twice at 100 x g and resuspended in BSS. After determining the number of cells, the cells are homogenized using an Ultra-Turrax and centrifuged for 10 minutes at 3000 × g. The supernatant is discarded and the pellet recentrifuged and resuspended in Tris buffer (10 mM Tris, 50 mM NaCl, 5 mM MgCl 2 , 1 mM EDTA, pH 7.40) supplemented with 1% bovine serum albumin and 0.1% bacitracin (1 ml / 1000000 cells). The homogenate is frozen at -80 ° C. The membrane preparations are stable under these conditions for more than 6 weeks.
Nach Auftauen wird das Homogenat 1:10 mit Assay-Puffer (50 mM Tris, 150 mM NaCl, 5 mM MgCl2, 1 mM EDTA, pH 7.40) verdünnt und 30 Sekunden lang mit einem Ultra-Turrax homogenisiert. 230 μl des Homogenats werden für 180 Minuten bei Raumtemperatur mit 50 pM 125I-Iodotyrosyl-Calcitonin-Gene-Related Peptide (Amersham) und ansteigenden Konzentrationen der Testsubstanzen in einem Gesamtvolumen von 250 μl inkubiert. Die Inkubation wird durch rasche Filtration durch mit Polyethylenimin (0.1 %) behandelte GF/B-Glasfaserfilter mittels eines Zellharvesters beendet. Die an Protein gebundene Radioaktivität wird mit Hilfe eines Gammacounters bestimmt. Als nichtspezifische Bindung wird die gebundene Radioaktivität nach Gegenwart von 1 μM humanem CGRP-alpha während der Inkubation definiert.After thawing, the homogenate is diluted 1:10 with assay buffer (50 mM Tris, 150 mM NaCl, 5 mM MgCl 2 , 1 mM EDTA, pH 7.40) and homogenized for 30 seconds with an Ultra-Turrax. 230 μl of the homogenate are incubated for 180 minutes at room temperature with 50 pM 125 I-iodotyrosyl-calcitonin gene-related peptides (Amersham) and increasing concentrations of the test substances in a total volume of 250 μl. Incubation is terminated by rapid filtration through polyethyleneimine (0.1%) treated GF / B glass fiber filters using a cell harvester. The protein bound radioactivity is determined using a gamma counter. Non-specific binding is defined as the bound radioactivity after the presence of 1 μM human CGRP-alpha during the incubation.
Die Analyse der Konzentrations-Bindungskurven erfolgt mit Hilfe einer computergestützten nichtlinearen Kurvenanpassung.The Analysis of the concentration-binding curves is carried out with the help of a computerized nonlinear curve fitting.
Die eingangs erwähnten Verbindungen zeigen in dem beschriebenen Test IC50-Werte ≤ 10000 nM.The compounds mentioned in the introduction exhibit IC 50 values ≦ 10000 nM in the test described.
B. CGRP-Antagonismus in SK-N-MC-ZellenB. CGRP antagonism in SK-N-MC cells
SK-N-MC-Zellen (1 Mio. Zellen) werden zweimal mit 250 μl Inkubationspuffer (Hanks' HEPES, 1 mM 3-Isobutyl-1-methylxanthin, 1% BSA, pH 7.4) gewaschen und bei 37°C für 15 Minuten vorinkubiert. Nach Zugabe von CGRP (10 μl) als Agonist in steigenden Konzentrationen (10–11 bis 10–6 M) bzw. zusätzlich von Substanz in 3 bis 4 verschiedenen Konzentrationen wird nochmals 15 Minuten inkubiert.SK-N-MC cells (1 million cells) are washed twice with 250 μl of incubation buffer (Hanks' HEPES, 1 mM 3-isobutyl-1-methylxanthine, 1% BSA, pH 7.4) and at 37 ° C for 15 minutes pre-incubated. After addition of CGRP (10 μl) as agonist in increasing concentrations (10 -11 to 10 -6 M) or additionally of substance in 3 to 4 different concentrations is incubated again for 15 minutes.
Intrazelluläres cAMP wird anschließend durch Zugabe von 20 μl 1 M HCl und Zentrifugation (2000 × g, 4°C für 15 Minuten) extrahiert. Die Überstände werden in flüssigem Stickstoff eingefroren und bei –20°C gelagert.Intracellular cAMP will follow by adding 20 μl 1M HCl and centrifugation (2000 xg, 4 ° C for 15 minutes). The supernatants are in liquid Nitrogen frozen and stored at -20 ° C.
Die cAMP-Gehalte der Proben werden mittels Radioimmunassay (Fa. Amersham) bestimmt und die pA2-Werte antagonistisch wirkender Substanzen graphisch ermittelt.The cAMP contents of the samples are determined by means of radioimmunoassay (Amersham) and the pA 2 values of antagonistic substances are determined graphically.
Die erfindungsgemäßen Verbindungen zeigen in dem beschriebenen in vitro-Testmodell CGRP-antagonistische Eigenschaften in einem Dosisbereich zwischen 10–12 bis 10–5 M.In the described in vitro test model, the compounds according to the invention exhibit CGRP-antagonistic properties in a dose range between 10 -12 to 10 -5 M.
Aufgrund ihrer pharmakologischen Eigenschaften eignen sich die erfindungsgemäßen Verbindungen und deren Salze mit physiologisch verträglichen Säuren somit zur akuten und prophylaktischen Behandlung von Kopfschmerzen, insbesondere Migräne- bzw. Cluster-Kopfschmerz. Weiterhin beeinflussen die erfindungsgemäßen Verbindungen auch die folgenden Erkrankungen positiv: Nicht-insulinabhängigen Diabetes mellitus ("NIDDM"), cardiovaskuläre Erkrankungen, Morphintoleranz, Clostritiumtoxin-bedingte Durchfallerkrankungen, Erkrankungen der Haut, insbesondere thermische und strahlenbedingte Hautschäden inklusive Sonnenbrand, entzündliche Erkrankungen, z.B. entzündliche Gelenkerkrankungen (Arthritis), neurogene Entzündungen der oralen Mucosa, entzündliche Lungenerkrankungen, allergische Rhinitis, Asthma, Erkrankungen, die mit einer überschießenden Gefäßerweiterung und dadurch bedingter verringerter Gewebedurchblutung einhergehen, z.B. Schock und Sepsis. Darüber hinaus zeigen die erfindungsgemäßen Verbindungen eine lindernde Wirkung auf Schmerzzustände im allgemeinen.Due to their pharmacological properties, the compounds of the invention are suitable and their salts with physiologically tolerated acids thus for the acute and prophylactic treatment of headache, especially migraine or cluster headache. Furthermore, the compounds according to the invention also have a positive influence on the following diseases: non-insulin-dependent diabetes mellitus ("NIDDM"), cardiovascular diseases, morphine tolerance, diarrheal diseases caused by Clostritium toxins, diseases of the skin, in particular thermal and radiation-related skin damage including sunburn, inflammatory diseases, eg inflammatory joint diseases (Arthritis), neurogenic inflammation of the oral mucosa, inflammatory lung disease, allergic rhinitis, asthma, diseases associated with excessive vasodilation and consequent reduced tissue perfusion, eg, shock and sepsis. In addition, the compounds according to the invention have a soothing effect on pain conditions in general.
Die Symptomatik menopausaler, durch Gefäßerweiterung und erhöhten Blutfluss verursachter Hitzewallungen östrogendefizienter Frauen sowie hormonbehandelter Prostatakarzinompatienten wird durch die CGRP-Antagonisten der vorliegenden Anwendung präventiv und akut-therapeutisch günstig beeinflusst, wobei sich dieser Therapieansatz vor der Hormonsubstitution durch Nebenwirkungsarmut auszeichnet.The Symptoms of menopausal, due to vasodilation and increased blood flow caused hot flashes estrogendefizienter Women as well as hormone-treated prostate cancer patients will by the CGRP antagonists of the present application are preventive and acutely beneficial influenced, this therapy approach before the hormone substitution characterized by low side effects.
Die zur Erzielung einer entsprechenden Wirkung erforderliche Dosierung beträgt zweckmäßigerweise bei intravenöser oder subkutaner Gabe 0.0001 bis 3 mg/kg Körpergewicht, vorzugsweise 0.01 bis 1 mg/kg Körpergewicht, und bei oraler, nasaler oder inhalativer Gabe 0.01 bis 10 mg/kg Körpergewicht, vorzugsweise 0.1 bis 10 mg/kg Körpergewicht, jeweils 1 bis 3 × täglich.The To achieve a corresponding effect required dosage is expediently at intravenous or subcutaneous administration 0.0001 to 3 mg / kg body weight, preferably 0.01 to 1 mg / kg body weight, and by oral, nasal or inhalation administration 0.01 to 10 mg / kg Body weight, preferably 0.1 to 10 mg / kg of body weight, 1 to 3 times a day.
Sofern die Behandlung mit CGRP-Antagonisten oder/und CGRP-Release-Hemmern in Ergänzung zu einer üblichen Hormonsubstitution erfolgt, empfiehlt sich eine Verringerung der vorstehend angegebenen Dosierungen, wobei die Dosierung dann 1/5 der vorstehend angegebenen Untergrenzen bis zu 1/1 der vorstehend angegebenen Obergrenzen betragen kann.Provided treatment with CGRP antagonists and / or CGRP release inhibitors in addition to a usual Hormone substitution takes place, it is recommended to reduce the above dosages, the dosage then 1/5 the lower limits specified above up to 1/1 of the above may be upper limits.
Die erfindungsgemäß hergestellten Verbindungen können entweder alleine oder gegebenenfalls in Kombination mit anderen Wirksubstanzen zur Behandlung von Migräne intravenös, subkutan, intramuskulär, intrarektal, intranasal, durch Inhalation, transdermal oder oral erfolgen, wobei zur Inhalation insbesondere Aerosolformulierungen geeignet sind. Die Kombinationen können entweder simultan oder sequentiell verabreicht werden.The produced according to the invention Connections can either alone or optionally in combination with others Active substances for the treatment of migraine intravenously, subcutaneously, intramuscularly, intrarectally, intranasally, by inhalation, transdermally or orally, wherein For inhalation in particular aerosol formulations are suitable. The combinations can be administered either simultaneously or sequentially.
Als Kombinationspartner denkbare Wirkstoffklassen sind z.B. Antiemetica, Prokinetica, Neuroleptica, Antidepressiva, Neurokinin-Antagonisten, Anticonvulsiva, Histamin-H1-Rezeptorantagonisten, Antimuscarinika, β-Blocker, α-Agonisten und α-Antagonisten, Ergotalkaloiden, schwachen Analgetica, nichtsteroidalen Antiphlogistica, Corticosteroiden, Calcium-Antagonisten, 5-HT1B/1D-Agonisten oder andere Antimigränemitteln, die zusammen mit einem oder mehreren inerten üblichen Trägerstoffen und/oder Verdünnungsmitteln, z.B. mit Maisstärke, Milchzucker, Rohrzucker, mikrokristalliner Zellulose, Magnesiumstearat, Polyvinylpyrrolidon, Zitronensäure, Weinsäure, Wasser, Wasser/Ethanol, Wasser/Glycerin, Wasser/-Sorbit, Wasser/Polyethylenglykol, Propylenglykol, Cetylstearylalkohol, Carboxymethylcellulose oder fetthaltigen Substanzen wie Hartfett oder deren geeigneten Gemischen, in übliche galenische Zubereitungen wie Tabletten, Dragees, Kapseln, Pulver, Suspensionen, Lösungen, Dosieraerosole oder Zäpfchen eingearbeitet werden können.Possible combinations of agents are, for example, antiemetics, prokinetics, neuroleptics, antidepressants, neurokinin antagonists, anticonvulsants, histamine H1 receptor antagonists, antimuscarinics, β-blockers, α-agonists and α-antagonists, ergot alkaloids, weak analgesics, non-steroidal anti-inflammatory drugs, corticosteroids, Calcium antagonists, 5-HT 1B / 1D agonists or other antimigraine agents, which together with one or more inert customary carriers and / or diluents, for example with corn starch, lactose, cane sugar, microcrystalline cellulose, magnesium stearate, polyvinylpyrrolidone, citric acid, tartaric acid, water , Water / ethanol, water / glycerin, water / sorbitol, water / polyethylene glycol, propylene glycol, cetylstearyl alcohol, carboxymethylcellulose or fatty substances such as hard fat or their suitable mixtures, in conventional pharmaceutical preparations such as tablets, dragees, capsules, powders, suspensions, solutions, Metered aerosols or z suppositories can be incorporated.
Für die oben erwähnten Kombinationen kommen somit als weitere Wirksubstanzen beispielsweise die nicht-steroidalen Antiphlogistika Acclofenac, Acemetacin, Acetylsalicylsäure, Azathioprin, Diclofenac, Diflunisal, Fenbufen, Fenoprofen, Flurbiprofen, Ibuprofen, Indometacin, Ketoprofen, Leflunomid, Lornoxicam, Mefenaminsäure, Naproxen, Phenylbutazon, Piroxicam, Sulfasalazin, Zomepirac oder deren pharmazeutisch verträgliche Salze sowie Meloxicam und andere selektive COX2-Inhibitoren, wie beispielsweise Rofecoxib und Celecoxib, in Betracht.For the above mentioned Combinations come thus as further active substances for example the non-steroidal anti-inflammatory drugs Acclofenac, Acemetacin, Acetylsalicylic acid, Azathioprine, Diclofenac, diflunisal, fenbufen, fenoprofen, flurbiprofen, ibuprofen, Indomethacin, ketoprofen, leflunomide, lornoxicam, mefenamic acid, naproxen, Phenylbutazone, piroxicam, sulfasalazine, zomepirac or their pharmaceutically compatible Salts as well as meloxicam and other selective COX2 inhibitors, such as For example, rofecoxib and celecoxib, into consideration.
Weiterhin können Ergotamin, Dihydroergotamin, Metoclopramid, Domperidon, Diphenhydramin, Cyclizin, Promethazin, Chlorpromazin, Vigabatrin, Timolol, Isomethepten, Pizotifen, Botox, Gabapentin, Topiramat, Riboflavin, Montelukast, Lisinopril, Prochlorperazin, Dexamethason, Flunarizin, Dextropropoxyphen, Meperidin, Metoprolol, Propranolol, Nadolol, Atenolol, Clonidin, Indoramin, Carbamazepin, Phenytoin, Valproat, Amitryptilin, Lidocain oder Diltiazem und andere 5-HT1B/1D-Agonisten wie z.B. Almotriptan, Avitriptan, Eletriptan, Frovatriptan, Naratriptan, Rizatriptan, Sumatriptan und Zolmitriptan verwendet werden.Furthermore, ergotamine, dihydroergotamine, metoclopramide, domperidone, diphenhydramine, cyclizine, promethazine, chlorpromazine, vigabatrin, timolol, isomethepten, pizotifen, botox, gabapentin, topiramate, riboflavin, montelukast, lisinopril, prochlorperazine, dexamethasone, flunarizine, dextropropoxyphene, meperidine, metoprolol, Propranolol, nadolol, atenolol, clonidine, indoramine, carbamazepine, phenytoin, valproate, amitryptiline, lidocaine or diltiazem and other 5-HT 1B / 1D agonists such as almotriptan, avitriptan, eletriptan, frovatriptan, naratriptan, rizatriptan, sumatriptan and zolmitriptan ,
Die Dosis für diese Wirksubstanzen beträgt hierbei zweckmäßigerweise 1/5 der üblicherweise empfohlenen niedrigsten Dosierung bis zu 1/1 der normalerweise empfohlenen Dosierung, also beispielsweise 20 bis 100 mg Sumatriptan.The Dose for these active substances is this expediently 1/5 of the usual recommended lowest dosage up to 1/1 of the normally recommended Dosage, so for example 20 to 100 mg Sumatriptan.
Ein weiterer Gegenstand der Erfindung ist die Verwendung der erfindungsgemäßen Verbindungen als wertvolle Hilfsmittel zur Erzeugung und Reinigung (Affinitätschromatographie) von Antikörpern sowie, nach geeigneter radioaktiver Markierung, beispielsweise durch Tritiierung geeigneter Vorstufen, beispielsweise durch katalytische Hydrierung mit Trithium oder Ersatz von Halogenatomen durch Tritium, in RIA- und ELISA-Assays und als diagnostische bzw. analytische Hilfsmittel in der Neurotransmitter-Forschung.One Another object of the invention is the use of the compounds of the invention as valuable tools for the production and purification (affinity chromatography) of antibodies and, after suitable radioactive labeling, for example by Tritiation of suitable precursors, for example by catalytic Hydrogenation with trithium or replacement of halogen atoms with tritium, in RIA and ELISA assays and as diagnostic or analytical Aids in neurotransmitter research.
Experimenteller Teilexperimental part
Für hergestellten
Verbindungen liegen in der Regel IR-, UV-, 1H-NMR
und/oder Massenspekten vor. Wenn nicht anders angegeben, wurden
Rf-Werte unter Verwendung von DC-Fertigplatten
Kieselgel 60 F254 (E. Merck, Darmstadt,
Artikel-Nr. 1.05714) ohne Kammersättigung bestimmt. Die unter
der Bezeichnung Alox ermittelten Rf-Werte wurden unter Verwendung
von DC-Fertigplatten Aluminiumoxid 60 F254 (E.
Merck, Darmstadt, Artikel-Nr. 1.05713) ohne Kammersättigung
bestimmt. Die bei den Fliessmitteln angegebenen Verhältnisse
beziehen sich auf Volumeneinheiten der jeweiligen Lösungsmittel.
Zu chromatographischen Reinigungen wurde Kieselgel der Firma Millipore
(MATREXTM, 35-70my) verwendet. Die angegebenen
HPLC-Daten werden unter nachstehend angeführten Parametern gemessen:
Analytische
Säule:
Zorbax-Säule
(Agilent Technologies), SB (Stable Bond) – C18; 3.5 μm; 4.6 × 75 mm; Säulentemperatur: 30°C; Fluss:
0.8 mL/min; Injektionsvolumen: 5 μL;
Detektion bei 254 nm For prepared compounds are usually present IR, UV, 1 H-NMR and / or mass spectra. Unless otherwise stated, R f values were determined using GCF Finished Tops Kieselgel 60 F 254 (E. Merck, Darmstadt, Article No. 1.05714) with no chamber saturation. The Rf values determined under the name Alox were determined using TLC plates alumina 60 F 254 (E. Merck, Darmstadt, Article No. 1.05713) without chamber saturation. The ratios indicated for the flow agents relate to volume units of the respective solvents. For chromatographic purifications silica gel from Millipore (MATREX ™ , 35-70my) was used. The indicated HPLC data are measured under the following parameters:
Analytical column: Zorbax column (Agilent Technologies), SB (stable bond) - C18; 3.5 μm; 4.6 × 75 mm; Column temperature: 30 ° C; Flow: 0.8 mL / min; Injection volume: 5 μL; Detection at 254 nm
Bei präparativen HPLC-Reinigungen werden in der Regel die gleichen Gradienten verwendet, die bei der Erhebung der analytischen HPLC-Daten benutzt wurden.at preparative HPLC purifications usually use the same gradients used in the collection of analytical HPLC data.
Die Sammlung der Produkte erfolgt massengesteuert, die Produkt enthaltenden Fraktionen werden vereinigt und gefriergetrocknet.The Collection of products is mass-controlled, containing the product Fractions are combined and freeze-dried.
Falls nähere Angaben zur Konfiguration fehlen, bleibt offen, ob es sich um reine Enantiomere handelt oder ob partielle oder gar völlige Racemisierung eingetreten ist.If details Information about the configuration is missing, remains open, whether it is pure Enantiomers or whether partial or even complete racemization occurred is.
In den Versuchsbeschreibungen werden die folgenden Abkürzungen verwendet:
- abs.
- absolutiert
- Boc
- tert.-Butoxycarbonyl
- CDI
- N,N'-Carbonyldiimidazol
- CDT
- 1,1'-Carbonyldi-(1,2,4-triazol)
- DMF
- N,N-Dimethylformamid
- EtOAc
- Essigsäureethylester
- EtOH
- Ethanol
- ges.
- gesättigt
- halbkonz.
- halbkonzentriert
- HCl
- Salzsäure
- HOAc
- Essigsäure
- HOBt
- 1-Hydroxybenzotriazol-hydrat
- i.vac.
- in vacuo (im Vakuum)
- KOH
- Kaliumhydroxid
- konz.
- konzentriert
- MeOH
- Methanol
- MTBE
- Methyl-tert.-butylether
- NaCl
- Natriumchlorid
- NaOH
- Natriumhydroxid
- org.
- organisch
- RT
- Raumtemperatur
- TBTU:
- 2-(1H-Benzotriazol-1-yl)-1,1,3,3-tetramethyluronium-Tetrafluorborat
- TFA
- Trifluoressigsäure
- THF
- Tetrahydrofuran
- wässr.
- wässrig
- Section.
- made absolute
- Boc
- tert-butoxycarbonyl
- CDI
- N, N'-carbonyldiimidazole
- CDT
- 1,1'-Carbonyldi- (1,2,4-triazole)
- DMF
- N, N-dimethylformamide
- EtOAc
- ethyl acetate
- EtOH
- ethanol
- ges.
- saturated
- half-concentrated.
- semi focused
- HCl
- hydrochloric acid
- HOAc
- acetic acid
- HOBt
- 1-hydroxybenzotriazole hydrate
- dried i.
- in vacuo (in vacuum)
- KOH
- potassium hydroxide
- conc.
- concentrated
- MeOH
- methanol
- MTBE
- Methyl tert-butyl ether
- NaCl
- sodium chloride
- NaOH
- sodium hydroxide
- org.
- organic
- RT
- room temperature
- TBTU:
- 2- (1H-benzotriazol-1-yl) -1,1,3,3-tetramethyluronium tetrafluoroborate
- TFA
- trifluoroacetic
- THF
- tetrahydrofuran
- aq.
- aqueous
A) Herstellung von ZwischenproduktenA) Preparation of intermediates
Zwischenprodukt 1:Intermediate 1:
1H-Indazol-5-carbaldehyd 1H-indazole-5-carbaldehyde
Zu
einer Lösung
von 11.64 g (59.08 mmol) 5-Brom-1H-indazol in 150 mL THF wurde unter
Argon portionsweise innerhalb von 10 Minuten 2.60 g (65.00 mmol)
Natriumhydrid (60% in Mineralöl)
zugegeben und das Gemisch 15 Minuten bei RT gerührt. Das Reaktionsgemisch wurde
auf –70 °C gekühlt und
innerhalb von 30 Minuten 100.00 mL (130.00 mmol) sec-Butyllithium
(1.3 M in Cyclohexan) zugetropft, wobei die Temperatur unter –60 °C gehalten
wurde. Das Gemisch wurde weitere 2 h bei –70 °C gerührt und anschließend eine
Lösung
von 20.00 mL (0.260 mol) DMF in 20 mL THF zugetropft, wobei die
Temperatur unter –50 °C gehalten wurde.
Das Reaktionsgemisch wurde langsam auf RT erwärmt und 16 h gerührt. Anschließend wurde
das Gemisch auf 0 °C
gekühlt
und langsam 180 mL 2N wässriger
HCl zugetropft, weitere 15 Minuten gerührt und mit ges. wässriger
Natriumbicarbonat-Lösung ein
pH von 9-10 eingestellt. Die wässrige
Phase wurde erschöpfend mit
EtOAc extrahiert, die vereinigten org. Phasen über Magnesiumsulfat getrocknet
und i. vac. eingeengt. Säulenchromatographie
(Kieselgel, Petrolether/EtOAc 1:1 v/v), Verreiben mit Hexan und
Trocknen i. vac. bei 50 °C
lieferte das Produkt.
Ausbeute: 4.40 g (51 % der Theorie)
Rf = 0.37 (Kieselgel, Petrolether/EtOAc 1/1
v/v)
ESI-MS: (M+H)+ = 147To a solution of 11.64 g (59.08 mmol) of 5-bromo-1H-indazole in 150 ml of THF was added under argon in portions within 10 minutes 2.60 g (65.00 mmol) of sodium hydride (60% in mineral oil) and the mixture for 15 minutes at RT touched. The reaction mixture was cooled to -70 ° C and added dropwise within 30 minutes 100.00 mL (130.00 mmol) sec-butyllithium (1.3 M in cyclohexane), keeping the temperature below -60 ° C. The mixture was stirred for a further 2 h at -70 ° C and then added dropwise a solution of 20.00 mL (0.260 mol) of DMF in 20 mL THF, the temperature was kept below -50 ° C. The reaction mixture was slowly warmed to RT and stirred for 16 h. The mixture was then cooled to 0 ° C and slowly added dropwise 180 mL of 2N aqueous HCl, stirred for a further 15 minutes and washed with sat. aqueous sodium bicarbonate solution has a pH of 9-10. The aqueous phase was exhaustively extracted with EtOAc, the combined org. Phases dried over magnesium sulfate and i. vac. concentrated. Column chromatography (silica gel, petroleum ether / EtOAc 1: 1 v / v), trituration with hexane and drying i. vac. at 50 ° C provided the product.
Yield: 4.40 g (51% of theory)
R f = 0.37 (silica gel, petroleum ether / EtOAc 1/1 v / v)
ESI-MS: (M + H) + = 147
Zwischenprodukt 2:Intermediate 2:
2-[1-(1H-Indazol-5-yl)-methyliden]-bernsteinsäure-methylester 2- [1- (1H-indazol-5-yl) -methylidene] -succinic acid methylester
Zu
einer Lösung
von 2.00 g (13.68 mmol) 1H-Indazol-5-carbaldehyd und 2.80 mL (20.97
mmol) Bernsteinsäure-dimethylester
in 100 mL tert-Butanol wurde 3.40 g (29.69 mmol) Kalium-tert-butylat
zugegeben und das Gemisch 2 h bei 60 °C gerührt. Das Reaktionsgemisch wurde
auf RT gekühlt,
mit 200 mL Wasser verdünnt und
die wässrige
Phase zweimal mit EtOAc gewaschen. Die wässrige Phase wurde mit halbkonz.
wässriger HCl
auf pH 3-4 angesäuert
und erschöpfend
mit EtOAc extrahiert. Die vereinigten org. Phasen wurde über Magnesiumsulfat
getrocknet, über
Aktivkohle filtriert und i. vac. eingeengt. Das Rohprodukt wurde
mit Diisopropylether und wenig Isopropanol verrieben, abfiltriert
und der Rückstand
mit Diisopropylether gewaschen (3.60 g, 1. Stereoisomer). Die Mutterlauge
wurde i. vac. eingeengt und der Rückstand mittels Säulenchromatographie (Kieselgel,
EtOAc / HOAc 10/0.1 v/v) gereinigt und i. vac. getrocknet (3.60
g, 2. Stereoisomer).
Ausbeute: 7.20 g (2 Stereoisomeren, 74
% der Theorie)
Rf = 0.49 (Kieselgel,
EtOAc/HOAc 100/1 v/v)
ESI-MS: (M+H)+ =
261To a solution of 2.00 g (13.68 mmol) of 1H-indazole-5-carbaldehyde and 2.80 mL (20.97 mmol) succinic acid dimethyl ester in 100 mL tert-butanol was added 3.40 g (29.69 mmol) of potassium tert-butoxide and the mixture 2 h stirred at 60 ° C. The reaction mixture was cooled to RT, diluted with 200 mL of water and the aqueous phase washed twice with EtOAc. The aqueous phase was washed with half-conc. Aqueous HCl acidified to pH 3-4 and exhaustively extracted with EtOAc. The united org. Phases were dried over magnesium sulfate, filtered through charcoal and i. vac. concentrated. The crude product was triturated with diisopropyl ether and a little isopropanol, filtered off and the residue was washed with diisopropyl ether (3.60 g, 1st stereoisomer). The mother liquor was i. vac. concentrated and the residue by column chromatography (Silica gel, EtOAc / HOAc 10 / 0.1 v / v) and i. vac. dried (3.60 g, 2nd stereoisomer).
Yield: 7.20 g (2 stereoisomers, 74% of theory)
R f = 0.49 (silica gel, EtOAc / HOAc 100/1 v / v)
ESI-MS: (M + H) + = 261
Zwischenprodukt 3:Intermediate 3:
2-(1H-Indazol-5-ylmethyl)-bernsteinsäure-methylester 2- (1 H-indazol-5-ylmethyl) -succinic acid methylester
Eine
Suspension von 1.30 g (5.00 mmol) 2-[1-(1H-Indazol-5-yl)-methyliden]-bernsteinsäure-methylester
und 0.60 g Pd/C (10%) in 40 mL MeOH/EtOAc (1:1) wurde 3 h bei 50 °C und 3 bar
Wasserstoffdruck hydriert. Der Katalysator wurde abfiltriert und
das Filtrat i. vac. eingeengt.
Ausbeute: 1.30 g (99 % der Theorie)
Rf = 0.64 (Kieselgel, EtOAc/HOAc 100/1 v/v)
ESI-MS:
(M+H)+ = 263A suspension of 1.30 g (5.00 mmol) of methyl 2- [1- (1H-indazol-5-yl) methylidene] -succinate and 0.60 g of Pd / C (10%) in 40 mL MeOH / EtOAc (1: 1 ) Was hydrogenated at 50 ° C and 3 bar hydrogen pressure for 3 h. The catalyst was filtered off and the filtrate i. vac. concentrated.
Yield: 1.30 g (99% of theory)
R f = 0.64 (silica gel, EtOAc / HOAc 100/1 v / v)
ESI-MS: (M + H) + = 263
Zwischenprodukt 4:Intermediate 4:
2-(1H-Indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-buttersäure-methylester 2- (1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 yl] butyric acid methylester
Zu
einer Lösung
von 1.50 g (5.72 mmol) 2-(1H-Indazol-5-ylmethyl)-bernsteinsäuremethylester
und 1.30 mL (7.25 mmol) Hünigsbase
in 50 mL THF wurde 2.30 g (6.88 mmol) TBTU zugegeben und das Gemisch 30
Minuten bei RT gerührt.
1.50 g (6.11 mmol) 3-Piperidin-4-yl-1,3,4,5-tetrahydro-1,3-benzodiazepin-2-on
wurde zugegeben und weitere 5 h bei RT gerührt. Das Reaktionsgemisch wurde
mit 50 mL EtOAc verdünnt,
die org. Phase zweimal mit 15% wässriger
Kaliumcarbonat-Lösung
gewaschen, über
Magnesiumsulfat getrocknet und i. vac. eingeengt. Der Rückstand
wurde mittels Säulenchromatographie
(Kieselgel, Dichlormethan/MeOH/ges. wässriger Ammoniak 50/45/5 v/v/v)
gereinigt und das Rohprodukt mit Diisopropylether verrieben.
Ausbeute:
1.60 g (57 % der Theorie)
Rf = 0.51
(Kieselgel, Dichlormethan/MeOH/ges. wässriger Ammoniak 50/45/5 v/v/v)
ESI-MS:
(M+H)+ = 492To a solution of 1.50 g (5.72 mmol) 2- (1H-indazol-5-ylmethyl) -succinic acid methyl ester and 1.30 mL (7.25 mmol) Hünigsbase in 50 mL THF was added 2.30 g (6.88 mmol) TBTU and the mixture at 30 minutes RT stirred. 1.50 g (6.11 mmol) of 3-piperidin-4-yl-1,3,4,5-tetrahydro-1,3-benzodiazepin-2-one was added and the mixture was stirred at RT for a further 5 h. The reaction mixture was diluted with 50 mL EtOAc, the org. Washed twice with 15% aqueous potassium carbonate solution, dried over magnesium sulfate and i. vac. concentrated. The residue was purified by column chromatography (silica gel, dichloromethane / MeOH / saturated aqueous ammonia 50/45/5 v / v / v) and the crude product triturated with diisopropyl ether.
Yield: 1.60 g (57% of theory)
R f = 0.51 (silica gel, dichloromethane / MeOH / saturated aqueous ammonia 50/45/5 v / v / v)
ESI-MS: (M + H) + = 492
Zwischenprodukt 5:Intermediate 5:
2-(1H-Indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-buttersäure 2- (1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 yl] butyric acid
Zu
einer Lösung
von 1.60 g (3.27 mmol) 2-(1H-Indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-buttersäure-methylester
in 20 mL THF wurde eine Lösung
von 0.20 g (8.18 mmol) Lithiumhydroxid in 10 mL Wasser zugegeben
und das Gemisch 16 h bei RT gerührt.
Das Reaktionsgemisch wurde mit 15 mL 1 N wässriger HCl angesäuert und
die wässrige
Phase mit EtOAc erschöpfend extrahiert.
Die vereinigten org. Phasen wurden über Magnesiumsulfat getrocknet
und i. vac. eingeengt. Das Rohprodukt wurde mit Diisopropylether
verrieben und i. vac. getrocknet.
Ausbeute: 1.20 g (77 % der
Theorie)
Rf = 0.05 (Kieselgel, Dichlormethan/Cyclohexan/MeOH/ges.
wässriger
Ammoniak 70/15/15/2 v/v/v/v)
ESI-MS: (M+H)+ =
476To a solution of 1.60 g (3.27 mmol) 2- (1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3- Benzodiazepin-3-yl) -piperidin-1-yl] -butyric acid methyl ester in 20 mL THF was added a solution of 0.20 g (8.18 mmol) of lithium hydroxide in 10 mL water and the mixture was stirred at RT for 16 h. The reaction mixture was acidified with 15 mL of 1 N aqueous HCl and the aqueous phase extracted exhaustively with EtOAc. The united org. Phases were dried over magnesium sulfate and i. vac. concentrated. The crude product was triturated with diisopropyl ether and i. vac. dried.
Yield: 1.20 g (77% of theory)
R f = 0.05 (silica gel, dichloromethane / cyclohexane / MeOH / saturated aqueous ammonia 70/15/15/2 v / v / v / v)
ESI-MS: (M + H) + = 476
Zwischenprodukt 6:Intermediate 6:
7-Methyl-1H-indazol-5-carbaldehyd 7-methyl-1H-indazol-5-carbaldehyde
Das
Zwischenprodukt wurde analog Zwischenprodukt 1 ausgehend von 5-Brom-7-methyl-1H-indazol erhalten.
Ausbeute:
7.10 g (69 % der Theorie)
Rf = 0.05
(Kieselgel, Petrolether/EtOAc 2/1 v/v)
ESI-MS: (M)+ =
160The intermediate was obtained analogously to Intermediate 1 starting from 5-bromo-7-methyl-1H-indazole.
Yield: 7.10 g (69% of theory)
R f = 0.05 (silica gel, petroleum ether / EtOAc 2/1 v / v)
ESI-MS: (M) + = 160
Zwischenprodukt 7:Intermediate 7:
2-[1-(7-Methyl-1H-indazol-5-yl)-meth-(E)-yliden]-bernsteinsäure-methylester 2- [1- (7-methyl-1H-indazol-5-yl) -meth- (E) -ylidene] -succinic acid methylester
Eine
Suspension von 5.90 g (36.84 mmol) 7-Methyl-1H-indazol-5-carbaldehyd
und 28.88 g (73.60 mmol) 2-(Triphenyl-λ5-phosphanyliden)-bernsteinsäure-methylester
in 120 mL THF wurde 5 Tage bei 40 °C gerührt. 50 mL DMSO und weitere
14.0 g 2-(Triphenyl-λ5-phosphanyliden)-bernsteinsäure-methylester
wurden zugegeben und das Gemisch 7 h bei 95 °C gerührt. Das Reaktionsgemisch wurde
auf 1 L Wasser gegossen, die wässrige
Phase mit 500 mL EtOAc gewaschen und die org. Phase je zweimal mit
Wasser und 15%-iger wässriger
Kaliumcarbonat-Lösung
extrahiert. Die vereinigten Wasserphasen wurden mit konz. wässriger
HCl auf pH 1 angesäuert
und die wässrigen
Phasen mit EtOAc erschöpfend
extrahiert. Die vereinigten org. Phasen wurden mit Wasser gewaschen, über Magnesiumsulfat
getrocknet und i. vac. eingeengt. Der Rückstand wurde mittels Säulenchromatographie
(Kieselgel, Gradient innerhalb von 60 Minuten, Dichlormethan/MeOH/ges. wässriger
Ammoniak 100/0/0 → 0/93/7
v/v/v) gereinigt.
Ausbeute: 2.40 g (24 % der Theorie)
Rf = 0.40 (Kieselgel, Dichlormethan/MeOH/ges.
wässriger
Ammoniak 85/15/1.5 v/v/v)
ESI-MS: (M+H)+ =
275A suspension of 5.90 g (36.84 mmol) of 7-methyl-1H-indazole-5-carbaldehyde and 28.88 g (73.60 mmol) of methyl 2- (triphenyl-λ 5 -phosphanylidene) -succinate in 120 mL of THF was kept at 40 for 5 days ° C stirred. 50 mL of DMSO and another 14.0 g of 2- (triphenyl-λ 5 -phosphanylidene) -succinic acid methyl ester were added and the mixture was stirred at 95 ° C for 7 h. The reaction mixture was poured onto 1 L of water, the aqueous phase was washed with 500 mL EtOAc and the org. Phase extracted twice each with water and 15% aqueous potassium carbonate solution. The combined aqueous phases were treated with conc. acidified to pH 1 aqueous HCl and the aqueous phases extracted exhaustively with EtOAc. The united org. phases were washed with water, dried over magnesium sulfate and i. vac. concentrated. The residue was purified by column chromatography (silica gel, gradient over 60 minutes, dichloromethane / MeOH / saturated aqueous ammonia 100/0/0 → 0/93/7 v / v / v).
Yield: 2.40 g (24% of theory)
R f = 0.40 (silica gel, dichloromethane / MeOH / saturated aqueous ammonia 85/15 / 1.5 v / v / v)
ESI-MS: (M + H) + = 275
Zwischenprodukt 8:Intermediate 8:
2-(7-Methyl-1H-indazol-5-ylmethyl)-bernsteinsäure-methylester 2- (7-methyl-1H-indazol-5-ylmethyl) -succinic acid methylester
Das
Zwischenprodukt wurde analog zu Zwischenprodukt 3 ausgehend von
2-[1-(7-Methyl-1H-indazol-5-yl)-meth-(E)-yliden]-bernsteinsäure-methylester
erhalten.
Ausbeute: 1.10 g (45 % der Theorie)
HPLC-MS:
5.6 Minuten (Agilent Zorbax Stable Bond SB C18, 5 μm, 75 × 4.6 mm,
Gradient in 9 Minuten, Wasser/Acetonitril/Ameisensäure 10/90/0.1 → 90/10/0.1
v/v/v)
ESI-MS: (M+H)+ = 277The intermediate was obtained analogously to intermediate 3 starting from methyl 2- [1- (7-methyl-1H-indazol-5-yl) -meth- (E) -ylidene] -succinate.
Yield: 1.10 g (45% of theory)
HPLC-MS: 5.6 minutes (Agilent Zorbax Stable Bond SB C18, 5 μm, 75 × 4.6 mm, gradient in 9 minutes, water / acetonitrile / formic acid 10/90 / 0.1 → 90/10 / 0.1 v / v / v)
ESI-MS: (M + H) + = 277
Zwischenprodukt 9:Intermediate 9:
2-(7-Methyl-1H-indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-buttersäure-methylester 2- (7-methyl-1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) piperidin-1-yl] -butyric acid methylester
Das
Zwischenprodukt wurde analog zu Zwischenprodukt 4 ausgehend von
2-(7-Methyl-1H-indazol-5-ylmethyl)-bernsteinsäure-methylester
und 3-Piperidin-4-yl-1,3,4,5-tetrahydro-1,3-benzodiazepin-2-on erhalten.
Das Rohprodukt wurde ohne weitere Reinigung in den nachfolgenden
Reaktionsschritt eingesetzt.
Ausbeute: 0.90 g (90 % der Theorie)
Rf = 0.35 (Kieselgel, EtOAc/MeOH 9/1 v/v)
HPLC-MS:
6.9 Minuten (Agilent Zorbax Stable Bond SB C18, 5 μm, 75 × 4.6 mm,
Gradient in 9 Minuten, Wasser/Acetonitril/Ameisensäure 10/90/0.1 → 90/10/0.1
v/v/v)
ESI-MS: (M+H)+ = 504The intermediate was analogously to intermediate 4 starting from methyl 2- (7-methyl-1H-indazol-5-ylmethyl) -succinate and 3-piperidin-4-yl-1,3,4,5-tetrahydro-1,3 -benzodiazepin-2-one obtained. The crude product was used without further purification in the subsequent reaction step.
Yield: 0.90 g (90% of theory)
R f = 0.35 (silica gel, EtOAc / MeOH 9/1 v / v)
HPLC-MS: 6.9 minutes (Agilent Zorbax Stable Bond SB C18, 5 μm, 75 × 4.6 mm, gradient in 9 minutes, water / acetonitrile / formic acid 10/90 / 0.1 → 90/10 / 0.1 v / v / v)
ESI-MS: (M + H) + = 504
Zwischenprodukt 10:Intermediate 10:
2-(7-Methyl-1H-indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-buttersäure 2- (7-methyl-1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) piperidin-1-yl] butyric acid
Das
Zwischenprodukt wurde analog zu Zwischenprodukt 5 ausgehend von 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-buttersäure-methylester
erhalten. Das Rohprodukt wurde ohne weitere Reinigung in den nachfolgenden Reaktionsschritt
eingesetzt.
Ausbeute: 0.80 g (82 % der Theorie)
HPLC-MS:
6.2 Minuten (Agilent Zorbax Stable Bond SB C18, 5 μm, 75 × 4.6 mm,
Gradient in 9 Minuten, Wasser/Acetonitril/Ameisensäure 10/90/0.1 → 90/10/0.1
v/v/v)
ESI-MS: (M+H)+ = 490The intermediate was analogously to intermediate 5 starting from 2- (7-methyl-1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1 Methyl 3-benzodiazepin-3-yl) piperidin-1-yl] butyrate. The crude product was used without further purification in the subsequent reaction step.
Yield: 0.80 g (82% of theory)
HPLC-MS: 6.2 minutes (Agilent Zorbax Stable Bond SB C18, 5 μm, 75 × 4.6 mm, gradient in 9 minutes, water / acetonitrile / formic acid 10/90 / 0.1 → 90/10 / 0.1 v / v / v)
ESI-MS: (M + H) + = 490
B) Herstellung von EndverbindungenB) Preparation of end compounds
Herstellung von Beispiel (5):Production of example (5):
(S)-2-(1H-Indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion (S) -2- (1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione
Zu
einer Lösung
von 600.0 mg (1.262 mmol) 2-(1H-Indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-buttersäure in 30
mL THF wurde bei RT 450.0 mg (1.345 mmol) TBTU und 0. 270 mL (1.532
mmol) Hünigsbase
zugegeben und das Gemisch 30 Minuten gerührt. 250.0 mg (1.373 mmol)
1-Methyl-4-piperidin-4-yl-piperazin wurde zugegeben und das Gemisch
weiter 16 h bei RT gerührt.
Das Reaktionsgemisch wurde mit 50 mL EtOAc verdünnt und die org. Phase zweimal
mit 15%-iger wässriger
Kaliumcarbonat-Lösung
gewaschen. Die org. Phase wurde über
Magnesiumsulfat getrocknet und i. vac. eingeengt. Das Rohprodukt
wurde mittels Säulenchromatographie
(Kieselgel, Gradient Dichlormethan/MeOH/ges. wässriger Ammoniak 100/0/0 → 80/18/2)
gereinigt. Der Rückstand
wurde mit Diisopropylether verrieben und i. vac. bei 50 °C getrocknet.
Ausbeute:
520 mg (64% der Theorie)
Rf = 0.37
(Kieselgel, Dichlormethan/Cyclohexan/MeOH/konz. wässriger
Ammoniak 70/15/15/2 v/v/v/v)
ESI-MS: (M+H)+ =
641To a solution of 600.0 mg (1.262 mmol) 2- (1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3- benzodiazepin-3-yl) -piperidin-1-yl] -butyric acid in 30 mL THF at RT 450.0 mg (1.345 mmol) TBTU and 0. 270 mL (1.532 mmol) Hünigsbase was added and the mixture was stirred for 30 minutes. 250.0 mg (1.373 mmol) of 1-methyl-4-piperidin-4-yl-piperazine was added and the mixture was stirred at RT for a further 16 h. The reaction mixture was diluted with 50 mL EtOAc and the org. Phase washed twice with 15% aqueous potassium carbonate solution. The org. Phase was dried over magnesium sulfate and i. vac. concentrated. The crude product was purified by column chromatography (silica gel, gradient dichloromethane / MeOH / saturated aqueous ammonia 100/0/0 → 80/18/2). The residue was triturated with diisopropyl ether and i. vac. dried at 50 ° C.
Yield: 520 mg (64% of theory)
R f = 0.37 (silica gel, dichloromethane / cyclohexane / MeOH / concentrated aqueous ammonia 70/15/15/2 v / v / v / v)
ESI-MS: (M + H) + = 641
Herstellung von Beispiel 39:Production of example 39:
2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion 2- (7-methyl-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione
Das
Produkte wurde analog zu Beispiel 1 aus 2-(7-Methyl-1H-indazol-5-ylmethyl)-4- oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-buttersäure (Zwischenprodukt
10) und 1-Methyl-4-piperidin-4-yl-piperazin erhalten. Das Rohprodukt
wurde mittels HPLC-MS (Agilent Zorbax Stable Bond SB C18, 5 μm, 75 × 4.6 mm,
Wasser/Acetonitril/Ameisensäure
10/90/0.1 → 90/10/0.1 v/v/v)
gereinigt.
Ausbeute: 360 mg (34% der Theorie)
Rf = 0.35 (Kieselgel, Dichlormethan/MeOH/konz.
wässriger
Ammoniak 85/15/1.5 v/v/v)
ESI-MS: (M+H)+ =
655The product was prepared analogously to Example 1 from 2- (7-methyl-1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1, 3-benzodiazepin-3-yl) -piperidin-1-yl] -butyric acid (interm. 10) and 1-methyl-4-piperidin-4-yl-piperazine. The crude product was purified by HPLC-MS (Agilent Zorbax Stable Bond SB C18, 5 μm, 75 x 4.6 mm, water / acetonitrile / formic acid 10/90 / 0.1 → 90/10 / 0.1 v / v / v).
Yield: 360 mg (34% of theory)
R f = 0.35 (silica gel, dichloromethane / MeOH / concentrated aqueous ammonia 85/15 / 1.5 v / v / v)
ESI-MS: (M + H) + = 655
Analog können folgende Beispiele hergestellt werden: 1-1,4'-Bipiperidinyl-1'-yl-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-1-[4-(4-methyl-perhydro-1,4-diazepin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-perhydro-1,4-diazepin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl)-butan-1,4-dion, 1-[4-(4-fluor-phenyl)-piperazin-1-yl]-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-[4-(4-fluor-phenyl)-piperidin-1-yl]-2-(1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-pyridin-4-yl-piperazin-1-yl)-butan-1,4-dion, (1'-{2-(1H-Indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butyryl}-4,4'-bipiperidinyl-1-yl)-essigsäure-methylester, 2-(1H-Indazol-5-ylmethyl)-1-(1'-methanesulfonyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-1,4'-bipiperidinyl-1'-yl-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(4-dimethylamino-piperidin-1-yl)-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(4-methyl-perhydro-1,4-diazepin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-perhydro-1,4-diazepin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-fluor-phenyl)-piperazin-1-yl]-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-fluor-phenyl)-piperidin-1-yl]-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-pyridin-4-yl-piperazin-1-yl)-ethyl]-amid, [1'-(3-(1H-Indazol-5-yl)-2-{[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonyl]-amino}-propionyl)-4,4'-bipiperidinyl-1-yl]-essigsäure-methylester, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-(1'-methanesulfonyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 1-1,4'-Bipiperidinyl-1'-yl-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-1H-indazol-5-ylmethyl)-4-(4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-perhydro-1,4-diazepin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-perhydro-1,4-diazepin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl)-butan-1,4-dion, 1-[4-(4-fluor-phenyl)-piperazin-1-yl]-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-[4-(4-fluor-phenyl)-piperidin-1-yl]-2-(7-methyl-1H-indazol-5-ylmethyl)-4-(4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-pyridin-4-yl-piperazin-1-yl)-butan-1,4-dion, (1'-{2-(7-Methyl-1H-indazol-5-ylmethyl)-4-oxo-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butyryl}-4,4'-bipiperidinyl-1-yl)-essigsäure-methylester, 1-(1'-Methanesulfonyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-1,4'-bipiperidinyl-1'-yl-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(4-dimethylamino-piperidin-1-yl)-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-perhydro-1,4-diazepin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-perhydro-1,4-diazepin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-fluor-phenyl)-piperazin-1-yl]-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-fluor-phenyl)-piperidin-1-yl]-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-pyridin-4-yl-piperazin-1-yl)-ethyl]-amid, [1'-(3-(7-Methyl-1H-indazol-5-yl)-2-{[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonyl]-amino}-propionyl)-4,4'-bipiperidinyl-1-yl]-essigsäure-methylester, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methanesulfonyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 2-(1H-Indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(1H-indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(1H-indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(1H-indazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure {1-(1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure [1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure [2-1,4'-bipiperidinyl-1'-yl-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure [2-(4-dimethylamino-piperidin-1-yl)-1-(1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 2-(7-Ethyl-1H-indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-ethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Ethyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Ethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-Ethyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Ethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 2-(7-Chlor-1H-indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-chlor-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-chlor-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 2-(7-Brom-1H-indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-brom-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Brom-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Brom-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-Brom-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Brom-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion, 2-(7-Methyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 4-[4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion, 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion, 4-[4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-2-(7-trifluormethyl-1H-indazol-5-ylmethyl)-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(1-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(1-methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1-Methyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(1-Methyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1-Methyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(1,7-dimethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1,7-Dimethyl-1H-indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 2-(1H-Benzotriazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Benzotriazol-5-ylmethyl)-1-4,4'-bipiperidinyl-1-yl-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Benzotriazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(1H-Benzotriazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-1H-benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-benzotriazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 2-(1H-Indol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(1H-Indol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(1H-Indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-indol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-Methyl-1H-indol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-1H-indol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-ethyl-1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-ethyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-ethyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-ethyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-ethyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-ethyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-chlor-1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-chlor-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-chlor-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-chlor-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-chlor-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-chlor-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-brom-1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-brom-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-brom-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-brom-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-brom-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-brom-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-1-(7-trifluormethyl-1H-indazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(1-methyl-H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(1-methyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1-methyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1-methyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1-methyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1,7-dimethyl-1H-indazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-benzotriazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-benzotriazol-5-ylmethyl)-2-4,4'-bipiperidinyl-1-yl-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-benzotriazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-benzotriazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-benzotriazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-benzotriazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-benzotriazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(1H-indol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(1H-indol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(1H-indol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-1H-indol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-1H-indol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure {1-(7-methyl-1H-indol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure [1-(7-methyl-1H-indol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-[4-(4-Methyl-piperazin-1-yl)-piperidin-1-yl]-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-(4-dimethylamino-piperidin-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-(4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-[4-(4-Methyl-piperazin-1-yl)-piperidin-1-yl]-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(2-Oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(4-methyl-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methylpiperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-(4-dimethylaminopiperidin-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-[4-(4-Methyl-piperazin-1-yl)-piperidin-1-yl]-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)-piperazin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-(4-dimethylamino-piperidin-1-yl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-[4-(4-Methyl-piperazin-1-yl)-piperidin-1-yl]-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 1-[4-(1-Methyl-piperidin-4-yl)-piperazin-1-yl]-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(2-Oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(1'-Methyl-4,4'-bipiperidinyl-1-yl)-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-ylpiperidin-1-yl)-butan-1,4-dion, 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(1-methylpiperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-yl-piperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-(4-Dimethylamino-piperidin-1-yl)-2-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-(1'-methyl-4,4'-bipiperidinyl-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 1-4,4'-Bipiperidinyl-1-yl-2-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperazin-1-yl-piperidin-1-yl)-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-1-(4-piperidin-4-ylpiperazin-1-yl)-butan-1,4-dion, 1-1,4'-Bipiperidinyl-1'-yl-2-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 2-(7-Chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-1-(4-dimethylamino-piperidin-1-yl)-4-[4-(5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-yl]-butan-1,4-dion, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-1,4'-bipiperidinyl-1'-yl-2-oxo-1-(2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-(4-dimethylamino-piperidin-1-yl)-2-oxo-1-(2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-4,4'-bipiperidinyl-1-yl-1-(4-methyl-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 2-(4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-1-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-4-[4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-yl]-butan-1,4-dion, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-{1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-1,4'-bipiperidinyl-1'-yl-1-(4-methyl-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-(4-dimethylamino-piperidin-1-yl)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-4,4'-bipiperidinyl-1-yl-1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-{1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-{1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-1,4'-bipiperidinyl-1'-yl-1-(4-chlor-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-dimethylamino-piperidin-1-yl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-piperazin-1-ylpiperidin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(4-methylpiperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-1-(4-methyl-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-[4-(1-methylpiperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(4-chlor-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl)-2-(4-dimethylamino-piperidin-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-1,4'-bipiperidinyl-1'-yl-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-(4-dimethylamino-piperidin-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-{1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-{1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-1,4'-bipiperidinyl-1'-yl-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-(4-dimethylamino-piperidin-1-yl)-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-4,4'-bipiperidinyl-1-yl-1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-{1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-{1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[2-1,4'-bipiperidinyl-1'-yl-1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidin-1-carbonsäure-[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-dimethylamino-piperidin-1-yl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-[4-(4-methyl-piperazin-1-yl)-piperidin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-piperazin-1-ylpiperidin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-[4-(1-methyl-piperidin-4-yl)-piperazin-1-yl]-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-piperidin-4-ylpiperazin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-2-oxo-1-(2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(4-methylpiperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(1-methylpiperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-(4-dimethylamino-piperidin-1-yl)-1-(7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(1'-methyl-4,4'-bipiperidinyl-1-yl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-4,4'-bipiperidinyl-1-yl-1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(4-methylpiperazin-1-yl)-piperidin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperazin-1-yl-piperidin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure{1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-[4-(1-methylpiperidin-4-yl)-piperazin-1-yl]-2-oxo-ethyl}-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-2-(4-piperidin-4-yl-piperazin-1-yl)-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[2-1,4'-bipiperidinyl-1'-yl-1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-oxo-ethyl]-amid, 4-(5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl)-piperidin-1-carbonsäure[1-(7-chlor-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl)-2-(4-dimethylamino-piperidin-1-yl)-2-oxo-ethyl]-amid, 2-(1H-Indazol-5-ylmethyl)-4-[4-(2-oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidin-1-yl]-1-(4-pyrrolidin-1-yl-piperidin-1-yl)-butan-1,4-dion, 4-(2-Oxo-1,2,4,5-tetrahydro-benzo[d][1,3]diazepin-3-yl)-piperidine-1-carbonsäure-[1-(1H-indazol-5-ylmethyl)-2-oxo-2-(4-pyrrolidin-1-yl-piperidin-1-yl)-ethyl]-amid. The following examples can be prepared analogously: 1-1,4'-Bipiperidinyl-1'-yl-2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3- benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4,5 tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine -3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3- benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] - 1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] - 1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 2- (1H-indazol-5-yl-methyl) -1- [4- (4-methyl-perhydro-1,4-diazepin-1-yl) piperidin-1-yl] -4- [4- (2- oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] - 1- (4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -perhydro-1,4-diazepin-1-yl] -4- [4- (2- oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] - 1- (4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl) -butan-1,4-dione, 1- [4- (4-fluoro-phenyl) -piperazin-1-yl] -2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5 tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- [4- (4-fluoro-phenyl) -piperidin-1-yl] -2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5 tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] - 1- (4-pyridin-4-yl-piperazin-1-yl) -butan-1,4-dione, (1 '- {2- (1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl ) piperidin-1-yl] -butyryl} -4,4'-bipiperidinyl-1-yl) -acetic acid methylester, 2- (1H-indazol-5-ylmethyl) -1- (1'-methanesulfonyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4,5 tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl-1 (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2- (1 'methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2- [4 - (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2-oxo] 2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2- [4 - (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2-oxo] 2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2- [4 - (4-methyl-perhydro-1,4-diazepin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2-oxo] 2- (4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2- [4 - (1-methyl-piperidin-4-yl) -perhydro-1,4-diazepin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2-oxo] 2- (4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-fluoro-phenyl) -piperazine-1 -yl] -1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-fluoro-phenyl) -piperidine-1 -yl] -1- (1H-indazol-5ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2-oxo] 2- (4-pyridin-4-yl-piperazin-1-yl) -ethyl] -amide, [1 '- (3- (1H-indazol-5-yl) -2 - {[4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine -1-carbonyl] -amino} -propionyl) -4,4'-bipiperidinyl-1-yl] -acetic acid methylester, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2- (1 '-methanesulfonyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 1-1,4'-Bipiperidinyl-1'-yl-2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro- 1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-1H-indazol-5-ylmethyl) -4- (4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro- 1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-methyl-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 2- (7-methyl-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-perhydro-1,4-diazepin-1-yl) piperidin-1-yl] -4- [4 - (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-methyl-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -perhydro-1,4-diazepin-1-yl] -4- [4 - (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl) -butan-1,4-dione, 1- [4- (4-fluoro-phenyl) -piperazin-1-yl] -2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- [4- (4-fluoro-phenyl) -piperidin-1-yl] -2- (7-methyl-1H-indazol-5-ylmethyl) -4- (4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-pyridin-4-yl-piperazin-1-yl) -butan-1,4-dione, (1 '- {2- (7-methyl-1H-indazol-5-ylmethyl) -4-oxo-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine -3-yl) -piperidin-1-yl] -butyryl} -4,4'-bipiperidinyl-1-yl) -acetic acid methylester, 1- (1'-Methanesulfonyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl-1 (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl-1 -yl) -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indazol-5-ylmethyl) - 2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indazol-5-ylmethyl) - 2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indazol-5-ylmethyl) - 2- [4- (4-methyl-perhydro-1,4-diazepin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-perhydro-1,4-diazepin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indazol-5-ylmethyl) - 2- [4- (1-methyl-piperidin-4-yl) -perhydro-1,4-diazepin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-piperidin-4-yl-perhydro-1,4-diazepin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-fluoro-phenyl) -piperazine-1 -yl] -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-fluoro-phenyl) -piperidine-1 -yl] -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-pyridin-4-yl-piperazin-1-yl) -ethyl] -amide, [1 '- (3- (7-Methyl-1H-indazol-5-yl) -2 - {[4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3- yl) -piperidine-1-carbonyl] -amino} -propionyl) -4,4'-bipiperidinyl-1-yl] -acetic acid methylester, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methanesulfonyl-4,4'-bipiperidinyl-1 -yl) -1- (7-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 2- (1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (5-oxo-3-phenyl-4,5- dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (1H-indazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4 triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (5-oxo-3-phenyl- 4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl ] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (5-oxo-3-phenyl- 4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (1H-indazol-5-yl-methyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl ] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (1H-indazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2, 4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (1H-indazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2, 4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 - (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2- oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (1H-indazol-5-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl) -2- oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl] 1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-Oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -] 1- (1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 2- (7-ethyl-1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-ethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-ethyl-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-ethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-ethyl-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-ethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 2- (7-chloro-1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-chloro-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-chloro-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 2- (7-bromo-1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-bromo-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-bromo-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-bromo-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-bromo-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-bromo-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) piperidin-1-yl] -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione, 2- (7-methyl-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperazin-1-yl-piperidine -1-yl) -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione, 1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine 3-yl) -piperidin-1-yl] -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione, 4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazine -1-yl) -2- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -butane-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (1-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (1-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1-methyl-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (1-methyl-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1-methyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1, 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro -1,3-benzodiazepine-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2- oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine -1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2- oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1,7-dimethyl-1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine -1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 2- (1H-benzotriazole-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4,5 tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-benzotriazol-5-ylmethyl) -1-4,4'-bipiperidinyl-1-yl-4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine -3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-benzotriazole-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-benzotriazole-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] - 1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (1H-benzotriazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-benzotriazole-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] - 1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 2- (7-methyl-1H-benzotriazole-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-methyl-1H-benzotriazole-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-benzotriazole-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-benzotriazole-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-methyl-1H-benzotriazole-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-benzotriazole-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 2- (1H-Indol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- (2-oxo-1,2,4,5 tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine -3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-Indol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-Indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] - 1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (1H-Indol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (1H-Indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] - 1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-methyl-1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1 , 3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-indol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-methyl-1H-indol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-1H-indol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1 -yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-ethyl-1H-indazol-5-ylmethyl) -] 2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 7-ethyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-ethyl-1H-indazol-5-ylmethyl) - 2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-ethyl-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-ethyl-1H-indazol-5-ylmethyl) - 2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-ethyl-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-1H-indazol-5-ylmethyl) -] 2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 7-chloro-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-chloro-1H-indazol-5-ylmethyl) - 2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-chloro-1H-indazol-5-ylmethyl) - 2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-bromo-1H-indazol-5-ylmethyl) - 2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 7-bromo-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-bromo-1H-indazol-5-ylmethyl) - 2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-bromo-1H-indazol-5-ylmethyl) - 2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-bromo-1H-indazol-5-ylmethyl) - 2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-bromo-1H-indazol-5-ylmethyl) - 2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl-1 -yl) -2-oxo-1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-2-oxo -1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-methylpiperazin-1-yl) piperidin-1-yl] -2-oxo-1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-2- (4-piperazin-1-yl-piperidine -1-yl) -1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (1-methylpiperidin-4-yl) piperazin-1-yl] -2-oxo-1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-2- (4-piperidin-4-yl-piperazine -1-yl) -1- (7-trifluoromethyl-1H-indazol-5-ylmethyl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl-1 -yl) -1- (1-methyl-H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 1-methyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1-methyl-1H-indazol-5-ylmethyl) - 2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1-methyl-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1-methyl-1H-indazol-5-ylmethyl) - 2- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1-methyl-1H-indazol-5-ylmethyl) -] 2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1,7-dimethyl-1H-indazol-5-ylmethyl ) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 1,7-dimethyl-1H-indazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1,7-dimethyl-1H-indazol-5-ylmethyl ) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1,7-dimethyl-1H-indazol-5-ylmethyl ) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1,7-dimethyl-1H-indazol-5-ylmethyl ) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1,7-dimethyl-1H-indazol-5-ylmethyl ) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-benzotriazol-5-ylmethyl) -2- (1 'methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-benzotriazol-5-ylmethyl) -2-4, 4'-bipiperidinyl-1-yl-2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-benzotriazol-5-ylmethyl) -2- [4 - (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-benzotriazol-5-ylmethyl) -2-oxo] 2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-benzotriazol-5-ylmethyl) -2- [4 - (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-benzotriazol-5-ylmethyl) -2-oxo] 2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-benzotriazol-5-ylmethyl) -] 2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 7-methyl-1H-benzotriazole-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-benzotriazol-5-ylmethyl) - 2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-benzotriazol-5-ylmethyl) -] 2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-benzotriazol-5-ylmethyl) - 2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-benzotriazol-5-ylmethyl) -] 2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indol-5-ylmethyl) -2- (1 'methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 1H-indol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indol-5-ylmethyl) -2- [4 - (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indol-5-ylmethyl) -2-oxo 2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (1H-indol-5-ylmethyl) -2- [4 - (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indol-5-ylmethyl) -2-oxo 2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl-1 -yl) -1- (7-methyl-1H-indol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 ( 7-methyl-1H-indol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indol-5-ylmethyl) - 2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indol-5-ylmethyl) -] 2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-1H-indol-5-ylmethyl) - 2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-Oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-1H-indol-5-ylmethyl) -] 2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5 tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- ( 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- ( 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4, 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4, 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- ( 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2 , 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine 3-yl) piperidine-1yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (4-Methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine 3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1, 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1, 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- ( 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2 , 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine 3-yl) -piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine 3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (2-oxo-1, 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- (4-dimethylamino-piperidin-1-yl) -4- [4- (2-oxo-1, 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo- 3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- (4- (5-oxo-3-phenyl-4,5 dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- ( 5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1- yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 1- [4- (1-methyl-piperidin-4-yl) -piperazin-1-yl] -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- ( 5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1- yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4, 5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4, 5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- ( 5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl -4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, -2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4- triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4- triazol-1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazine-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-yl-methyl) -4- [4- (5-oxo- 3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (4-methyl-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl- 4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4- ( 5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl -4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methylpiperazin-1-yl) piperidin-1-yl] -4- [4 - (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4- triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (1-methylpiperidin-4-yl) piperazin-1-yl] -4- [4 - (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4- triazol-1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -4- [4- (5-oxo-3- phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- (4-dimethylaminopiperidine-1-yl) -4- [4- (5-oxo-3-phenyl- 4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2- oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4 , 5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4 - (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3- yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4 - (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3- yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2, 4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4 - (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] - 4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3- benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] - 4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3- benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4 - (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1 , 2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] - 4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3- benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butane-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (1-methylpiperidin-4-yl) piperazin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3- benzodiazepin-3-yl) -piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- (4-dimethylamino-piperidin-1-yl) -4- [4- (2-oxo- 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5- oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4 , 5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4 - (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione; 2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazole 1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4 - (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazole 1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl- 4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl- 4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4 - (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3 -phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] - 4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2, 4-triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (1-methylpiperidin-4-yl) piperazin-1-yl] -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2, 4-triazol-1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo- 3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1- (4-dimethylamino-piperidin-1-yl) -2- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo- 3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- (1'-methyl-4,4'-bipiperidinyl-1-yl) -4- [4 - (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 1-4,4'-bipiperidinyl-1-yl-2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3 -phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] - 4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2, 4-triazol-1-yl) piperidin-1-yl] -1- (4-piperazin-1-yl-piperidin-1-yl) -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] - 4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo-3-phenyl-4,5-dihydro-1,2, 4-triazol-1-yl) piperidin-1-yl] -1- (4-piperidin-4-yl-piperazin-1-yl) -butan-1,4-dione, 1-1,4'-Bipiperidinyl-1'-yl-2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -4- [4- (5-oxo- 3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 2- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -1- (4-dimethylamino-piperidin-1-yl) -4- [4- (5-oxo- 3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) piperidin-1-yl] -butan-1,4-dione, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl- 1-yl) -2-oxo-1- (2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-2- oxo-1- (2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-methyl-piperazin-1-yl ) piperidin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (1-methyl-piperidin-4-yl ) piperazin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2,3- -dihydro-benzoxazol-ylmethyl 6) -2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl-2 oxo-1- (2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -2 oxo-1- (2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl- 1-yl) -1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1- (4-methyl-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 2- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -1- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -4- [4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidin-1-yl] -butan-1,4-dione, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-methyl-2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (4-methyl-2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-methyl-2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl-1 - (4-methyl-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -1 - (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (4-chloro-2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (4-chloro-2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl-1 - (4-chloro-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2,3- dihydro-benzoxazol-6-ylmethyl) -2- (4-dimethylamino-piperidin-1-yl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl -1-yl) -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-2 oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- [4- (4-methyl-piperazin-1- yl) piperidin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- [4- (1-methyl-piperidin-4- yl) piperazin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl 2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) - 2-oxo-1- (2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl -1-yl) -1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 - (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (4-methyl-2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2- [4- (4-methylpiperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-methyl-2-oxo-2,3 dihydro-benzoxazol-6--ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (4-methyl-2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-methyl-2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl 1- (4-methyl-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) - 1- (4-methyl-2-oxo-2,3-dihydrobenzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 - (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (4-chloro-2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (4-chloro-2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2- [4- (1-methylpiperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl 1- (4-chloro-2-oxo-2,3-dihydro-benzoxazol-6-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (4-chloro-2-oxo-2,3 dihydro-benzoxazol-6-ylmethyl) -2- (4-dimethylamino-piperidin-1-yl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl- 1-yl) -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-2- oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (4-methyl-piperazin-1-yl ) piperidin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-oxo 1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- [4- (1-methyl-piperidin-4-yl ) piperazin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl-2 oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -2 oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl- 1-yl) -1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-methyl-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-methyl-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl-1 - (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) -1 - (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-chloro-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (4-methyl-piperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid {1- (7-chloro-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (1-methyl-piperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl-1 - (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2,3- dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-dimethylamino-piperidin-1-yl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl -1-yl) -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-2 oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- [4- (4-methyl-piperazin-1- yl) piperidin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-piperazin-1-ylpiperidin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- [4- (1-methyl-piperidin-4- yl) piperazin-1-yl] -2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-oxo-1- (2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl 2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) - 2-oxo-1- (2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (1'-methyl-4,4'-bipiperidinyl -1-yl) -1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 - (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (7-methyl-2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (4-methylpiperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-methyl-2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (7-methyl-2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (1-methylpiperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-methyl-2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl 1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2- (4-dimethylamino-piperidin-1-yl) - 1- (7-methyl-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2- (1'-methyl-4,4'-bipiperidinyl-1-yl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-4,4'-bipiperidinyl-1-yl-1 - (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (7-chloro-2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (4-methylpiperazin-1-yl) piperidin-1-yl] -2-oxo-ethyl} -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-2- (4-piperazin-1-yl-piperidin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid {1- (7-chloro-2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2- [4- (1-methylpiperidin-4-yl) piperazin-1-yl] -2-oxo-ethyl} -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2,3 dihydro-1H-benzimidazol-5ylmethyl) -2-oxo-2- (4-piperidin-4-yl-piperazin-1-yl) -ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [2-1,4'-bipiperidinyl-1'-yl 1- (7-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-5-ylmethyl) -2-oxo-ethyl] -amide, 4- (5-oxo-3-phenyl-4,5-dihydro-1,2,4-triazol-1-yl) -piperidine-1-carboxylic acid [1- (7-chloro-2-oxo-2,3 dihydro-1H-benzimidazol-5-ylmethyl) -2- (4-dimethylamino-piperidin-1-yl) -2-oxo-ethyl] -amide, 2- (1H-indazol-5-ylmethyl) -4- [4- (2-oxo-1,2,4,5-tetrahydro-benzo [d] [1,3] diazepin-3-yl) -piperidine 1-yl] -1- (4-pyrrolidin-1-yl-piperidin-1-yl) -butan-1,4-dione, 4- (2-oxo-1,2,4,5-tetrahydro-benzo [d] [1,3] diazepin-3-yl) -piperidine-1-carboxylic acid [1- (1H-indazol-5-ylmethyl ) -2-oxo-2- (4-pyrrolidin-1-yl-piperidin-1-yl) -ethyl] -amide.
Die nachfolgenden Beispiele beschreiben die Herstellung pharmazeutischer Anwendungsformen, die als Wirkstoff eine beliebige Verbindung der allgemeinen Formel (I) enthalten:The The following examples describe the preparation of pharmaceutical Forms of use, as the active ingredient any compound of general formula (I) include:
Beispiel I:Example I:
Kapseln zur Pulverinhalation mit 1 mg WirkstoffCapsules for powder inhalation with 1 mg of active ingredient
Zusammensetzung:Composition:
1
Kapsel zur Pulverinhalation enthält:
Herstellungsverfahren:Production method:
Der Wirkstoff wird auf die für Inhalativa erforderliche Korngröße gemahlen. Der gemahlene Wirkstoff wird mit dem Milchzucker homogen gemischt. Die Mischung wird in Hartgelatinekapseln abgefüllt.Of the Active ingredient will be on the for Inhalativa required grain size ground. The ground active substance is mixed homogeneously with the milk sugar. The mixture is filled into hard gelatin capsules.
Beispiel II:Example II:
Inhalationslösung für Respimat® mit 1 mg WirkstoffInhalation solution for Respimat ® with 1 mg active substance
Zusammensetzung:Composition:
1
Hub enthält:
Herstellungsverfahren:Production method:
Der Wirkstoff und Benzalkoniumchlorid werden in Wasser gelöst und in Respimat®-Kartuschen abgefüllt.The active ingredient and benzalkonium chloride are dissolved in water and filled into Respimat ® cartridges.
Beispiel III:Example III:
Inhalationslösung für Vernebler mit 1 mg WirkstoffInhalation solution for nebulizers with 1 mg of active ingredient
Zusammensetzung:Composition:
1
Fläschchen
enthält:
Herstellungsverfahren:Production method:
Wirkstoff, Natriumchlorid und Benzalkoniumchlorid werden in Wasser gelöst.agent Sodium chloride and benzalkonium chloride are dissolved in water.
Beispiel IV:Example IV:
Treibgas-Dosieraerosol mit 1 mg WirkstoffLPG metered with 1 mg of active ingredient
Zusammensetzung:Composition:
1
Hub enthält:
Herstellungsverfahren:Production method:
Der mikronisierte Wirkstoff wird in dem Gemisch aus Lecithin und Treibgas homogen suspendiert. Die Suspension wird in einen Druckbehälter mit Dosierventil abgefüllt.Of the Micronized drug is in the mixture of lecithin and propellant homogeneously suspended. The suspension is in a pressure vessel with Dispensed filling valve.
Beispiel V:Example V:
Nasalspray mit 1 mg WirkstoffNasal spray with 1 mg of active ingredient
Zusammensetzung:
Herstellunasverfahren:Herstellunasverfahren:
Der Wirkstoff und die Hilfsstoffe werden in Wasser gelöst und in ein entsprechendes Behältnis abgefüllt.Of the Active ingredient and the excipients are dissolved in water and in a corresponding container bottled.
Beispiel VI:Example VI:
Injektionslösung mit 5 mg Wirksubstanz pro 5 mlSolution for injection with 5 mg of active substance per 5 ml
Zusammensetzung:
Herstellung:production:
Glykofurol und Glucose in Wasser für Injektionszwecke auflösen (Wfl); Human-Serum-Albumin zugeben; Wirkstoff unter Erwärmen auflösen; mit Wfl auf Ansatzvolumen auffüllen; unter Stickstoff-Begasung in Ampullen abfüllen.glycofurol and glucose in water for Dissolve injections (Wfl); Human serum albumin release; Active ingredient with heating dissolve; fill with Wfl to batch volume; Fill into ampoules under nitrogen fumigation.
Beispiel VII:Example VII:
Injektionslösung mit 100 mg Wirksubstanz pro 20 mlSolution for injection with 100 mg of active substance per 20 ml
Zusammensetzung:
Herstellung:production:
Polysorbat 80, Natriumchlorid, Monokaliumdihydrogenphosphat und Dinatriumhydrogenphosphat in Wasser für Injektionszwecke (Wfl) auflösen; Human-Serum-Albumin zugeben; Wirkstoff unter Erwärmen auflösen; mit Wfl auf Ansatzvolumen auffüllen; in Ampullen abfüllen.polysorbate 80, sodium chloride, monopotassium dihydrogen phosphate and disodium hydrogen phosphate in water for Injection (Wfl) dissolve; Add human serum albumin; Dissolve active ingredient with heating; with Wfl on batch volume fill up; fill in ampoules.
Beispiel VIII:Example VIII:
Lyophilisat mit 10 mg WirksubstanzLyophilisate with 10 mg active substance
Zusammensetzung:
Herstellung:production:
Mannit in Wasser für Injektionszwecke (Wfl) auflösen; Human-Serum-Albumin zugeben; Wirkstoff unter Erwärmen auflösen; mit Wfl auf Ansatzvolumen auffüllen; in Vials abfüllen; gefriertrocknen.mannitol in water for Injection (Wfl) dissolve; Add human serum albumin; Dissolve active ingredient with heating; with Wfl on batch volume fill up; to fill in vials; freeze-dry.
Lösungsmittel
für Lyophilisat:
Herstellung:production:
Polysorbat 80 und Mannit in Wasser für Injektionszwecke (Wfl) auflösen; in Ampullen abfüllen.polysorbate 80 and mannitol in water for Injection (Wfl) dissolve; fill in ampoules.
Beispiel IX:Example IX:
Tabletten mit 20 mg WirksubstanzTablets containing 20 mg of active substance
Zusammensetzung:
Herstellung:production:
Wirksubstanz, Lactose und Maisstärke homogen mischen; mit einer wässerigen Lösung von Povidon granulieren; mit Magnesiumstearat mischen; auf einer Tablettenpresse abpressen; Tablettengewicht 200 mg.Active substance, Lactose and corn starch mix homogeneously; with a watery solution granulate of povidone; mix with magnesium stearate; on a Press off tablet press; Tablet weight 200 mg.
Beispiel X:Example X:
Kapseln mit 20 mg WirksubstanzCapsules with 20 mg active substance
Zusammensetzung:
Herstellung:production:
Wirksubstanz, Maisstärke und Kieselsäure homogen mischen; mit Magnesiumstearat mischen; Mischung auf einer Kapselfüllmaschine in Hartgelatine-Kapseln Grösse 3 abfüllen.Active substance, corn starch and silica mix homogeneously; mix with magnesium stearate; Mix on one capsule in hard gelatin capsules size 3 fill.
Beispiel XI:Example XI:
Zäpfchen mit 50 mg WirksubstanzSuppository with 50 mg active substance
Zusammensetzung:
Herstellung:production:
Hartfett bei ca. 38°C aufschmelzen; gemahlene Wirksubstanz im geschmolzenen Hartfett homogen dispergieren; nach Abkühlen auf ca. 35°C in vorgekühlte Formen ausgiessen.hard fat at about 38 ° C melt; homogeneously disperse the ground active substance in the molten hard fat; after cooling to about 35 ° C in pre-cooled Pour out molds.
Beispiel XII:Example XII:
Injektionslösung mit 10 mg Wirksubstanz pro 1 mlSolution for injection with 10 mg of active substance per 1 ml
Zusammensetzung:
Herstellung:production:
Mannitol in Wasser für Injektionszwecke auflösen (Wfl); Human-Serum-Albumin zugeben; Wirkstoff unter Erwärmen auflösen; mit Wfl auf Ansatzvolumen auffüllen; unter Stickstoff-Begasung in Ampullen abfüllen.mannitol in water for Dissolve injections (Wfl); Add human serum albumin; Dissolve active ingredient with heating; With Fill Wfl to batch volume; Fill into ampoules under nitrogen fumigation.
Claims (10)
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200410028751 DE102004028751A1 (en) | 2004-06-15 | 2004-06-15 | New 4-heterocyclyl-1-acyl-piperidine derivatives, useful e.g. for treating headache, diabetes and cardiovascular disease, are antagonists of calcitonin-gene related peptide |
| PCT/EP2005/002082 WO2005084672A1 (en) | 2004-03-03 | 2005-02-26 | Selected cgrp-antagonists, method for the production and use thereof as medicaments |
| EP05715592A EP1722792A1 (en) | 2004-03-03 | 2005-02-26 | Selected cgrp-antagonists, method for the production and use thereof as medicaments |
| US11/073,341 US7205294B2 (en) | 2004-03-03 | 2005-03-03 | Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE200410028751 DE102004028751A1 (en) | 2004-06-15 | 2004-06-15 | New 4-heterocyclyl-1-acyl-piperidine derivatives, useful e.g. for treating headache, diabetes and cardiovascular disease, are antagonists of calcitonin-gene related peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE102004028751A1 true DE102004028751A1 (en) | 2006-01-05 |
Family
ID=35483244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE200410028751 Withdrawn DE102004028751A1 (en) | 2004-03-03 | 2004-06-15 | New 4-heterocyclyl-1-acyl-piperidine derivatives, useful e.g. for treating headache, diabetes and cardiovascular disease, are antagonists of calcitonin-gene related peptide |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE102004028751A1 (en) |
-
2004
- 2004-06-15 DE DE200410028751 patent/DE102004028751A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1558600B1 (en) | Selected cgrp antagonists, method for production and use thereof as medicament | |
| EP1487821B1 (en) | Benzodiazepine-substituted piperidines for utilization in the treatment of cardiovascular diseases | |
| DE10250082A1 (en) | Selected CGRP antagonists, process for their preparation and their use as pharmaceuticals | |
| EP1732917B1 (en) | Selected cgrp antagonists, methods for the production thereof and their use as medicaments | |
| EP1722792A1 (en) | Selected cgrp-antagonists, method for the production and use thereof as medicaments | |
| EP1587795B1 (en) | N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) -1-piperidincarboxamid-derivatives and related compounds use as cgrp-antagonists for treating a headache | |
| EP1228059B1 (en) | Novel cyclopropanes as cgrp antagonists, medicaments containing said compounds and method for the production thereof | |
| DE102004019492A1 (en) | Selected CGRP antagonists, process for their preparation and their use as pharmaceuticals | |
| WO2005100360A1 (en) | Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments | |
| EP1737842B1 (en) | Selected cgrp antagonists, method for producing the same and the use thereof as drugs | |
| WO2001032649A1 (en) | Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof | |
| EP1863799A1 (en) | Cgrp-antagonists, process for their preparation as well as their use as medicaments | |
| DE19963868A1 (en) | New substituted piperidines, pharmaceutical compositions containing these compounds and process for their preparation | |
| WO2007036532A2 (en) | Selected cgrp antagonists, methods for the production thereof and their use as medicaments | |
| EP1737860A1 (en) | Selected cgrp-antagonists, their preparation processes and their use as medicaments | |
| DE102004028751A1 (en) | New 4-heterocyclyl-1-acyl-piperidine derivatives, useful e.g. for treating headache, diabetes and cardiovascular disease, are antagonists of calcitonin-gene related peptide | |
| DE102004010254A1 (en) | New 4-heterocyclyl-1-acyl-piperidine derivatives, useful e.g. for treating headache, diabetes and cardiovascular disease, are antagonists of calcitonin-gene related peptide | |
| EP1863791A1 (en) | 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R012 | Request for examination validly filed |
Effective date: 20110519 |
|
| R119 | Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee |
Effective date: 20120103 |